Glioblastoma Multiforme: PARADIGM pathway analysis of mRNA expression data
Maintained by TCGA GDAC Team (Broad Institute/MD Anderson Cancer Center/Harvard Medical School)
Overview
Introduction

PAthway Representation and Analysis by Direct Inference on Graphical Models (PARADIGM) predicts the activity of a diverse set of molecular concepts such as genes, complexes, and processes. The predicted activities are called Inferred Pathway Levels (IPLs) and are derived from a probabilistic belief propagation strategy that incorporates multimodal data such as copy number and gene expression estimates with a concept's pathway context.

Summary

There were 48 significant pathways identified in this analysis.

Table 1.  Get Full Table Top 10 out of 131 pathways in order of significance.

Pathway.Name Avg.Num.Perturbations
TCGA08_retinoblastoma 228
Glypican 2 network 225
HIF-1-alpha transcription factor network 214
FOXM1 transcription factor network 205
Osteopontin-mediated events 129
Endothelins 129
Syndecan-1-mediated signaling events 122
EGFR-dependent Endothelin signaling events 118
amb2 Integrin signaling 109
LPA receptor mediated events 104
Results
Summary Table

The following list describes the columns found in Table 2.

  • Pathway.Name = Full pathway name of curated PARADIGM pathway

  • Avg.Num.Perturbations = Average number of samples with perturbations across the pathway concepts determined by a background permutation model (>2 standard deviations away from the permuted distribution)

  • Total.Perturbations = Total number of perturbed concepts across all samples (>2 standard deviations away from the permuted distribution)

  • Num.Entities = Number of concepts that belong to the pathway

  • Min.Mean.Truth = Minimum IPL for concepts in the pathway among real samples

  • Max.Mean.Truth = Maximum IPL for concepts in the pathway among real samples

  • Min.Mean.Within = Minimum IPL for concepts in the pathway among null samples using "within permutation" (values are permuted across genes)

  • Max.Mean.Within = Maximum IPL for concepts in the pathway among null samples using "within permutation" (values are permuted across genes)

  • Min.Mean.Any = Minimum IPL for concepts in the pathway among null samples using "any permutation" (values are permuted across samples and genes)

  • Max.Mean.Any = Maximum IPL for concepts in the pathway among null samples using "any permutation" (values are permuted across samples and genes).

Table 2.  Get Full Table This summary table provides a report of cancer type specific pathway perturbations. Click on the links in the first column to display more detailed results for each pathway.

Pathway.Name Avg.Num.Perturbations Total.Perturbations Num.Entities Min.Mean.Truth Max.Mean.Truth Min.Mean.Within Max.Mean.Within Min.Mean.Any Max.Mean.Within.1
TCGA08_retinoblastoma 228 1824 8 -0.23 0.072 1000 -1000 -0.004 -1000
Glypican 2 network 225 900 4 -0.23 0 1000 -1000 0 -1000
HIF-1-alpha transcription factor network 214 16314 76 -0.55 0.023 1000 -1000 -0.012 -1000
FOXM1 transcription factor network 205 10479 51 -0.75 0.017 1000 -1000 -0.048 -1000
Osteopontin-mediated events 129 4921 38 -0.32 0.017 1000 -1000 0 -1000
Endothelins 129 12399 96 -0.47 0.083 1000 -1000 -0.011 -1000
Syndecan-1-mediated signaling events 122 4165 34 -0.29 0.018 1000 -1000 -0.001 -1000
EGFR-dependent Endothelin signaling events 118 2490 21 -0.14 0.017 1000 -1000 -0.007 -1000
amb2 Integrin signaling 109 8959 82 -0.24 0.022 1000 -1000 -0.002 -1000
LPA receptor mediated events 104 10679 102 -0.18 0.017 1000 -1000 -0.027 -1000
PLK1 signaling events 90 7674 85 -0.25 0.022 1000 -1000 -0.01 -1000
BARD1 signaling events 85 4867 57 -0.26 0.049 1000 -1000 -0.017 -1000
Syndecan-4-mediated signaling events 80 5371 67 -0.39 0.021 1000 -1000 -0.01 -1000
HIF-2-alpha transcription factor network 75 3240 43 -0.21 0.11 1000 -1000 -0.032 -1000
Wnt signaling 71 497 7 -0.12 0.017 1000 -1000 0.004 -1000
Fc-epsilon receptor I signaling in mast cells 67 6588 97 -0.19 0.032 1000 -1000 -0.029 -1000
TCGA08_p53 67 474 7 -0.024 0.009 1000 -1000 -0.003 -1000
Aurora B signaling 67 4502 67 -0.31 0.023 1000 -1000 -0.011 -1000
VEGFR1 specific signals 64 3600 56 -0.25 0.039 1000 -1000 -0.006 -1000
Signaling events mediated by VEGFR1 and VEGFR2 62 7775 125 -0.25 0.026 1000 -1000 -0.037 -1000
Regulation of nuclear SMAD2/3 signaling 61 8312 136 -0.28 0.16 1000 -1000 -0.01 -1000
PDGFR-alpha signaling pathway 57 2541 44 -0.25 0.023 1000 -1000 0 -1000
FAS signaling pathway (CD95) 54 2538 47 -0.045 0.031 1000 -1000 -0.01 -1000
Stabilization and expansion of the E-cadherin adherens junction 53 3985 74 -0.35 0.033 1000 -1000 -0.029 -1000
Noncanonical Wnt signaling pathway 51 1341 26 -0.12 0.017 1000 -1000 -0.021 -1000
Paxillin-independent events mediated by a4b1 and a4b7 51 1905 37 -0.27 0.042 1000 -1000 -0.006 -1000
S1P1 pathway 50 1804 36 -0.21 0.022 1000 -1000 -0.031 -1000
Class I PI3K signaling events 50 3653 73 -0.094 0.035 1000 -1000 -0.003 -1000
Circadian rhythm pathway 48 1075 22 -0.046 0.026 1000 -1000 -0.01 -1000
Aurora A signaling 46 2775 60 -0.16 0.042 1000 -1000 -0.002 -1000
Ras signaling in the CD4+ TCR pathway 46 791 17 -0.095 0.016 1000 -1000 -0.004 -1000
E-cadherin signaling in keratinocytes 45 1938 43 -0.14 0.028 1000 -1000 -0.007 -1000
Plasma membrane estrogen receptor signaling 44 3847 86 -0.42 0.13 1000 -1000 -0.032 -1000
IL1-mediated signaling events 41 2591 62 -0.12 0.049 1000 -1000 -0.014 -1000
Signaling events mediated by Stem cell factor receptor (c-Kit) 41 3251 78 -0.047 0.032 1000 -1000 -0.014 -1000
Integrins in angiogenesis 40 3397 84 -0.22 0.04 1000 -1000 -0.015 -1000
BCR signaling pathway 39 3891 99 -0.088 0.048 1000 -1000 -0.032 -1000
Angiopoietin receptor Tie2-mediated signaling 36 3220 88 -0.2 0.037 1000 -1000 -0.045 -1000
Syndecan-2-mediated signaling events 35 2442 69 -0.19 0.034 1000 -1000 -0.001 -1000
Syndecan-3-mediated signaling events 35 1229 35 -0.14 0.032 1000 -1000 -0.005 -1000
Signaling events mediated by HDAC Class I 34 3633 104 -0.13 0.034 1000 -1000 -0.018 -1000
Glypican 1 network 32 1552 48 -0.22 0.028 1000 -1000 -0.005 -1000
Regulation of cytoplasmic and nuclear SMAD2/3 signaling 31 735 23 -0.086 0.018 1000 -1000 -0.005 -1000
Visual signal transduction: Cones 29 1104 38 -0.13 0.04 1000 -1000 -0.001 -1000
Nongenotropic Androgen signaling 29 1554 52 -0.059 0.027 1000 -1000 -0.013 -1000
Signaling mediated by p38-alpha and p38-beta 28 1269 44 -0.044 0.033 1000 -1000 0 -1000
S1P3 pathway 28 1176 42 -0.21 0.022 1000 -1000 0 -1000
Paxillin-dependent events mediated by a4b1 27 994 36 -0.27 0.042 1000 -1000 -0.008 -1000
ErbB2/ErbB3 signaling events 26 1699 65 -0.094 0.022 1000 -1000 -0.02 -1000
Signaling events mediated by PRL 26 893 34 -0.038 0.025 1000 -1000 -0.006 -1000
Arf6 downstream pathway 25 1094 43 -0.016 0.025 1000 -1000 -0.012 -1000
HIV-1 Nef: Negative effector of Fas and TNF-alpha 25 1166 45 -0.13 0.026 1000 -1000 -0.007 -1000
Caspase cascade in apoptosis 24 1783 74 -0.13 0.024 1000 -1000 -0.012 -1000
TRAIL signaling pathway 24 1197 48 -0.02 0.022 1000 -1000 -0.002 -1000
RXR and RAR heterodimerization with other nuclear receptor 24 1262 52 -0.24 0.051 1000 -1000 0 -1000
Canonical Wnt signaling pathway 24 1269 51 -0.11 0.099 1000 -1000 -0.01 -1000
IL6-mediated signaling events 24 1831 75 -0.2 0.034 1000 -1000 -0.022 -1000
Signaling events mediated by PTP1B 23 1753 76 -0.2 0.033 1000 -1000 -0.007 -1000
FoxO family signaling 23 1474 64 -0.2 0.022 1000 -1000 -0.007 -1000
Presenilin action in Notch and Wnt signaling 22 1362 61 -0.092 0.035 1000 -1000 -0.008 -1000
TCGA08_rtk_signaling 22 585 26 -0.14 0.021 1000 -1000 0 -1000
Regulation of Telomerase 22 2273 102 -0.14 0.044 1000 -1000 -0.035 -1000
Ceramide signaling pathway 21 1648 76 -0.13 0.039 1000 -1000 -0.006 -1000
E-cadherin signaling in the nascent adherens junction 20 1576 76 -0.086 0.039 1000 -1000 -0.032 -1000
Coregulation of Androgen receptor activity 19 1481 76 -0.34 0.047 1000 -1000 -0.001 -1000
BMP receptor signaling 19 1580 81 -0.086 0.047 1000 -1000 -0.031 -1000
Glucocorticoid receptor regulatory network 19 2261 114 -0.099 0.075 1000 -1000 -0.025 -1000
ceramide signaling pathway 19 936 49 -0.13 0.025 1000 -1000 -0.003 -1000
Calcineurin-regulated NFAT-dependent transcription in lymphocytes 19 1309 68 -0.19 0.083 1000 -1000 -0.023 -1000
IL23-mediated signaling events 19 1180 60 -0.025 0.047 1000 -1000 -0.03 -1000
IFN-gamma pathway 18 1251 68 -0.064 0.043 1000 -1000 -0.033 -1000
IL2 signaling events mediated by PI3K 18 1067 58 -0.043 0.037 1000 -1000 -0.011 -1000
Neurotrophic factor-mediated Trk receptor signaling 18 2274 120 -0.12 0.05 1000 -1000 -0.022 -1000
EPO signaling pathway 17 963 55 -0.033 0.053 1000 -1000 -0.01 -1000
Retinoic acid receptors-mediated signaling 17 1040 58 -0.18 0.068 1000 -1000 -0.002 -1000
TCR signaling in naïve CD8+ T cells 17 1596 93 -0.094 0.033 1000 -1000 -0.021 -1000
Lissencephaly gene (LIS1) in neuronal migration and development 16 883 54 -0.086 0.026 1000 -1000 -0.008 -1000
Regulation of p38-alpha and p38-beta 16 909 54 -0.053 0.033 1000 -1000 -0.002 -1000
IL2 signaling events mediated by STAT5 16 354 22 -0.096 0.042 1000 -1000 -0.003 -1000
p75(NTR)-mediated signaling 15 1901 125 -0.12 0.082 1000 -1000 -0.032 -1000
Canonical NF-kappaB pathway 14 548 39 -0.13 0.06 1000 -1000 -0.002 -1000
ErbB4 signaling events 14 991 69 -0.14 0.05 1000 -1000 -0.011 -1000
IL4-mediated signaling events 14 1343 91 -0.15 0.05 1000 -1000 -0.1 -1000
PDGFR-beta signaling pathway 14 1429 97 -0.066 0.04 1000 -1000 -0.029 -1000
IL12-mediated signaling events 13 1191 87 -0.22 0.048 1000 -1000 -0.061 -1000
Signaling mediated by p38-gamma and p38-delta 13 208 15 -0.013 0.025 1000 -1000 -0.005 -1000
Insulin Pathway 13 1019 74 -0.11 0.048 1000 -1000 -0.024 -1000
Cellular roles of Anthrax toxin 12 474 39 -0.084 0.016 1000 -1000 -0.011 -1000
IGF1 pathway 12 733 57 -0.032 0.034 1000 -1000 -0.009 -1000
Arf6 signaling events 11 743 62 -0.14 0.044 1000 -1000 -0.001 -1000
Nectin adhesion pathway 11 693 63 -0.086 0.054 1000 -1000 -0.032 -1000
JNK signaling in the CD4+ TCR pathway 10 186 17 -0.017 0.027 1000 -1000 -0.005 -1000
Thromboxane A2 receptor signaling 10 1120 105 -0.14 0.035 1000 -1000 -0.035 -1000
Class I PI3K signaling events mediated by Akt 10 728 68 -0.026 0.036 1000 -1000 -0.004 -1000
Hypoxic and oxygen homeostasis regulation of HIF-1-alpha 10 351 33 -0.039 0.041 1000 -1000 -0.003 -1000
E-cadherin signaling events 10 51 5 0.004 0.023 1000 -1000 0.006 -1000
Signaling events activated by Hepatocyte Growth Factor Receptor (c-Met) 9 781 85 -0.084 0.049 1000 -1000 -0.015 -1000
EPHB forward signaling 9 820 85 -0.094 0.048 1000 -1000 -0.03 -1000
Calcium signaling in the CD4+ TCR pathway 9 299 31 -0.081 0.055 1000 -1000 -0.02 -1000
Sumoylation by RanBP2 regulates transcriptional repression 9 257 27 -0.036 0.036 1000 -1000 -0.022 -1000
Sphingosine 1-phosphate (S1P) pathway 8 234 28 -0.036 0.024 1000 -1000 -0.002 -1000
Signaling events mediated by the Hedgehog family 8 463 52 -0.03 0.045 1000 -1000 -0.003 -1000
Hedgehog signaling events mediated by Gli proteins 8 549 65 -0.065 0.042 1000 -1000 -0.007 -1000
Aurora C signaling 8 58 7 -0.005 0.02 1000 -1000 0 -1000
Arf6 trafficking events 8 581 71 -0.026 0.028 1000 -1000 -0.007 -1000
mTOR signaling pathway 7 396 53 -0.1 0.034 1000 -1000 -0.028 -1000
Signaling events mediated by HDAC Class III 7 294 40 -0.034 0.038 1000 -1000 -0.013 -1000
Ephrin B reverse signaling 7 369 48 -0.016 0.026 1000 -1000 -0.014 -1000
Signaling events regulated by Ret tyrosine kinase 6 556 82 -0.021 0.043 1000 -1000 -0.027 -1000
S1P5 pathway 6 104 17 -0.036 0.017 1000 -1000 -0.006 -1000
Atypical NF-kappaB pathway 6 191 31 -0.012 0.033 1000 -1000 0 -1000
Nephrin/Neph1 signaling in the kidney podocyte 5 179 34 -0.027 0.047 1000 -1000 -0.009 -1000
FOXA2 and FOXA3 transcription factor networks 5 264 46 -0.017 0.19 1000 -1000 -0.002 -1000
p38 MAPK signaling pathway 5 250 44 -0.02 0.048 1000 -1000 -0.008 -1000
Regulation of Androgen receptor activity 5 402 70 -0.028 0.067 1000 -1000 -0.004 -1000
Insulin-mediated glucose transport 4 132 32 -0.01 0.021 1000 -1000 -0.001 -1000
Reelin signaling pathway 4 268 56 -0.003 0.08 1000 -1000 -0.001 -1000
S1P4 pathway 4 124 25 -0.036 0.022 1000 -1000 0 -1000
Signaling events mediated by HDAC Class II 3 237 75 -0.029 0.043 1000 -1000 -0.02 -1000
a4b1 and a4b7 Integrin signaling 3 17 5 0.013 0.023 1000 -1000 0.004 -1000
Role of Calcineurin-dependent NFAT signaling in lymphocytes 3 269 83 -0.061 0.047 1000 -1000 -0.007 -1000
IL27-mediated signaling events 3 200 51 -0.025 0.044 1000 -1000 -0.03 -1000
LPA4-mediated signaling events 1 12 12 0 0.014 1000 -1000 -0.003 -1000
Effects of Botulinum toxin 1 41 26 0 0.035 1000 -1000 0 -1000
Arf1 pathway 1 68 54 0 0.027 1000 -1000 -0.003 -1000
Alternative NF-kappaB pathway 1 22 13 0 0.049 1000 -1000 0 -1000
PLK2 and PLK4 events 0 0 3 0.012 0.017 1000 -1000 0.004 -1000
Ephrin A reverse signaling 0 2 7 0 0.023 1000 -1000 0 -1000
Rapid glucocorticoid signaling 0 4 20 0 0.017 1000 -1000 0 -1000
Visual signal transduction: Rods 0 5 52 0 0.042 1000 -1000 -0.003 -1000
Class IB PI3K non-lipid kinase events 0 0 3 -0.017 0.017 1000 -1000 -0.003 -1000
Total 4483 250367 7203 -16 5.1 131000 -131000 -1.7 -131000
TCGA08_retinoblastoma

Figure S1.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S1.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
CDKN2B 0 0.018 -10000 0 -10000 0 0
CDKN2C -0.23 0.21 -10000 0 -0.41 310 310
CDKN2A -0.013 0.13 -10000 0 -0.38 58 58
CCND2 0.043 0.061 0.089 311 -10000 0 311
RB1 -0.048 0.068 -10000 0 -0.097 311 311
CDK4 0.031 0.071 0.14 115 -0.081 87 202
CDK6 0.072 0.073 0.13 321 -10000 0 321
G1/S progression 0.048 0.068 0.097 311 -10000 0 311
Glypican 2 network

Figure S2.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S2.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
MDK -0.23 0.21 -9999 0 -0.41 300 300
GPC2 0 0 -9999 0 -10000 0 0
GPC2/Midkine -0.16 0.15 -9999 0 -0.29 300 300
neuron projection morphogenesis -0.16 0.15 -9999 0 -0.29 300 300
HIF-1-alpha transcription factor network

Figure S3.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S3.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
PKM2 -0.45 0.47 -10000 0 -0.79 301 301
HDAC7 -0.006 0.012 -10000 0 -10000 0 0
HIF1A/ARNT/Cbp/p300/Src-1 -0.34 0.37 0.36 28 -0.65 269 297
SMAD4 -0.085 0.18 -10000 0 -0.41 127 127
ID2 -0.45 0.47 -10000 0 -0.79 300 300
AP1 -0.047 0.13 -10000 0 -0.29 125 125
ABCG2 -0.45 0.47 -10000 0 -0.79 302 302
HIF1A -0.062 0.08 -10000 0 -0.14 143 143
TFF3 -0.45 0.47 -10000 0 -0.79 303 303
GATA2 0.017 0.019 -10000 0 -0.41 1 1
AKT1 -0.055 0.082 0.26 2 -0.14 82 84
response to hypoxia -0.068 0.068 0.3 1 -0.13 226 227
MCL1 -0.45 0.47 -10000 0 -0.8 301 301
NDRG1 -0.45 0.47 -10000 0 -0.79 301 301
SERPINE1 -0.52 0.53 -10000 0 -0.88 313 313
FECH -0.45 0.47 -10000 0 -0.79 301 301
FURIN -0.45 0.47 -10000 0 -0.79 301 301
NCOA2 0.019 0.001 -10000 0 -10000 0 0
EP300 -0.026 0.12 0.43 6 -0.19 6 12
HMOX1 -0.55 0.53 -10000 0 -0.9 329 329
BHLHE40 -0.45 0.47 -10000 0 -0.8 301 301
BHLHE41 -0.45 0.47 -10000 0 -0.8 301 301
HIF1A/ARNT/SMAD3/SMAD4/SP1 -0.1 0.13 -10000 0 -0.3 99 99
ENG -0.07 0.15 0.35 3 -0.3 88 91
JUN 0.017 0.019 -10000 0 -0.41 1 1
RORA -0.45 0.47 -10000 0 -0.79 300 300
ABCB1 -0.093 0.087 -10000 0 -0.18 213 213
TFRC -0.45 0.47 -10000 0 -0.79 303 303
CXCR4 -0.54 0.53 -10000 0 -0.88 324 324
TF -0.42 0.47 -10000 0 -0.81 270 270
CITED2 -0.45 0.48 -10000 0 -0.8 301 301
HIF1A/ARNT -0.49 0.57 0.48 28 -0.93 284 312
LDHA -0.052 0.054 -10000 0 -10000 0 0
ETS1 -0.45 0.47 -10000 0 -0.79 301 301
PGK1 -0.45 0.47 -10000 0 -0.79 301 301
NOS2 -0.45 0.47 -10000 0 -0.8 301 301
ITGB2 -0.52 0.53 -10000 0 -0.89 310 310
ALDOA -0.45 0.47 -10000 0 -0.79 301 301
Cbp/p300/CITED2 -0.45 0.48 -10000 0 -0.83 284 284
FOS -0.084 0.18 -10000 0 -0.41 125 125
HK2 -0.45 0.47 -10000 0 -0.79 301 301
SP1 0.023 0.008 -10000 0 -10000 0 0
GCK -0.037 0.17 0.58 5 -0.26 6 11
HK1 -0.45 0.47 -10000 0 -0.8 299 299
NPM1 -0.45 0.47 -10000 0 -0.79 302 302
EGLN1 -0.45 0.47 -10000 0 -0.79 301 301
CREB1 0.023 0.002 -10000 0 -10000 0 0
PGM1 -0.45 0.47 -10000 0 -0.79 301 301
SMAD3 0.017 0.003 -10000 0 -10000 0 0
EDN1 -0.036 0.15 0.51 1 -0.29 42 43
IGFBP1 -0.45 0.47 -10000 0 -0.8 302 302
VEGFA -0.41 0.42 -10000 0 -0.71 316 316
HIF1A/JAB1 -0.033 0.054 -10000 0 -0.4 2 2
CP -0.49 0.51 -10000 0 -0.85 308 308
CXCL12 -0.45 0.48 -10000 0 -0.8 301 301
COPS5 0.018 0.001 -10000 0 -10000 0 0
SMAD3/SMAD4 -0.048 0.13 -10000 0 -0.28 127 127
BNIP3 -0.45 0.47 -10000 0 -0.79 301 301
EGLN3 -0.45 0.47 -10000 0 -0.79 301 301
CA9 -0.46 0.48 -10000 0 -0.81 302 302
TERT -0.45 0.47 -10000 0 -0.79 301 301
ENO1 -0.45 0.47 -10000 0 -0.79 301 301
PFKL -0.45 0.47 -10000 0 -0.79 301 301
NCOA1 0.017 0.003 -10000 0 -10000 0 0
ADM -0.55 0.52 -10000 0 -0.87 334 334
ARNT -0.063 0.07 -10000 0 -0.14 91 91
HNF4A 0.021 0 -10000 0 -10000 0 0
ADFP -0.52 0.52 -10000 0 -0.88 316 316
SLC2A1 -0.32 0.36 -10000 0 -0.64 268 268
LEP -0.45 0.47 -10000 0 -0.79 301 301
HIF1A/ARNT/Cbp/p300 -0.35 0.38 0.36 28 -0.68 269 297
EPO -0.18 0.28 0.52 6 -0.44 229 235
CREBBP -0.026 0.12 0.43 6 -0.19 6 12
HIF1A/ARNT/Cbp/p300/HDAC7 -0.39 0.4 0.35 28 -0.7 297 325
PFKFB3 -0.45 0.47 -10000 0 -0.79 301 301
NT5E -0.47 0.48 -10000 0 -0.81 306 306
FOXM1 transcription factor network

Figure S4.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S4.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
NFATC3 -0.55 0.55 -9999 0 -1 275 275
PLK1 -0.03 0.098 -9999 0 -0.46 22 22
BIRC5 -0.18 0.23 -9999 0 -0.46 212 212
HSPA1B -0.56 0.55 -9999 0 -1 275 275
MAP2K1 -0.013 0.036 -9999 0 -10000 0 0
BRCA2 -0.55 0.55 -9999 0 -1 273 273
FOXM1 -0.75 0.8 -9999 0 -1.3 304 304
XRCC1 -0.55 0.55 -9999 0 -1 275 275
FOXM1B/p19 -0.63 0.61 -9999 0 -1.1 284 284
Cyclin D1/CDK4 -0.6 0.55 -9999 0 -1 289 289
CDC2 -0.63 0.63 -9999 0 -1.2 275 275
TGFA -0.49 0.48 -9999 0 -0.91 271 271
SKP2 -0.55 0.55 -9999 0 -1 271 271
CCNE1 0.005 0.05 -9999 0 -0.42 7 7
CKS1B -0.59 0.58 -9999 0 -1.1 279 279
RB1 -0.26 0.23 -9999 0 -0.47 233 233
FOXM1C/SP1 -0.68 0.68 -9999 0 -1.2 278 278
AURKB -0.034 0.11 -9999 0 -0.46 27 27
CENPF -0.6 0.59 -9999 0 -1.1 281 281
CDK4 -0.27 0.21 -9999 0 -0.43 343 343
MYC -0.53 0.5 -9999 0 -0.93 292 292
CHEK2 -0.025 0.085 -9999 0 -0.46 16 16
ONECUT1 -0.55 0.54 -9999 0 -1 276 276
CDKN2A -0.031 0.13 -9999 0 -0.41 58 58
LAMA4 -0.55 0.55 -9999 0 -1 276 276
FOXM1B/HNF6 -0.68 0.68 -9999 0 -1.3 276 276
FOS -0.59 0.56 -9999 0 -1 292 292
SP1 0.016 0.006 -9999 0 -10000 0 0
CDC25B -0.56 0.56 -9999 0 -1 277 277
response to radiation -0.02 0.026 -9999 0 -10000 0 0
CENPB -0.56 0.56 -9999 0 -1 274 274
CENPA -0.57 0.58 -9999 0 -1.1 275 275
NEK2 -0.56 0.56 -9999 0 -1 275 275
HIST1H2BA -0.56 0.55 -9999 0 -1 275 275
CCNA2 -0.1 0.19 -9999 0 -0.43 139 139
EP300 0.017 0 -9999 0 -10000 0 0
CCNB1/CDK1 -0.71 0.71 -9999 0 -1.3 284 284
CCNB2 -0.65 0.6 -9999 0 -1.1 298 298
CCNB1 -0.64 0.63 -9999 0 -1.2 282 282
ETV5 -0.55 0.55 -9999 0 -1 273 273
ESR1 -0.55 0.55 -9999 0 -1 275 275
CCND1 -0.56 0.53 -9999 0 -1 278 278
GSK3A -0.009 0.029 -9999 0 -10000 0 0
Cyclin A-E1/CDK1-2 -0.075 0.16 -9999 0 -0.31 146 146
CDK2 -0.011 0.097 -9999 0 -0.43 27 27
G2/M transition of mitotic cell cycle -0.024 0.033 -9999 0 -10000 0 0
FOXM1B/Cbp/p300 -0.61 0.62 -9999 0 -1.1 275 275
GAS1 -0.57 0.56 -9999 0 -1 280 280
MMP2 -0.63 0.57 -9999 0 -1.1 302 302
RB1/FOXM1C -0.59 0.55 -9999 0 -1 284 284
CREBBP 0.017 0 -9999 0 -10000 0 0
Osteopontin-mediated events

Figure S5.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S5.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
IKK alpha homodimer -0.066 0.13 -9999 0 -0.23 186 186
NF kappa B1 p50/RelA/I kappa B alpha -0.056 0.14 -9999 0 -0.3 83 83
alphaV/beta3 Integrin/Osteopontin/Src -0.097 0.16 -9999 0 -0.31 185 185
AP1 -0.2 0.22 -9999 0 -0.43 203 203
ILK -0.08 0.13 -9999 0 -0.24 185 185
bone resorption -0.21 0.16 -9999 0 -0.31 306 306
PTK2B 0.017 0 -9999 0 -10000 0 0
PYK2/p130Cas -0.065 0.14 -9999 0 -0.23 200 200
ITGAV 0 0.074 -9999 0 -0.42 16 16
mol:GTP 0 0 -9999 0 -10000 0 0
CD44/Rho Family GTPase/ROCK2 -0.22 0.13 -9999 0 -0.28 416 416
alphaV/beta3 Integrin/Osteopontin -0.076 0.15 -9999 0 -0.27 185 185
MAP3K1 -0.082 0.13 -9999 0 -0.25 186 186
JUN 0.014 0.019 -9999 0 -0.41 1 1
MAPK3 -0.079 0.14 -9999 0 -0.25 185 185
MAPK1 -0.08 0.14 -9999 0 -0.25 185 185
Rac1/GDP 0.013 0 -9999 0 -10000 0 0
NFKB1 0.014 0.037 -9999 0 -0.41 4 4
MAPK8 -0.084 0.12 -9999 0 -0.24 186 186
ITGB3 0.013 0.011 -9999 0 -10000 0 0
NFKBIA -0.075 0.14 -9999 0 -0.27 129 129
FOS -0.087 0.18 -9999 0 -0.42 125 125
CD44 -0.32 0.18 -9999 0 -0.41 416 416
CHUK 0.016 0.019 -9999 0 -0.41 1 1
PLAU -0.13 0.22 -9999 0 -0.48 131 131
NF kappa B1 p50/RelA -0.06 0.15 -9999 0 -0.33 83 83
BCAR1 0 0 -9999 0 -10000 0 0
RELA 0.017 0 -9999 0 -10000 0 0
alphaV beta3 Integrin 0.009 0.057 -9999 0 -0.29 16 16
mol:GDP 0 0 -9999 0 -10000 0 0
SYK -0.087 0.15 -9999 0 -0.26 200 200
VAV3 -0.093 0.14 -9999 0 -0.25 222 222
MAP3K14 -0.079 0.14 -9999 0 -0.25 185 185
ROCK2 0.017 0 -9999 0 -10000 0 0
SPP1 -0.14 0.21 -9999 0 -0.42 181 181
RAC1 0.017 0 -9999 0 -10000 0 0
Rac1/GTP -0.079 0.14 -9999 0 -0.22 222 222
MMP2 -0.24 0.24 -9999 0 -0.44 298 298
Endothelins

Figure S6.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S6.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
AKT1 -0.26 0.22 -10000 0 -0.42 293 293
PTK2B 0.017 0 -10000 0 -10000 0 0
mol:Ca2+ -0.039 0.099 -10000 0 -0.48 5 5
EDN1 -0.11 0.11 -10000 0 -0.24 143 143
EDN3 0.014 0.037 -10000 0 -0.41 4 4
EDN2 0.016 0.019 -10000 0 -0.41 1 1
HRAS/GDP -0.023 0.1 0.18 1 -0.22 53 54
ETA receptor/Endothelin-1/Gq/GTP/PLC beta -0.087 0.1 -10000 0 -0.2 177 177
ADCY4 -0.21 0.18 -10000 0 -0.35 291 291
ADCY5 -0.21 0.18 -10000 0 -0.35 291 291
ADCY6 -0.21 0.18 -10000 0 -0.34 291 291
ADCY7 -0.21 0.18 -10000 0 -0.35 291 291
ADCY1 -0.21 0.18 -10000 0 -0.34 291 291
ADCY2 -0.21 0.18 -10000 0 -0.34 291 291
ADCY3 -0.21 0.18 -10000 0 -0.35 291 291
ADCY8 -0.21 0.18 -10000 0 -0.34 293 293
ADCY9 -0.21 0.18 -10000 0 -0.34 291 291
arachidonic acid secretion -0.067 0.14 -10000 0 -0.3 104 104
ETB receptor/Endothelin-1/Gq/GTP -0.032 0.062 -10000 0 -0.18 38 38
GNAO1 0.002 0.005 -10000 0 -10000 0 0
HRAS 0.016 0.019 -10000 0 -0.41 1 1
ETA receptor/Endothelin-1/G12/GTP -0.23 0.21 0.25 1 -0.38 294 295
ETA receptor/Endothelin-1/Gs/GTP -0.22 0.2 0.24 1 -0.36 291 292
mol:GTP 0 0.003 -10000 0 -10000 0 0
COL3A1 -0.41 0.28 -10000 0 -0.55 400 400
EDNRB -0.046 0.11 -10000 0 -0.42 40 40
response to oxidative stress 0 0 -10000 0 -10000 0 0
CYSLTR2 -0.26 0.21 -10000 0 -0.41 291 291
CYSLTR1 -0.26 0.21 -10000 0 -0.35 396 396
SLC9A1 -0.13 0.11 -10000 0 -0.21 291 291
mol:GDP -0.03 0.11 0.18 1 -0.23 55 56
SLC9A3 -0.084 0.12 -10000 0 -0.37 31 31
RAF1 -0.05 0.12 -10000 0 -0.26 96 96
JUN -0.041 0.098 -10000 0 -0.38 8 8
JAK2 -0.26 0.22 -10000 0 -0.42 291 291
mol:IP3 -0.077 0.09 -10000 0 -0.18 165 165
ETA receptor/Endothelin-1 -0.3 0.25 0.28 1 -0.41 396 397
PLCB1 0.016 0.002 -10000 0 -10000 0 0
PLCB2 0.016 0.003 -10000 0 -10000 0 0
ETA receptor/Endothelin-3 -0.16 0.18 -10000 0 -0.43 155 155
FOS -0.075 0.18 -10000 0 -0.38 125 125
Gai/GDP -0.47 0.17 -10000 0 -0.52 482 482
CRK 0.017 0 -10000 0 -10000 0 0
mol:Ca ++ -0.23 0.21 -10000 0 -0.38 296 296
BCAR1 0 0 -10000 0 -10000 0 0
PRKCB1 -0.015 0.046 -10000 0 -0.19 18 18
GNAQ 0.018 0.004 -10000 0 -10000 0 0
GNAZ 0.015 0.006 -10000 0 -10000 0 0
GNAL 0.017 0 -10000 0 -10000 0 0
Gs family/GDP -0.023 0.1 0.17 1 -0.22 53 54
ETA receptor/Endothelin-1/Gq/GTP -0.11 0.12 -10000 0 -0.25 181 181
MAPK14 -0.018 0.052 -10000 0 -0.17 24 24
TRPC6 -0.04 0.1 -10000 0 -0.37 11 11
GNAI2 0.017 0.001 -10000 0 -10000 0 0
GNAI3 -0.036 0.14 -10000 0 -0.41 65 65
GNAI1 0.014 0.02 -10000 0 -0.41 1 1
ETB receptor/Endothelin-1/Gq/GTP/PLC beta -0.021 0.055 -10000 0 -0.17 25 25
ETB receptor/Endothelin-2 -0.022 0.082 -10000 0 -0.29 41 41
ETB receptor/Endothelin-3 -0.023 0.085 -10000 0 -0.29 44 44
ETB receptor/Endothelin-1 -0.11 0.12 -10000 0 -0.25 167 167
MAPK3 -0.068 0.17 -10000 0 -0.35 127 127
MAPK1 -0.072 0.17 -10000 0 -0.35 127 127
Rac1/GDP -0.022 0.1 0.18 1 -0.22 53 54
cAMP biosynthetic process -0.17 0.16 -10000 0 -0.3 266 266
MAPK8 -0.053 0.11 -10000 0 -0.26 41 41
SRC 0.017 0 -10000 0 -10000 0 0
ETB receptor/Endothelin-1/Gi/GTP -0.033 0.078 -10000 0 -0.2 87 87
p130Cas/CRK/Src/PYK2 0.005 0.098 -10000 0 -0.26 15 15
mol:K + 0 0 -10000 0 -10000 0 0
G12/GDP -0.024 0.1 0.18 1 -0.22 55 56
COL1A2 -0.35 0.29 -10000 0 -0.57 304 304
EntrezGene:2778 0 0 -10000 0 -10000 0 0
ETA receptor/Endothelin-2 -0.16 0.18 -10000 0 -0.42 157 157
mol:DAG -0.077 0.09 -10000 0 -0.18 165 165
MAP2K2 -0.06 0.14 -10000 0 -0.3 116 116
MAP2K1 -0.059 0.15 -10000 0 -0.3 116 116
EDNRA -0.24 0.23 -10000 0 -0.41 279 279
positive regulation of muscle contraction -0.22 0.19 -10000 0 -0.36 293 293
Gq family/GDP 0.033 0.097 -10000 0 -0.24 18 18
HRAS/GTP -0.04 0.1 -10000 0 -0.2 89 89
PRKCH -0.071 0.09 -10000 0 -0.18 154 154
RAC1 0.017 0 -10000 0 -10000 0 0
PRKCA -0.07 0.088 -10000 0 -0.18 154 154
PRKCB -0.075 0.088 -10000 0 -0.18 165 165
PRKCE -0.071 0.087 -10000 0 -0.18 154 154
PRKCD -0.071 0.089 -10000 0 -0.18 154 154
PRKCG -0.071 0.089 -10000 0 -0.18 154 154
regulation of vascular smooth muscle contraction -0.08 0.19 -10000 0 -0.4 127 127
PRKCQ -0.072 0.088 -10000 0 -0.18 154 154
PLA2G4A -0.071 0.15 -10000 0 -0.31 104 104
GNA14 0.016 0.027 -10000 0 -0.41 2 2
GNA15 0.012 0.049 -10000 0 -0.41 7 7
GNA12 0.014 0.037 -10000 0 -0.41 4 4
GNA11 0.017 0.003 -10000 0 -10000 0 0
Rac1/GTP -0.23 0.21 0.25 1 -0.38 291 292
MMP1 0.083 0.15 0.19 242 -0.34 43 285
Syndecan-1-mediated signaling events

Figure S7.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S7.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
TGFB1 -0.005 0.094 -9999 0 -0.41 27 27
CCL5 -0.006 0.096 -9999 0 -0.41 28 28
SDCBP 0.017 0 -9999 0 -10000 0 0
FGFR/FGF2/Syndecan-1 -0.077 0.14 -9999 0 -0.21 219 219
mol:PI-4-5-P2 0 0 -9999 0 -10000 0 0
RP11-540L11.1 0 0 -9999 0 -10000 0 0
Syndecan-1/Laminin-5 -0.072 0.14 -9999 0 -0.3 109 109
Syndecan-1/Syntenin -0.067 0.14 -9999 0 -0.3 100 100
MAPK3 -0.19 0.16 -9999 0 -0.25 395 395
HGF/MET 0.018 0.046 -9999 0 -0.28 12 12
TGFB1/TGF beta receptor Type II -0.005 0.094 -9999 0 -0.41 27 27
BSG 0.017 0 -9999 0 -10000 0 0
keratinocyte migration -0.071 0.14 -9999 0 -0.3 109 109
Syndecan-1/RANTES -0.077 0.16 -9999 0 -0.33 107 107
Syndecan-1/CD147 -0.2 0.17 -9999 0 -0.27 395 395
Syndecan-1/Syntenin/PIP2 -0.065 0.13 -9999 0 -0.29 100 100
LAMA5 0.006 0.069 -9999 0 -0.41 14 14
positive regulation of cell-cell adhesion -0.064 0.13 -9999 0 -0.28 100 100
MMP7 -0.046 0.15 -9999 0 -0.41 78 78
HGF 0.015 0.026 -9999 0 -0.41 2 2
Syndecan-1/CASK -0.074 0.13 -9999 0 -0.3 100 100
Syndecan-1/HGF/MET -0.062 0.14 -9999 0 -0.29 108 108
regulation of cell adhesion -0.18 0.15 -9999 0 -0.32 216 216
HPSE -0.019 0.12 -9999 0 -0.41 44 44
positive regulation of cell migration -0.077 0.14 -9999 0 -0.21 219 219
SDC1 -0.078 0.14 -9999 0 -0.21 219 219
Syndecan-1/Collagen -0.077 0.14 -9999 0 -0.21 219 219
PPIB -0.29 0.2 -9999 0 -0.41 374 374
MET 0.009 0.058 -9999 0 -0.41 10 10
PRKACA 0.017 0 -9999 0 -10000 0 0
MMP9 -0.13 0.2 -9999 0 -0.41 179 179
MAPK1 -0.19 0.16 -9999 0 -0.25 393 393
homophilic cell adhesion -0.077 0.14 -9999 0 -0.21 219 219
MMP1 -0.018 0.12 -9999 0 -0.41 43 43
EGFR-dependent Endothelin signaling events

Figure S8.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S8.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
HRAS 0.016 0.019 -9999 0 -0.41 1 1
EGFR -0.14 0.21 -9999 0 -0.41 194 194
EGF/EGFR -0.11 0.14 -9999 0 -0.22 304 304
EGF/EGFR dimer/SHC/GRB2/SOS1 -0.067 0.12 -9999 0 -0.2 237 237
mol:GTP 0 0 -9999 0 -10000 0 0
EDNRA -0.11 0.2 -9999 0 -0.41 154 154
response to oxidative stress 0 0 -9999 0 -10000 0 0
EGF 0.015 0.026 -9999 0 -0.41 2 2
EGF/EGFR dimer/SHC -0.088 0.14 -9999 0 -0.24 238 238
mol:GDP -0.068 0.12 -9999 0 -0.2 237 237
mol:Ca2+ 0 0 -9999 0 -10000 0 0
EDN1 0.01 0.055 -9999 0 -0.41 9 9
GRB2/SOS1 0.013 0.001 -9999 0 -10000 0 0
HRAS/GTP -0.066 0.1 -9999 0 -0.18 238 238
SHC1 -0.021 0.12 -9999 0 -0.41 47 47
HRAS/GDP -0.062 0.11 -9999 0 -0.18 238 238
FRAP1 -0.07 0.11 -9999 0 -0.19 237 237
EGF/EGFR dimer -0.09 0.15 -9999 0 -0.28 196 196
SOS1 0 0 -9999 0 -10000 0 0
GRB2 0.017 0.002 -9999 0 -10000 0 0
ETA receptor/Endothelin-1 -0.07 0.15 -9999 0 -0.29 158 158
amb2 Integrin signaling

Figure S9.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S9.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
alphaM/beta2 Integrin/proMMP-2 -0.2 0.18 -9999 0 -0.31 357 357
alphaM/beta2 Integrin/GPIbA -0.079 0.14 -9999 0 -0.24 221 221
alphaM/beta2 Integrin/proMMP-9 -0.16 0.19 -9999 0 -0.31 299 299
PLAUR -0.021 0.12 -9999 0 -0.41 47 47
HMGB1 0.015 0.011 -9999 0 -10000 0 0
alphaM/beta2 Integrin/Talin -0.1 0.16 -9999 0 -0.26 242 242
AGER 0.012 0.04 -9999 0 -0.43 4 4
RAP1A 0.017 0 -9999 0 -10000 0 0
SELPLG 0.017 0 -9999 0 -10000 0 0
mol:LDL 0 0 -9999 0 -10000 0 0
alphaM/beta2 Integrin/RAGE/HMGB1 -0.065 0.14 -9999 0 -0.22 223 223
mol:GTP 0 0 -9999 0 -10000 0 0
MMP9 -0.13 0.2 -9999 0 -0.41 179 179
CYR61 -0.12 0.2 -9999 0 -0.41 163 163
TLN1 -0.02 0.12 -9999 0 -0.41 46 46
Rap1/GTP -0.037 0.09 -9999 0 -0.18 110 110
RHOA 0.017 0.001 -9999 0 -10000 0 0
P-selectin oligomer 0.016 0.019 -9999 0 -0.41 1 1
MYH2 -0.024 0.096 -9999 0 -0.23 58 58
MST1R 0.015 0.026 -9999 0 -0.41 2 2
leukocyte activation during inflammatory response -0.062 0.12 -9999 0 -0.2 224 224
APOB 0.015 0.032 -9999 0 -0.41 3 3
mol:GDP 0 0 -9999 0 -10000 0 0
complement component iC3b receptor activity 0 0 -9999 0 -10000 0 0
MMP2 -0.19 0.21 -9999 0 -0.41 251 251
JAM3 0.016 0.019 -9999 0 -0.41 1 1
GP1BA 0.017 0 -9999 0 -10000 0 0
alphaM/beta2 Integrin/CTGF -0.096 0.15 -9999 0 -0.26 236 236
alphaM/beta2 Integrin -0.046 0.1 -9999 0 -0.22 111 111
JAM3 homodimer 0.016 0.019 -9999 0 -0.41 1 1
ICAM2 0.015 0.032 -9999 0 -0.41 3 3
ICAM1 0.002 0.078 -9999 0 -0.41 18 18
phagocytosis triggered by activation of immune response cell surface activating receptor -0.046 0.1 -9999 0 -0.22 111 111
cell adhesion -0.079 0.14 -9999 0 -0.24 221 221
NFKB1 -0.07 0.15 -9999 0 -0.22 237 237
THY1 0.012 0.008 -9999 0 -10000 0 0
RhoA/GDP 0.013 0.001 -9999 0 -10000 0 0
Lipoprotein(a) 0.022 0.02 -9999 0 -0.24 3 3
alphaM/beta2 Integrin/LRP/tPA -0.18 0.18 -9999 0 -0.28 353 353
IL6 -0.08 0.18 -9999 0 -0.5 56 56
ITGB2 -0.16 0.21 -9999 0 -0.42 221 221
elevation of cytosolic calcium ion concentration -0.13 0.21 -9999 0 -0.32 256 256
alphaM/beta2 Integrin/JAM2/JAM3 -0.097 0.14 -9999 0 -0.23 267 267
JAM2 -0.044 0.15 -9999 0 -0.41 75 75
alphaM/beta2 Integrin/ICAM1 -0.061 0.13 -9999 0 -0.21 231 231
alphaM/beta2 Integrin/uPA/Plg -0.11 0.18 -9999 0 -0.28 255 255
RhoA/GTP -0.029 0.1 -9999 0 -0.2 109 109
positive regulation of phagocytosis -0.089 0.16 -9999 0 -0.31 148 148
Ron/MSP 0.021 0.038 -9999 0 -0.28 8 8
alphaM/beta2 Integrin/uPAR/uPA -0.13 0.21 -9999 0 -0.32 256 256
alphaM/beta2 Integrin/uPAR -0.099 0.17 -9999 0 -0.28 227 227
PLAU -0.083 0.18 -9999 0 -0.41 123 123
PLAT -0.18 0.21 -9999 0 -0.41 244 244
actin filament polymerization -0.023 0.093 -9999 0 -0.2 83 83
MST1 0.012 0.045 -9999 0 -0.41 6 6
alphaM/beta2 Integrin/lipoprotein(a) -0.06 0.12 -9999 0 -0.2 224 224
TNF -0.062 0.14 -9999 0 -0.39 42 42
RAP1B 0 0 -9999 0 -10000 0 0
alphaM/beta2 Integrin/uPA -0.13 0.19 -9999 0 -0.32 255 255
fibrinolysis -0.11 0.18 -9999 0 -0.28 255 255
HCK -0.053 0.16 -9999 0 -0.41 86 86
dendritic cell antigen processing and presentation -0.046 0.1 -9999 0 -0.22 111 111
VTN 0.015 0.026 -9999 0 -0.41 2 2
alphaM/beta2 Integrin/CYR61 -0.15 0.19 -9999 0 -0.31 286 286
LPA 0.017 0 -9999 0 -10000 0 0
LRP1 0.002 0.078 -9999 0 -0.41 18 18
cell migration -0.24 0.22 -9999 0 -0.35 389 389
FN1 -0.065 0.17 -9999 0 -0.41 101 101
alphaM/beta2 Integrin/Thy1 -0.077 0.12 -9999 0 -0.24 187 187
MPO 0.017 0 -9999 0 -10000 0 0
KNG1 0.016 0.019 -9999 0 -0.41 1 1
RAP1/GDP 0.012 0 -9999 0 -10000 0 0
ROCK1 -0.024 0.096 -9999 0 -0.2 83 83
ELA2 0.017 0 -9999 0 -10000 0 0
PLG 0.017 0 -9999 0 -10000 0 0
CTGF -0.014 0.11 -9999 0 -0.41 38 38
alphaM/beta2 Integrin/Hck -0.12 0.19 -9999 0 -0.32 224 224
ITGAM 0.015 0.011 -9999 0 -10000 0 0
alphaM/beta2 Integrin/P-Selectin/PSGL1 -0.063 0.13 -9999 0 -0.21 221 221
HP -0.051 0.16 -9999 0 -0.41 84 84
leukocyte adhesion -0.074 0.12 -9999 0 -0.31 61 61
SELP 0.016 0.019 -9999 0 -0.41 1 1
LPA receptor mediated events

Figure S10.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S10.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
GNB1/GNG2 -0.069 0.091 -10000 0 -0.16 251 251
NF kappa B1 p50/RelA/I kappa B alpha -0.008 0.053 -10000 0 -0.21 5 5
AP1 -0.1 0.12 -10000 0 -0.19 303 303
mol:PIP3 -0.12 0.11 -10000 0 -0.24 194 194
AKT1 -0.032 0.073 0.17 3 -0.21 9 12
PTK2B -0.041 0.059 -10000 0 -0.1 251 251
RHOA -0.035 0.049 -10000 0 -0.15 6 6
PIK3CB 0.017 0.001 -10000 0 -10000 0 0
mol:Ca2+ -0.008 0.029 -10000 0 -10000 0 0
MAGI3 0 0.001 -10000 0 -0.003 13 13
RELA 0.017 0 -10000 0 -10000 0 0
apoptosis -0.098 0.12 -10000 0 -0.19 285 285
HRAS/GDP 0.012 0.013 -10000 0 -0.29 1 1
positive regulation of microtubule depolymerization -0.006 0.069 0.13 57 -0.1 1 58
NF kappa B1 p50/RelA -0.055 0.06 -10000 0 -0.16 23 23
endothelial cell migration -0.18 0.21 -10000 0 -0.4 251 251
ADCY4 -0.015 0.054 -10000 0 -0.19 45 45
ADCY5 -0.015 0.054 -10000 0 -0.19 45 45
ADCY6 -0.015 0.053 -10000 0 -0.18 45 45
ADCY7 -0.016 0.056 -10000 0 -0.19 48 48
ADCY1 -0.015 0.053 -10000 0 -0.18 45 45
ADCY2 -0.015 0.053 -10000 0 -0.18 45 45
ADCY3 -0.015 0.054 -10000 0 -0.19 45 45
ADCY8 -0.015 0.054 -10000 0 -0.18 46 46
ADCY9 -0.015 0.053 -10000 0 -0.18 45 45
GSK3B -0.035 0.056 -10000 0 -0.094 251 251
arachidonic acid secretion -0.048 0.069 -10000 0 -0.13 198 198
GNG2 0 0.001 -10000 0 -0.004 23 23
TRIP6 -0.11 0.11 -10000 0 -0.21 285 285
GNAO1 -0.005 0.032 -10000 0 -0.18 16 16
HRAS 0.016 0.019 -10000 0 -0.41 1 1
NFKBIA -0.02 0.047 -10000 0 -0.13 8 8
GAB1 0.014 0.037 -10000 0 -0.41 4 4
mol:GTP 0 0 -10000 0 -10000 0 0
lamellipodium assembly 0.002 0.14 -10000 0 -0.7 21 21
JUN 0.016 0.019 -10000 0 -0.41 1 1
LPA/LPA2/NHERF2 -0.024 0.04 -10000 0 -10000 0 0
TIAM1 -0.008 0.16 -10000 0 -0.8 21 21
PIK3R1 0.016 0.004 -10000 0 -10000 0 0
mol:IP3 -0.009 0.03 -10000 0 -0.1 7 7
PLCB3 -0.017 0.035 -10000 0 -10000 0 0
FOS -0.084 0.18 -10000 0 -0.41 125 125
positive regulation of mitosis -0.048 0.069 -10000 0 -0.13 198 198
LPA/LPA1-2-3 -0.077 0.088 -10000 0 -0.17 251 251
mol:Ca ++ 0 0 -10000 0 -10000 0 0
JNK cascade 0 0 -10000 0 -10000 0 0
BCAR1 0 0 -10000 0 -10000 0 0
stress fiber formation -0.041 0.065 -10000 0 -0.11 251 251
GNAZ -0.068 0.097 -10000 0 -0.18 216 216
EGFR/PI3K-beta/Gab1 -0.12 0.12 -10000 0 -0.25 194 194
positive regulation of dendritic cell cytokine production -0.077 0.087 -10000 0 -0.17 251 251
LPA/LPA2/MAGI-3 -0.032 0.036 -10000 0 -0.07 251 251
ARHGEF1 -0.06 0.089 -10000 0 -0.15 252 252
GNAI2 -0.079 0.1 -10000 0 -0.18 251 251
GNAI3 -0.11 0.13 -10000 0 -0.22 282 282
GNAI1 -0.072 0.098 -10000 0 -0.18 223 223
LPA/LPA3 -0.04 0.045 -10000 0 -0.087 251 251
LPA/LPA2 -0.04 0.045 -10000 0 -0.087 251 251
LPA/LPA1 -0.1 0.12 -10000 0 -0.23 251 251
HB-EGF/EGFR -0.16 0.16 -10000 0 -0.27 320 320
HBEGF -0.086 0.14 -10000 0 -0.29 179 179
mol:DAG -0.009 0.03 -10000 0 -0.1 7 7
cAMP biosynthetic process 0.001 0.089 0.15 9 -0.16 50 59
NFKB1 0.014 0.037 -10000 0 -0.41 4 4
SRC 0.017 0 -10000 0 -10000 0 0
GNB1 0.017 0.002 -10000 0 -10000 0 0
LYN -0.039 0.073 -10000 0 -0.19 64 64
GNAQ -0.023 0.035 -10000 0 -0.063 15 15
LPAR2 0 0.001 -10000 0 -0.003 15 15
LPAR3 0 0 -10000 0 -10000 0 0
LPAR1 -0.063 0.07 -10000 0 -0.14 251 251
IL8 -0.16 0.15 -10000 0 -0.28 296 296
PTK2 -0.065 0.084 -10000 0 -0.15 251 251
Rac1/GDP 0.013 0 -10000 0 -10000 0 0
CASP3 -0.098 0.12 -10000 0 -0.19 285 285
EGFR -0.14 0.21 -10000 0 -0.41 194 194
PLCG1 -0.016 0.033 -10000 0 -0.1 9 9
PLD2 -0.065 0.084 -10000 0 -0.15 251 251
G12/G13 -0.064 0.1 -10000 0 -0.17 252 252
PI3K-beta -0.054 0.06 -10000 0 -0.2 5 5
cell migration -0.046 0.059 -10000 0 -0.21 21 21
SLC9A3R2 0.017 0 -10000 0 -10000 0 0
PXN -0.041 0.066 -10000 0 -0.11 251 251
HRAS/GTP -0.049 0.07 -10000 0 -0.14 196 196
RAC1 0.017 0 -10000 0 -10000 0 0
MMP9 -0.13 0.2 -10000 0 -0.41 179 179
PRKCE 0.017 0.001 -10000 0 -10000 0 0
PRKCD -0.005 0.028 -10000 0 -10000 0 0
Gi(beta/gamma) -0.017 0.056 -10000 0 -0.19 50 50
mol:LPA -0.063 0.07 -10000 0 -0.14 251 251
TRIP6/p130 Cas/FAK1/Paxillin -0.11 0.1 -10000 0 -0.16 381 381
MAPKKK cascade -0.048 0.069 -10000 0 -0.13 198 198
contractile ring contraction involved in cytokinesis -0.035 0.049 -10000 0 -0.16 7 7
mol:GDP 0 0 -10000 0 -10000 0 0
GNA14 -0.024 0.036 -10000 0 -0.18 2 2
GNA15 -0.026 0.043 -10000 0 -0.24 7 7
GNA12 0.014 0.037 -10000 0 -0.41 4 4
GNA13 0.016 0.026 -10000 0 -0.41 2 2
MAPT -0.022 0.048 -10000 0 -0.11 1 1
GNA11 -0.023 0.035 -10000 0 -0.064 4 4
Rac1/GTP 0.002 0.15 -10000 0 -0.73 21 21
MMP2 -0.18 0.21 -10000 0 -0.41 251 251
PLK1 signaling events

Figure S11.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S11.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
regulation of centriole-centriole cohesion 0.006 0.012 0.041 37 -10000 0 37
BUB1B -0.098 0.12 -10000 0 -0.21 242 242
PLK1 -0.012 0.035 -10000 0 -0.12 37 37
PLK1S1 -0.008 0.02 -10000 0 -0.066 37 37
KIF2A -0.006 0.033 0.14 2 -0.14 19 21
regulation of mitotic centrosome separation -0.012 0.035 -10000 0 -0.12 37 37
GOLGA2 0.017 0 -10000 0 -10000 0 0
Hec1/SPC24 -0.074 0.12 -10000 0 -0.23 185 185
WEE1 -0.099 0.11 -10000 0 -0.22 218 218
cytokinesis -0.1 0.14 -10000 0 -0.26 208 208
PP2A-alpha B56 0.004 0.038 -10000 0 -10000 0 0
AURKA -0.008 0.036 -10000 0 -0.15 25 25
PICH/PLK1 -0.2 0.2 -10000 0 -0.34 307 307
CENPE -0.034 0.094 -10000 0 -0.26 70 70
RhoA/GTP 0.013 0.001 -10000 0 -10000 0 0
positive regulation of microtubule depolymerization -0.006 0.033 0.14 2 -0.14 19 21
PPP2CA 0.017 0.001 -10000 0 -10000 0 0
FZR1 0.017 0 -10000 0 -10000 0 0
TPX2 -0.065 0.067 -10000 0 -0.12 296 296
PAK1 0.015 0.001 -10000 0 -10000 0 0
SPC24 0 0 -10000 0 -10000 0 0
FBXW11 0.017 0 -10000 0 -10000 0 0
CLSPN -0.001 0.019 -10000 0 -0.089 13 13
GORASP1 0.017 0 -10000 0 -10000 0 0
metaphase -0.001 0.002 -10000 0 -0.01 22 22
mol:GTP 0 0 -10000 0 -10000 0 0
NLP -0.008 0.02 -10000 0 -0.066 37 37
G2 phase of mitotic cell cycle -0.002 0.002 -10000 0 -0.01 25 25
STAG2 -0.005 0.094 -10000 0 -0.41 27 27
GRASP65/GM130/RAB1/GTP -0.011 0.028 -10000 0 -10000 0 0
spindle elongation -0.012 0.035 -10000 0 -0.12 37 37
ODF2 0.015 0.002 -10000 0 -10000 0 0
BUB1 -0.013 0.036 -10000 0 -0.24 4 4
TPT1 -0.003 0.02 -10000 0 -0.088 16 16
CDC25C 0.001 0.019 -10000 0 -0.099 7 7
CDC25B -0.007 0.074 -10000 0 -0.42 16 16
SGOL1 -0.006 0.012 -10000 0 -0.041 37 37
RHOA 0.017 0.001 -10000 0 -10000 0 0
CCNB1/CDK1 -0.2 0.2 -10000 0 -0.31 366 366
CDC14B 0.008 0.002 -10000 0 -10000 0 0
CDC20 -0.23 0.21 -10000 0 -0.41 304 304
PLK1/PBIP1 -0.18 0.083 -10000 0 -0.21 450 450
mitosis -0.003 0.005 0.016 9 -0.021 21 30
FBXO5 -0.084 0.11 -10000 0 -0.21 196 196
CDC2 -0.15 0.21 -10000 0 -0.42 194 194
NDC80 -0.13 0.2 -10000 0 -0.41 184 184
metaphase plate congression -0.002 0.021 -10000 0 -0.096 13 13
ERCC6L -0.2 0.2 -10000 0 -0.33 307 307
NLP/gamma Tubulin -0.008 0.024 -10000 0 -0.086 31 31
microtubule cytoskeleton organization -0.003 0.02 -10000 0 -0.088 16 16
G2/M transition DNA damage checkpoint -0.002 0.002 -10000 0 -0.008 21 21
PPP1R12A 0.016 0.019 -10000 0 -0.41 1 1
interphase -0.002 0.002 -10000 0 -0.008 21 21
PLK1/PRC1-2 -0.15 0.2 -10000 0 -0.35 249 249
GRASP65/GM130/RAB1/GTP/PLK1 0.019 0.032 -10000 0 -0.13 13 13
RAB1A 0.017 0 -10000 0 -10000 0 0
prophase 0 0 -10000 0 -10000 0 0
Aurora A/BORA -0.014 0.055 -10000 0 -0.22 30 30
mitotic prometaphase -0.001 0.001 -10000 0 -0.007 13 13
proteasomal ubiquitin-dependent protein catabolic process -0.028 0.048 -10000 0 -0.11 13 13
microtubule-based process -0.078 0.12 -10000 0 -0.24 187 187
Golgi organization -0.012 0.035 -10000 0 -0.12 37 37
Cohesin/SA2 -0.014 0.059 -10000 0 -0.18 50 50
PPP1CB/MYPT1 0.022 0.023 -10000 0 -0.29 3 3
KIF20A -0.13 0.2 -10000 0 -0.41 186 186
APC/C/CDC20 -0.13 0.13 -10000 0 -0.24 304 304
PPP2R1A 0.017 0.003 -10000 0 -10000 0 0
chromosome segregation -0.17 0.082 -10000 0 -0.2 450 450
PRC1 -0.16 0.21 -10000 0 -0.41 224 224
ECT2 -0.081 0.12 -10000 0 -0.24 183 183
C13orf34 -0.014 0.055 -10000 0 -0.25 24 24
NUDC -0.002 0.021 -10000 0 -0.096 13 13
regulation of attachment of spindle microtubules to kinetochore -0.097 0.12 -10000 0 -0.21 242 242
spindle assembly -0.01 0.031 -10000 0 -0.1 36 36
spindle stabilization -0.008 0.02 -10000 0 -0.066 37 37
APC/C/HCDH1 0.018 0.001 -10000 0 -10000 0 0
MKLP2/PLK1 -0.079 0.12 -10000 0 -0.24 187 187
CCNB1 -0.23 0.22 -10000 0 -0.42 296 296
PPP1CB 0.015 0.026 -10000 0 -0.41 2 2
BTRC 0.017 0 -10000 0 -10000 0 0
ROCK2 0.003 0.024 -10000 0 -0.12 7 7
TUBG1 -0.003 0.023 -10000 0 -0.11 15 15
G2/M transition of mitotic cell cycle -0.2 0.19 -10000 0 -0.34 307 307
MLF1IP -0.25 0.11 -10000 0 -0.3 450 450
INCENP 0.016 0.001 -10000 0 -10000 0 0
BARD1 signaling events

Figure S12.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S12.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
BARD1/CSTF1 -0.048 0.13 -10000 0 -0.28 126 126
ATM -0.003 0.091 -10000 0 -0.41 25 25
UBE2D3 0.017 0.001 -10000 0 -10000 0 0
PRKDC -0.002 0.088 -10000 0 -0.41 23 23
ATR 0.017 0 -10000 0 -10000 0 0
UBE2L3 0.017 0 -10000 0 -10000 0 0
FANCD2 0.005 0.042 -10000 0 -0.18 25 25
protein ubiquitination -0.035 0.14 -10000 0 -0.24 149 149
XRCC5 0.017 0 -10000 0 -10000 0 0
XRCC6 0.017 0 -10000 0 -10000 0 0
M/R/N Complex 0.035 0 -10000 0 -10000 0 0
MRE11A 0.017 0 -10000 0 -10000 0 0
DNA-PK 0.023 0.055 -10000 0 -0.23 23 23
FA complex/FANCD2/Ubiquitin 0 0.071 -10000 0 -0.17 68 68
FANCF 0.015 0.026 -10000 0 -0.41 2 2
BRCA1 0.013 0.042 -10000 0 -0.41 5 5
CCNE1 0.011 0.049 -10000 0 -0.41 7 7
CDK2/Cyclin E1 0.006 0.082 -10000 0 -0.32 30 30
FANCG -0.036 0.14 -10000 0 -0.41 66 66
BRCA1/BACH1/BARD1 -0.051 0.14 -10000 0 -0.29 127 127
FANCE 0.016 0.019 -10000 0 -0.41 1 1
FANCC 0.017 0 -10000 0 -10000 0 0
NBN 0.017 0 -10000 0 -10000 0 0
FANCA 0.017 0 -10000 0 -10000 0 0
DNA repair -0.14 0.16 -10000 0 -0.34 154 154
BRCA1/BARD1/ubiquitin -0.051 0.14 -10000 0 -0.29 127 127
BARD1/DNA-PK -0.026 0.12 -10000 0 -0.22 139 139
FANCL 0 0 -10000 0 -10000 0 0
mRNA polyadenylation 0.048 0.13 0.28 126 -10000 0 126
BRCA1/BARD1/CTIP/M/R/N Complex -0.1 0.1 -10000 0 -0.24 141 141
BRCA1/BACH1/BARD1/TopBP1 -0.032 0.12 -10000 0 -0.24 127 127
BRCA1/BARD1/P53 -0.048 0.15 -10000 0 -0.25 167 167
BARD1/CSTF1/BRCA1 -0.031 0.12 -10000 0 -0.24 127 127
BRCA1/BACH1 0.013 0.041 -10000 0 -0.41 5 5
BARD1 -0.085 0.18 -10000 0 -0.41 126 126
PCNA -0.26 0.2 -10000 0 -0.41 343 343
BRCA1/BARD1/UbcH5C -0.031 0.12 -10000 0 -0.24 127 127
BRCA1/BARD1/UbcH7 -0.031 0.12 -10000 0 -0.24 127 127
BRCA1/BARD1/RAD51/PCNA -0.17 0.17 -10000 0 -0.27 360 360
BARD1/DNA-PK/P53 -0.045 0.15 -10000 0 -0.24 172 172
BRCA1/BARD1/Ubiquitin -0.051 0.14 -10000 0 -0.29 127 127
BRCA1/BARD1/CTIP -0.22 0.16 -10000 0 -0.28 424 424
FA complex 0.01 0.051 -10000 0 -0.12 67 67
BARD1/EWS -0.048 0.13 -10000 0 -0.28 126 126
RBBP8 -0.23 0.14 -10000 0 -0.3 412 412
TP53 -0.039 0.14 -10000 0 -0.41 69 69
TOPBP1 0.016 0.019 -10000 0 -0.41 1 1
G1/S transition of mitotic cell cycle 0.049 0.14 0.25 167 -10000 0 167
BRCA1/BARD1 -0.032 0.15 -10000 0 -0.24 149 149
CSTF1 0.017 0 -10000 0 -10000 0 0
BARD1/EWS-Fli1 -0.059 0.13 -10000 0 -0.29 126 126
CDK2 -0.005 0.094 -10000 0 -0.41 27 27
UniProt:Q9BZD1 0 0 -10000 0 -10000 0 0
RAD51 0.017 0 -10000 0 -10000 0 0
RAD50 0.017 0 -10000 0 -10000 0 0
BRCA1/BARD1/DNA-directed RNA polymerase II holoenzyme -0.051 0.14 -10000 0 -0.29 127 127
EWSR1 0.017 0 -10000 0 -10000 0 0
Syndecan-4-mediated signaling events

Figure S13.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S13.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
PTK2 -0.031 0.099 -9999 0 -0.22 104 104
Syndecan-4/Syndesmos -0.066 0.12 -9999 0 -0.3 80 80
positive regulation of JNK cascade -0.15 0.17 -9999 0 -0.35 176 176
Syndecan-4/ADAM12 -0.058 0.13 -9999 0 -0.29 80 80
CCL5 -0.006 0.096 -9999 0 -0.41 28 28
Rac1/GDP 0.013 0 -9999 0 -10000 0 0
DNM2 0.017 0 -9999 0 -10000 0 0
ITGA5 -0.043 0.15 -9999 0 -0.41 74 74
SDCBP 0.017 0 -9999 0 -10000 0 0
PLG 0.019 0.005 -9999 0 -10000 0 0
ADAM12 0.016 0.019 -9999 0 -0.41 1 1
mol:GTP 0 0 -9999 0 -10000 0 0
NUDT16L1 0 0 -9999 0 -10000 0 0
mol:PI-4-5-P2 0 0 -9999 0 -10000 0 0
Syndecan-4/PKC alpha -0.025 0.04 -9999 0 -10000 0 0
Syndecan-4/Laminin alpha1 -0.066 0.12 -9999 0 -0.3 80 80
Syndecan-4/CXCL12/CXCR4 -0.15 0.18 -9999 0 -0.37 176 176
Syndecan-4/Laminin alpha3 -0.063 0.13 -9999 0 -0.3 89 89
MDK -0.23 0.21 -9999 0 -0.41 300 300
Syndecan-4/FZD7 -0.15 0.16 -9999 0 -0.36 148 148
Syndecan-4/Midkine -0.17 0.16 -9999 0 -0.36 173 173
FZD7 -0.18 0.21 -9999 0 -0.41 245 245
Syndecan-4/FGFR1/FGF -0.045 0.13 -9999 0 -0.27 83 83
THBS1 -0.018 0.12 -9999 0 -0.41 43 43
integrin-mediated signaling pathway -0.24 0.12 -9999 0 -0.36 229 229
positive regulation of MAPKKK cascade -0.15 0.17 -9999 0 -0.35 176 176
Syndecan-4/TACI -0.058 0.13 -9999 0 -0.29 80 80
CXCR4 -0.21 0.21 -9999 0 -0.41 276 276
cell adhesion -0.026 0.091 -9999 0 -0.2 102 102
Syndecan-4/Dynamin -0.058 0.13 -9999 0 -0.29 80 80
Syndecan-4/TSP1 -0.073 0.15 -9999 0 -0.33 96 96
Syndecan-4/GIPC -0.058 0.13 -9999 0 -0.29 80 80
Syndecan-4/RANTES -0.068 0.14 -9999 0 -0.32 90 90
ITGB1 0.017 0 -9999 0 -10000 0 0
LAMA1 0 0 -9999 0 -10000 0 0
LAMA3 0.005 0.071 -9999 0 -0.41 15 15
RAC1 0.017 0 -9999 0 -10000 0 0
PRKCA 0.021 0.03 -9999 0 -10000 0 0
Syndecan-4/alpha-Actinin -0.073 0.14 -9999 0 -0.31 95 95
TFPI -0.077 0.18 -9999 0 -0.41 116 116
F2 0.01 0.028 -9999 0 -0.42 2 2
alpha5/beta1 Integrin -0.018 0.11 -9999 0 -0.28 74 74
positive regulation of cell adhesion -0.064 0.13 -9999 0 -0.29 89 89
ACTN1 -0.017 0.12 -9999 0 -0.41 42 42
TNC -0.39 0.089 -9999 0 -0.41 505 505
Syndecan-4/CXCL12 -0.063 0.14 -9999 0 -0.31 83 83
FGF6 0.017 0 -9999 0 -10000 0 0
RHOA 0.017 0.001 -9999 0 -10000 0 0
CXCL12 0.005 0.071 -9999 0 -0.41 15 15
TNFRSF13B 0.017 0 -9999 0 -10000 0 0
FGF2 0.015 0.026 -9999 0 -0.41 2 2
FGFR1 0.015 0.026 -9999 0 -0.41 2 2
Syndecan-4/PI-4-5-P2 -0.066 0.12 -9999 0 -0.3 80 80
mol:GDP 0 0 -9999 0 -10000 0 0
FN1 -0.064 0.17 -9999 0 -0.41 101 101
cell migration -0.012 0.012 -9999 0 -10000 0 0
PRKCD 0.019 0.005 -9999 0 -10000 0 0
vasculogenesis -0.071 0.14 -9999 0 -0.32 96 96
SDC4 -0.063 0.13 -9999 0 -0.23 181 181
Syndecan-4/Tenascin C -0.24 0.13 -9999 0 -0.37 229 229
Syndecan-4/PI-4-5-P2/PKC alpha -0.024 0.029 -9999 0 -10000 0 0
Syndecan-4/Syntenin -0.058 0.13 -9999 0 -0.29 80 80
MMP9 -0.13 0.2 -9999 0 -0.41 179 179
Rac1/GTP -0.026 0.092 -9999 0 -0.2 101 101
cytoskeleton organization -0.064 0.12 -9999 0 -0.29 80 80
GIPC1 0.017 0 -9999 0 -10000 0 0
Syndecan-4/TFPI -0.1 0.15 -9999 0 -0.34 115 115
HIF-2-alpha transcription factor network

Figure S14.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S14.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
MMP14 -0.008 0.032 -10000 0 -0.41 2 2
oxygen homeostasis -0.008 0.013 -10000 0 -10000 0 0
TCEB2 0.017 0 -10000 0 -10000 0 0
TCEB1 0.017 0 -10000 0 -10000 0 0
VHL/Elongin B/Elongin C/HIF2A -0.017 0.075 -10000 0 -0.19 13 13
EPO -0.076 0.18 -10000 0 -0.28 182 182
FIH (dimer) 0.006 0.016 -10000 0 -10000 0 0
APEX1 0.005 0.021 -10000 0 -10000 0 0
SERPINE1 -0.18 0.28 -10000 0 -0.47 228 228
FLT1 -0.006 0.027 -10000 0 -10000 0 0
ADORA2A -0.11 0.2 -10000 0 -0.34 182 182
germ cell development -0.11 0.2 -10000 0 -0.34 182 182
SLC11A2 -0.11 0.21 -10000 0 -0.35 182 182
BHLHE40 -0.12 0.2 -10000 0 -0.35 182 182
HIF1AN 0.006 0.016 -10000 0 -10000 0 0
HIF2A/ARNT/SIRT1 -0.045 0.13 -10000 0 -0.26 40 40
ETS1 0.027 0.012 -10000 0 -10000 0 0
CITED2 -0.016 0.066 -10000 0 -0.4 14 14
KDR -0.016 0.077 -10000 0 -0.42 17 17
PGK1 -0.11 0.21 -10000 0 -0.35 182 182
SIRT1 0.017 0 -10000 0 -10000 0 0
response to hypoxia 0 0 -10000 0 -10000 0 0
HIF2A/ARNT -0.11 0.25 -10000 0 -0.39 182 182
EPAS1 -0.029 0.083 0.29 1 -0.22 13 14
SP1 0.023 0.004 -10000 0 -10000 0 0
ABCG2 -0.11 0.21 -10000 0 -0.35 183 183
EFNA1 -0.12 0.22 -10000 0 -0.36 191 191
FXN -0.11 0.2 -10000 0 -0.34 182 182
POU5F1 -0.12 0.2 -10000 0 -0.35 182 182
neuron apoptosis 0.11 0.24 0.38 182 -10000 0 182
EP300 0.017 0 -10000 0 -10000 0 0
EGLN3 0.003 0.042 -10000 0 -0.44 4 4
EGLN2 0.006 0.016 -10000 0 -10000 0 0
EGLN1 0.006 0.025 -10000 0 -0.42 1 1
VHL/Elongin B/Elongin C 0.023 0 -10000 0 -10000 0 0
VHL 0 0 -10000 0 -10000 0 0
ARNT 0.005 0.021 -10000 0 -10000 0 0
SLC2A1 -0.11 0.2 -10000 0 -0.34 183 183
TWIST1 -0.12 0.22 -10000 0 -0.36 192 192
ELK1 0.021 0.011 -10000 0 -10000 0 0
HIF2A/ARNT/Cbp/p300 -0.044 0.13 -10000 0 -0.26 40 40
VEGFA -0.21 0.28 -10000 0 -0.42 298 298
CREBBP 0.017 0 -10000 0 -10000 0 0
Wnt signaling

Figure S15.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S15.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
Noncanonical Wnts/FZD -0.047 0.1 -9999 0 -0.16 221 221
FZD6 -0.065 0.17 -9999 0 -0.41 101 101
WNT6 0.017 0 -9999 0 -10000 0 0
WNT4 0.015 0.026 -9999 0 -0.41 2 2
FZD3 0.014 0.032 -9999 0 -0.41 3 3
WNT5A -0.12 0.2 -9999 0 -0.41 168 168
WNT11 0.015 0.026 -9999 0 -0.41 2 2
Fc-epsilon receptor I signaling in mast cells

Figure S16.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S16.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
PPAP2A 0.016 0.019 -10000 0 -0.41 1 1
LAT2 -0.058 0.1 -10000 0 -0.26 66 66
AP1 -0.063 0.12 -10000 0 -0.27 99 99
mol:PIP3 -0.054 0.11 -10000 0 -0.27 66 66
IKBKB -0.026 0.07 -10000 0 -0.18 41 41
AKT1 -0.056 0.11 0.23 12 -0.31 17 29
IKBKG -0.026 0.07 -10000 0 -0.18 41 41
MS4A2 0.021 0.005 -10000 0 -10000 0 0
mol:Sphingosine-1-phosphate 0 0 -10000 0 -10000 0 0
PIK3CA -0.004 0.091 -10000 0 -0.41 25 25
MAP3K1 -0.041 0.095 -10000 0 -0.22 80 80
mol:Ca2+ -0.041 0.092 -10000 0 -0.21 66 66
LYN -0.038 0.14 -10000 0 -0.42 64 64
CBLB -0.057 0.1 -10000 0 -0.26 66 66
SHC1 -0.021 0.12 -10000 0 -0.41 47 47
RasGAP/p62DOK 0.024 0.044 -10000 0 -0.21 18 18
positive regulation of cell migration 0.009 0.001 -10000 0 -10000 0 0
INPP5D 0 0 -10000 0 -10000 0 0
PLD2 -0.078 0.1 -10000 0 -0.18 260 260
PTPN13 -0.049 0.1 -10000 0 -0.31 38 38
PTPN11 0.013 0.01 -10000 0 -10000 0 0
GO:0007205 0 0 -10000 0 -10000 0 0
regulation of mast cell degranulation -0.027 0.089 0.21 9 -0.2 40 49
SYK -0.015 0.11 -10000 0 -0.42 36 36
GRB2 0.017 0.002 -10000 0 -10000 0 0
LAT/PLCgamma1/GRB2/SLP76/GADs -0.078 0.1 -10000 0 -0.28 66 66
LAT -0.058 0.1 -10000 0 -0.26 67 67
PAK2 -0.048 0.1 -10000 0 -0.24 80 80
NFATC2 -0.039 0.04 -10000 0 -0.079 260 260
HRAS -0.046 0.099 -10000 0 -0.24 71 71
GAB2 0.016 0.019 -10000 0 -0.41 1 1
PLA2G1B 0.031 0.021 -10000 0 -10000 0 0
Fc epsilon R1 -0.1 0.14 -10000 0 -0.24 260 260
Antigen/IgE/Fc epsilon R1 -0.09 0.13 -10000 0 -0.22 260 260
mol:GDP -0.045 0.096 -10000 0 -0.23 69 69
JUN 0.016 0.019 -10000 0 -0.41 1 1
mol:Ca++ 0 0 -10000 0 -10000 0 0
PIK3R1 0.015 0.004 -10000 0 -10000 0 0
FOS -0.084 0.18 -10000 0 -0.41 125 125
Antigen/IgE/Fc epsilon R1/LYN/SYK -0.063 0.11 -10000 0 -0.16 260 260
CHUK -0.026 0.07 -10000 0 -0.18 42 42
KLRG1 -0.06 0.1 -10000 0 -0.24 76 76
VAV1 -0.059 0.1 -10000 0 -0.24 76 76
calcium-dependent protein kinase C activity 0 0 -10000 0 -10000 0 0
CBL -0.057 0.1 -10000 0 -0.24 76 76
negative regulation of mast cell degranulation -0.057 0.095 -10000 0 -0.25 66 66
BTK -0.047 0.094 -10000 0 -0.23 67 67
Fc epsilon R1/FcgammaRIIB/SHIP/RasGAP/p62DOK -0.07 0.11 -10000 0 -0.22 142 142
GAB2/PI3K/SHP2 -0.086 0.09 -10000 0 -0.22 73 73
Antigen/IgE/Fc epsilon R1/LYN/SYK/WIP -0.077 0.13 -10000 0 -0.18 268 268
RAF1 0.025 0.019 -10000 0 -10000 0 0
Fc epsilon R1/FcgammaRIIB/SHIP -0.13 0.17 -10000 0 -0.27 283 283
FCER1G -0.19 0.22 -10000 0 -0.41 256 256
FCER1A 0.005 0.059 -10000 0 -0.42 10 10
Antigen/IgE/Fc epsilon R1/Fyn -0.078 0.12 -10000 0 -0.2 260 260
MAPK3 0.032 0.02 -10000 0 -10000 0 0
MAPK1 0.028 0.027 -10000 0 -10000 0 0
NFKB1 0.014 0.037 -10000 0 -0.41 4 4
MAPK8 -0.004 0.076 -10000 0 -0.34 21 21
DUSP1 0.002 0.078 -10000 0 -0.41 18 18
NF-kappa-B/RelA -0.014 0.047 -10000 0 -0.12 40 40
actin cytoskeleton reorganization -0.043 0.099 -10000 0 -0.32 28 28
mol:Glucocorticoid Dexamethasone 0 0 -10000 0 -10000 0 0
PI3K -0.044 0.1 -10000 0 -0.24 76 76
FER -0.057 0.1 -10000 0 -0.24 76 76
RELA 0.017 0 -10000 0 -10000 0 0
ITK -0.011 0.032 -10000 0 -0.093 31 31
SOS1 0 0 -10000 0 -10000 0 0
PLCG1 -0.044 0.099 -10000 0 -0.24 66 66
cytokine secretion -0.02 0.026 -10000 0 -0.095 33 33
SPHK1 -0.065 0.11 -10000 0 -0.27 80 80
PTK2 -0.045 0.1 -10000 0 -0.33 28 28
NTAL/PLCgamma1/GRB2/SLP76/GADs -0.081 0.1 -10000 0 -0.29 66 66
EDG1 0.009 0.001 -10000 0 -10000 0 0
mol:DAG -0.05 0.11 -10000 0 -0.26 67 67
MAP2K2 0.026 0.016 -10000 0 -10000 0 0
MAP2K1 0.029 0.025 -10000 0 -10000 0 0
MAP2K7 0.017 0 -10000 0 -10000 0 0
KLRG1/SHP2 -0.055 0.1 -10000 0 -0.25 66 66
MAP2K4 -0.008 0.14 -10000 0 -0.72 21 21
Fc epsilon R1/FcgammaRIIB -0.14 0.18 -10000 0 -0.29 283 283
mol:Choline -0.077 0.1 -10000 0 -0.18 260 260
SHC/Grb2/SOS1 -0.063 0.12 -10000 0 -0.27 95 95
FYN 0.015 0.026 -10000 0 -0.41 2 2
DOK1 0.017 0 -10000 0 -10000 0 0
PXN -0.039 0.096 -10000 0 -0.31 28 28
HCLS1 -0.094 0.16 -10000 0 -0.35 118 118
PRKCB -0.04 0.09 -10000 0 -0.21 67 67
FCGR2B -0.088 0.18 -10000 0 -0.41 129 129
IGHE -0.004 0.006 -10000 0 -10000 0 0
KLRG1/SHIP -0.057 0.096 -10000 0 -0.25 66 66
LCP2 -0.008 0.1 -10000 0 -0.41 30 30
PLA2G4A -0.11 0.14 -10000 0 -0.28 172 172
RASA1 0.017 0.002 -10000 0 -10000 0 0
mol:Phosphatidic acid -0.077 0.1 -10000 0 -0.18 260 260
IKK complex -0.014 0.056 -10000 0 -0.14 39 39
WIPF1 0.008 0.061 -10000 0 -0.41 11 11
TCGA08_p53

Figure S17.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S17.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
CDKN2A -0.024 0.093 -10000 0 -0.29 58 58
TP53 -0.02 0.066 0.16 16 -0.14 95 111
Senescence -0.02 0.066 0.16 16 -0.14 95 111
Apoptosis -0.02 0.066 0.16 16 -0.14 95 111
Activated_Oncogenes 0 0 -10000 0 -10000 0 0
MDM2 0.009 0.07 0.16 52 -0.26 18 70
MDM4 0.007 0.066 -10000 0 -0.41 13 13
Aurora B signaling

Figure S18.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S18.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
Condensin I complex -0.16 0.18 -9999 0 -0.22 406 406
STMN1 0.001 0.067 -9999 0 -0.29 27 27
Aurora B/RasGAP/Survivin -0.083 0.15 -9999 0 -0.26 208 208
Chromosomal passenger complex/Cul3 protein complex -0.038 0.085 -9999 0 -0.13 212 212
BIRC5 -0.16 0.21 -9999 0 -0.42 212 212
DES -0.004 0.058 -9999 0 -0.24 11 11
Aurora C/Aurora B/INCENP 0.017 0.057 -9999 0 -0.22 29 29
Aurora B/TACC1 0.009 0.057 -9999 0 -0.23 27 27
Aurora B/PP2A 0.009 0.069 -9999 0 -0.29 27 27
mol:GTP 0 0 -9999 0 -10000 0 0
CBX5 0.007 0.021 -9999 0 -0.082 27 27
mitotic metaphase/anaphase transition 0 0.003 -9999 0 -10000 0 0
NDC80 -0.1 0.17 -9999 0 -0.33 185 185
Cul3 protein complex 0.023 0.003 -9999 0 -10000 0 0
KIF2C -0.046 0.1 -9999 0 -0.19 134 134
PEBP1 0.014 0.005 -9999 0 -10000 0 0
KIF20A -0.14 0.21 -9999 0 -0.42 186 186
mol:GDP 0 0 -9999 0 -10000 0 0
Aurora B/RasGAP 0.008 0.069 -9999 0 -0.29 27 27
SEPT1 0 0 -9999 0 -10000 0 0
SMC2 -0.032 0.14 -9999 0 -0.41 61 61
SMC4 -0.31 0.18 -9999 0 -0.41 402 402
NSUN2/NPM1/Nucleolin -0.023 0.078 -9999 0 -0.28 30 30
PSMA3 0.017 0.001 -9999 0 -10000 0 0
G2/M transition of mitotic cell cycle -0.001 0.003 -9999 0 -10000 0 0
H3F3B 0.004 0.044 -9999 0 -0.19 27 27
AURKB -0.006 0.097 -9999 0 -0.42 27 27
AURKC 0.015 0.026 -9999 0 -0.41 2 2
CDCA8 0 0.079 -9999 0 -0.43 17 17
cytokinesis -0.11 0.2 -9999 0 -0.34 191 191
Aurora B/Septin1 -0.1 0.19 -9999 0 -0.33 187 187
AURKA 0.001 0.08 -9999 0 -0.42 19 19
INCENP 0.013 0.007 -9999 0 -10000 0 0
KLHL13 0 0 -9999 0 -10000 0 0
BUB1 0.014 0.038 -9999 0 -0.42 4 4
hSgo1/Aurora B/Survivin -0.084 0.14 -9999 0 -0.24 212 212
EVI5 0.016 0.002 -9999 0 -10000 0 0
RhoA/GTP -0.12 0.22 -9999 0 -0.38 180 180
SGOL1 0 0 -9999 0 -10000 0 0
CENPA -0.039 0.11 -9999 0 -0.25 87 87
NCAPG -0.077 0.18 -9999 0 -0.41 116 116
Aurora B/HC8 Proteasome 0.009 0.069 -9999 0 -0.29 27 27
NCAPD2 -0.068 0.17 -9999 0 -0.41 105 105
Aurora B/PP1-gamma 0.009 0.069 -9999 0 -0.29 27 27
RHOA 0.017 0.001 -9999 0 -10000 0 0
NCAPH 0.004 0.073 -9999 0 -0.41 16 16
NPM1 -0.009 0.064 -9999 0 -0.24 32 32
RASA1 0.017 0.002 -9999 0 -10000 0 0
KLHL9 0.017 0.003 -9999 0 -10000 0 0
mitotic prometaphase -0.003 0.005 -9999 0 -10000 0 0
proteasomal ubiquitin-dependent protein catabolic process 0.009 0.068 -9999 0 -0.29 27 27
PPP1CC 0.017 0.001 -9999 0 -10000 0 0
Centraspindlin -0.13 0.23 -9999 0 -0.38 204 204
RhoA/GDP 0.013 0.001 -9999 0 -10000 0 0
NSUN2 -0.013 0.055 -9999 0 -0.24 27 27
MYLK -0.003 0.059 -9999 0 -0.2 42 42
KIF23 -0.049 0.16 -9999 0 -0.42 79 79
VIM -0.01 0.085 -9999 0 -0.29 45 45
RACGAP1 -0.12 0.2 -9999 0 -0.42 166 166
mitosis 0 0 -9999 0 -10000 0 0
NCL -0.006 0.055 -9999 0 -0.23 27 27
Chromosomal passenger complex -0.066 0.13 -9999 0 -0.21 186 186
Chromosomal passenger complex/EVI5 -0.069 0.16 -9999 0 -0.24 212 212
TACC1 0.017 0.001 -9999 0 -10000 0 0
PPP2R5D 0.017 0 -9999 0 -10000 0 0
CUL3 0.017 0 -9999 0 -10000 0 0
response to DNA damage stimulus 0 0 -9999 0 -10000 0 0
VEGFR1 specific signals

Figure S19.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S19.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
VEGFR1 homodimer/VEGFB homodimer 0.031 0.016 -9999 0 -0.22 2 2
VEGFR1 homodimer/NRP1 0.019 0.015 -9999 0 -0.23 2 2
mol:DAG 0.019 0.047 -9999 0 -0.2 23 23
VEGFR1 homodimer/NRP1/VEGFR 121 -0.099 0.12 -9999 0 -0.21 288 288
CaM/Ca2+ 0.026 0.045 -9999 0 -0.18 22 22
HIF1A 0.024 0.026 -9999 0 -0.4 2 2
GAB1 0.014 0.037 -9999 0 -0.41 4 4
AKT1 0.016 0.059 -9999 0 -0.31 3 3
PLCG1 0.019 0.047 -9999 0 -0.2 23 23
NOS3 0.03 0.042 -9999 0 -0.19 3 3
CBL 0.017 0 -9999 0 -10000 0 0
mol:NO 0.03 0.042 -9999 0 -0.19 3 3
FLT1 0.025 0.018 -9999 0 -0.27 2 2
PGF 0 0.084 -9999 0 -0.41 21 21
VEGFR1 homodimer/NRP2/VEGFR121 -0.092 0.12 -9999 0 -0.2 289 289
CALM1 0.016 0.004 -9999 0 -10000 0 0
PIK3CA -0.003 0.091 -9999 0 -0.41 25 25
eNOS/Hsp90 0.039 0.042 -9999 0 -0.2 2 2
endothelial cell proliferation 0.021 0.04 -9999 0 -0.17 23 23
mol:Ca2+ 0.018 0.046 -9999 0 -0.2 23 23
MAPK3 0.019 0.04 -9999 0 -0.17 23 23
MAPK1 0.018 0.04 -9999 0 -0.17 23 23
PIK3R1 0.016 0.004 -9999 0 -10000 0 0
PLGF homodimer 0 0.084 -9999 0 -0.41 21 21
PRKACA 0.017 0 -9999 0 -10000 0 0
RP11-342D11.1 0 0 -9999 0 -10000 0 0
CAV1 -0.25 0.21 -9999 0 -0.41 325 325
VEGFA homodimer -0.22 0.21 -9999 0 -0.41 286 286
VEGFR1 homodimer/VEGFA homodimer -0.11 0.13 -9999 0 -0.23 288 288
platelet activating factor biosynthetic process 0.02 0.039 -9999 0 -10000 0 0
PI3K 0.026 0.069 -9999 0 -0.2 43 43
PRKCA 0.018 0.043 -9999 0 -0.18 23 23
PRKCB 0.013 0.042 -9999 0 -0.18 23 23
VEGFR1 homodimer/PLGF homodimer 0.021 0.053 -9999 0 -0.23 23 23
VEGFA -0.22 0.21 -9999 0 -0.41 286 286
VEGFB 0.017 0 -9999 0 -10000 0 0
mol:IP3 0.019 0.047 -9999 0 -0.2 23 23
RASA1 0.027 0.014 -9999 0 -0.2 2 2
NRP2 0.016 0.019 -9999 0 -0.41 1 1
VEGFR1 homodimer 0.025 0.018 -9999 0 -0.27 2 2
VEGFB homodimer 0.017 0 -9999 0 -10000 0 0
NCK1 0.008 0.061 -9999 0 -0.41 11 11
eNOS/Caveolin-1 -0.079 0.1 -9999 0 -0.25 34 34
PTPN11 0.017 0 -9999 0 -10000 0 0
mol:PI-3-4-5-P3 0.025 0.068 -9999 0 -0.19 43 43
mol:L-citrulline 0.03 0.042 -9999 0 -0.19 3 3
VEGFR1 homodimer/VEGFA homodimer/CBL/CD2AP -0.099 0.13 -9999 0 -0.2 314 314
VEGFR1 homodimer/VEGFA homodimer/NCK1 -0.096 0.12 -9999 0 -0.2 297 297
CD2AP -0.023 0.12 -9999 0 -0.41 49 49
PI3K/GAB1 0.031 0.07 -9999 0 -0.19 46 46
PDPK1 0.014 0.06 -9999 0 -0.18 43 43
VEGFR1 homodimer/VEGFA homodimer/SHP2 -0.092 0.12 -9999 0 -0.2 288 288
mol:NADP 0.03 0.042 -9999 0 -0.19 3 3
HSP90AA1 0.017 0 -9999 0 -10000 0 0
ubiquitin-dependent protein catabolic process -0.098 0.13 -9999 0 -0.2 314 314
VEGFR1 homodimer/NRP2 0.031 0.019 -9999 0 -0.23 3 3
Signaling events mediated by VEGFR1 and VEGFR2

Figure S20.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S20.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
alphaV beta3 Integrin 0.016 0.053 -10000 0 -0.28 16 16
AKT1 -0.048 0.11 -10000 0 -0.28 48 48
PTK2B -0.088 0.13 -10000 0 -0.36 40 40
VEGFR2 homodimer/Frs2 0.021 0.072 -10000 0 -0.33 20 20
CAV1 -0.25 0.21 -10000 0 -0.41 325 325
CALM1 0.016 0.004 -10000 0 -10000 0 0
VEGFR2 homodimer/VEGFA homodimer/Frs2 -0.097 0.14 -10000 0 -0.22 289 289
endothelial cell proliferation -0.039 0.1 -10000 0 -0.28 37 37
mol:Ca2+ -0.09 0.14 -10000 0 -0.4 39 39
VEGFR2 homodimer/VEGFA homodimer/IQGAP1/Rac -0.13 0.18 -10000 0 -0.41 104 104
RP11-342D11.1 -0.096 0.13 -10000 0 -0.4 39 39
CDH5 -0.006 0.098 -10000 0 -0.41 29 29
VEGFA homodimer -0.098 0.12 -10000 0 -0.21 288 288
SHC1 -0.021 0.12 -10000 0 -0.41 47 47
SHC2 0.017 0 -10000 0 -10000 0 0
HRAS/GDP -0.093 0.13 -10000 0 -0.37 55 55
SH2D2A 0.017 0 -10000 0 -10000 0 0
VEGFR2 homodimer/VEGFA homodimer/SHP1/eNOS -0.047 0.11 -10000 0 -0.31 36 36
VEGFR2 homodimer/VEGFA homodimer/TsAd -0.095 0.14 -10000 0 -0.22 289 289
VEGFR1 homodimer 0.017 0 -10000 0 -10000 0 0
SHC/GRB2/SOS1 -0.093 0.15 -10000 0 -0.41 55 55
GRB10 -0.095 0.15 -10000 0 -0.48 39 39
PTPN11 0.017 0 -10000 0 -10000 0 0
GRB2 0.017 0.002 -10000 0 -10000 0 0
PAK1 0.017 0 -10000 0 -10000 0 0
VEGFR2 homodimer/VEGFA homodimer/IQGAP1/Cadherin/beta catenin -0.13 0.19 -10000 0 -0.4 121 121
HRAS 0.016 0.019 -10000 0 -0.41 1 1
VEGF/Rho/ROCK1/Integrin Complex -0.034 0.077 -10000 0 -0.2 40 40
HIF1A 0.015 0.026 -10000 0 -0.41 2 2
FRS2 0.015 0.032 -10000 0 -0.41 3 3
oxygen and reactive oxygen species metabolic process -0.13 0.17 -10000 0 -0.4 104 104
mol:GTP 0 0 -10000 0 -10000 0 0
FLT4 0.017 0 -10000 0 -10000 0 0
Nck/Pak 0.019 0.044 -10000 0 -0.28 11 11
VEGFR2 homodimer/VEGFA homodimer/Fyn -0.097 0.14 -10000 0 -0.22 288 288
mol:GDP -0.095 0.14 -10000 0 -0.4 55 55
mol:NADP -0.041 0.098 -10000 0 -0.27 35 35
eNOS/Hsp90 -0.034 0.096 -10000 0 -0.26 35 35
PIK3R1 0.016 0.004 -10000 0 -10000 0 0
mol:IP3 -0.091 0.14 -10000 0 -0.4 39 39
HIF1A/ARNT 0.024 0.019 -10000 0 -0.28 2 2
SHB 0.017 0 -10000 0 -10000 0 0
VEGFA -0.21 0.22 -10000 0 -0.41 286 286
VEGFC 0.007 0.066 -10000 0 -0.41 13 13
FAK1/Vinculin -0.058 0.12 -10000 0 -0.3 40 40
mol:Ca ++ 0 0 -10000 0 -10000 0 0
RHOA 0.017 0.001 -10000 0 -10000 0 0
VEGFR2 homodimer/VEGFA homodimer/alphaV beta3 Integrin -0.089 0.14 -10000 0 -0.38 40 40
PTPN6 0.008 0.061 -10000 0 -0.41 11 11
EPAS1 0.018 0.051 -10000 0 -0.24 17 17
mol:L-citrulline -0.041 0.098 -10000 0 -0.27 35 35
ITGAV 0.004 0.073 -10000 0 -0.41 16 16
PIK3CA -0.003 0.091 -10000 0 -0.41 25 25
VEGFR2 homodimer/VEGFA homodimer/Frs2/GRB2 -0.084 0.14 -10000 0 -0.37 35 35
VEGFR2 homodimer/VEGFA homodimer -0.095 0.16 -10000 0 -0.44 39 39
VEGFR2/3 heterodimer 0.022 0.069 -10000 0 -0.35 17 17
VEGFB 0.017 0 -10000 0 -10000 0 0
MAPK11 -0.089 0.13 -10000 0 -0.39 39 39
VEGFR2 homodimer 0.016 0.08 -10000 0 -0.41 17 17
FLT1 0.017 0 -10000 0 -10000 0 0
NEDD4 0.008 0.066 -10000 0 -0.39 14 14
MAPK3 -0.086 0.12 -10000 0 -0.37 39 39
MAPK1 -0.086 0.12 -10000 0 -0.37 39 39
VEGFA145/NRP2 -0.14 0.16 -10000 0 -0.28 287 287
VEGFR1/2 heterodimer 0.022 0.069 -10000 0 -0.35 17 17
KDR 0.016 0.08 -10000 0 -0.41 17 17
VEGFA165/NRP1/VEGFR2 homodimer -0.081 0.14 -10000 0 -0.4 39 39
SRC 0.017 0 -10000 0 -10000 0 0
platelet activating factor biosynthetic process -0.084 0.13 -10000 0 -0.37 39 39
PI3K -0.066 0.13 -10000 0 -0.33 51 51
VEGFR2 homodimer/VEGFA homodimer/NCK1 -0.1 0.14 -10000 0 -0.22 298 298
FES -0.092 0.14 -10000 0 -0.41 39 39
GAB1 -0.077 0.13 -10000 0 -0.32 58 58
VEGFR2 homodimer/VEGFA homodimer/Src -0.095 0.14 -10000 0 -0.22 289 289
CTNNB1 0.017 0 -10000 0 -10000 0 0
SOS1 0 0 -10000 0 -10000 0 0
ARNT 0.017 0 -10000 0 -10000 0 0
eNOS/Caveolin-1 -0.14 0.14 -10000 0 -0.27 222 222
VEGFR2 homodimer/VEGFA homodimer/Yes -0.13 0.16 -10000 0 -0.24 325 325
PI3K/GAB1 -0.052 0.12 -10000 0 -0.3 50 50
VEGFR2 homodimer/VEGFA homodimer/Frs2/Nck/Pak -0.079 0.14 -10000 0 -0.36 37 37
PRKACA 0.017 0 -10000 0 -10000 0 0
VEGFR2/3 heterodimer/VEGFC homodimer 0.026 0.078 -10000 0 -0.29 27 27
HSP90AA1 0.017 0 -10000 0 -10000 0 0
CDC42 -0.092 0.14 -10000 0 -0.41 39 39
actin cytoskeleton reorganization -0.095 0.14 -10000 0 -0.22 289 289
PTK2 -0.068 0.12 -10000 0 -0.32 40 40
EDG1 -0.089 0.14 -10000 0 -0.4 39 39
mol:DAG -0.091 0.14 -10000 0 -0.4 39 39
CaM/Ca2+ -0.079 0.13 -10000 0 -0.37 39 39
MAP2K3 -0.085 0.13 -10000 0 -0.39 39 39
VEGFR2 homodimer/VEGFA homodimer/GRB10/NEDD4 -0.089 0.16 -10000 0 -0.49 39 39
PLCG1 -0.092 0.14 -10000 0 -0.41 39 39
VEGFR2 homodimer/VEGFA homodimer/Src/Shb -0.082 0.14 -10000 0 -0.37 32 32
IQGAP1 -0.086 0.18 -10000 0 -0.41 127 127
YES1 -0.048 0.15 -10000 0 -0.41 80 80
VEGFR2 homodimer/VEGFA homodimer/SHP2 -0.095 0.14 -10000 0 -0.22 289 289
VEGFR2 homodimer/VEGFA homodimer/SHP1 -0.1 0.15 -10000 0 -0.22 297 297
cell migration -0.076 0.14 -10000 0 -0.29 105 105
mol:PI-3-4-5-P3 -0.062 0.12 -10000 0 -0.31 51 51
FYN 0.015 0.026 -10000 0 -0.41 2 2
VEGFB/NRP1 -0.085 0.13 -10000 0 -0.38 39 39
mol:NO -0.041 0.098 -10000 0 -0.27 35 35
PXN 0.017 0 -10000 0 -10000 0 0
HRAS/GTP -0.11 0.12 -10000 0 -0.37 55 55
VEGFR2 homodimer/VEGFA homodimer/GRB10 -0.091 0.16 -10000 0 -0.49 39 39
VHL 0 0 -10000 0 -10000 0 0
ITGB3 0.017 0 -10000 0 -10000 0 0
NOS3 -0.045 0.11 -10000 0 -0.3 35 35
VEGFR2 homodimer/VEGFA homodimer/Sck -0.095 0.14 -10000 0 -0.36 39 39
RAC1 0.017 0 -10000 0 -10000 0 0
PRKCA -0.084 0.13 -10000 0 -0.38 39 39
PRKCB -0.088 0.13 -10000 0 -0.38 39 39
VCL 0.017 0 -10000 0 -10000 0 0
VEGFA165/NRP1 -0.094 0.14 -10000 0 -0.41 39 39
VEGFR1/2 heterodimer/VEGFA homodimer -0.095 0.14 -10000 0 -0.22 289 289
VEGFA165/NRP2 -0.14 0.16 -10000 0 -0.28 287 287
MAPKKK cascade -0.083 0.15 0.25 1 -0.43 51 52
NRP2 0.016 0.019 -10000 0 -0.41 1 1
VEGFC homodimer 0.007 0.066 -10000 0 -0.41 13 13
NCK1 0.008 0.061 -10000 0 -0.41 11 11
ROCK1 0.017 0 -10000 0 -10000 0 0
FAK1/Paxillin -0.058 0.12 -10000 0 -0.3 40 40
MAP3K13 -0.092 0.14 -10000 0 -0.41 39 39
PDPK1 -0.056 0.11 -10000 0 -0.28 51 51
Regulation of nuclear SMAD2/3 signaling

Figure S21.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S21.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
EP300 0.008 0.012 -10000 0 -10000 0 0
HSPA8 0.019 0.003 -10000 0 -10000 0 0
SMAD3/SMAD4/ER alpha -0.018 0.16 0.18 26 -0.26 121 147
AKT1 0.016 0.037 -10000 0 -0.41 4 4
GSC 0.017 0.037 0.11 11 -10000 0 11
NKX2-5 0.016 0.007 -10000 0 -10000 0 0
muscle cell differentiation 0.025 0.098 0.23 66 -10000 0 66
SMAD2-3/SMAD4/SP1 -0.083 0.15 -10000 0 -0.32 99 99
SMAD4 -0.11 0.2 -10000 0 -0.44 129 129
CBFB 0.014 0.037 -10000 0 -0.41 4 4
SAP18 0.018 0.001 -10000 0 -10000 0 0
Cbp/p300/MSG1 0.007 0.059 -10000 0 -0.24 25 25
SMAD3/SMAD4/VDR -0.034 0.11 -10000 0 -0.24 83 83
MYC -0.097 0.19 -10000 0 -0.42 137 137
CDKN2B 0.043 0.053 -10000 0 -10000 0 0
AP1 -0.074 0.14 -10000 0 -0.28 125 125
SMAD2/SMAD2/SMAD4/SnoN/SIN3/HDAC complex/NCoR1 -0.013 0.095 -10000 0 -0.19 87 87
SMAD2-3/SMAD4/FOXO1-3a-4/FOXG1 0.001 0.065 -10000 0 -0.24 8 8
SP3 -0.045 0.15 -10000 0 -0.41 77 77
CREB1 0.017 0 -10000 0 -10000 0 0
FOXH1 0.016 0.007 -10000 0 -10000 0 0
SMAD3/SMAD4/GR -0.037 0.14 -10000 0 -0.26 124 124
GATA3 0.018 0.041 -10000 0 -0.41 5 5
SKI/SIN3/HDAC complex/NCoR1 0.005 0.058 -10000 0 -0.17 21 21
MEF2C/TIF2 -0.016 0.083 -10000 0 -0.21 34 34
endothelial cell migration 0.16 0.2 0.4 215 -10000 0 215
MAX 0.025 0.012 -10000 0 -10000 0 0
RBBP7 0.018 0.001 -10000 0 -10000 0 0
RBBP4 -0.064 0.17 -10000 0 -0.41 101 101
RUNX2 0.017 0 -10000 0 -10000 0 0
RUNX3 0.015 0.032 -10000 0 -0.41 3 3
RUNX1 0.017 0 -10000 0 -10000 0 0
CTBP1 0.017 0.002 -10000 0 -10000 0 0
NR3C1 0.025 0.012 -10000 0 -10000 0 0
VDR 0.017 0 -10000 0 -10000 0 0
CDKN1A -0.098 0.17 -10000 0 -0.4 95 95
KAT2B -0.003 0.004 -10000 0 -10000 0 0
SMAD2/SMAD2/SMAD4/FOXH1 -0.034 0.11 -10000 0 -0.23 113 113
DCP1A 0.017 0 -10000 0 -10000 0 0
SKI 0.018 0.001 -10000 0 -10000 0 0
SERPINE1 -0.16 0.2 -10000 0 -0.4 215 215
SMAD3/SMAD4/ATF2 -0.058 0.14 -10000 0 -0.26 131 131
SMAD3/SMAD4/ATF3 -0.11 0.18 -10000 0 -0.31 208 208
SAP30 0.018 0.001 -10000 0 -10000 0 0
Cbp/p300/PIAS3 0.016 0.029 -10000 0 -0.24 2 2
JUN -0.077 0.14 -10000 0 -0.28 124 124
SMAD3/SMAD4/IRF7 -0.058 0.15 -10000 0 -0.28 127 127
TFE3 -0.032 0.06 -10000 0 -0.13 88 88
COL1A2 -0.2 0.21 -10000 0 -0.41 261 261
mesenchymal cell differentiation 0.058 0.14 0.26 133 -10000 0 133
DLX1 0 0 -10000 0 -10000 0 0
TCF3 0.017 0 -10000 0 -10000 0 0
FOS -0.094 0.18 -10000 0 -0.42 125 125
SMAD3/SMAD4/Max -0.037 0.14 -10000 0 -0.27 112 112
Cbp/p300/SNIP1 0.029 0.008 -10000 0 -10000 0 0
ZBTB17 0.015 0 -10000 0 -10000 0 0
LAMC1 -0.18 0.24 -10000 0 -0.45 217 217
TGIF2/HDAC complex/SMAD3/SMAD4 -0.061 0.15 -10000 0 -0.27 135 135
IRF7 0.01 0.064 -10000 0 -0.41 12 12
ESR1 0.03 0.017 -10000 0 -10000 0 0
HNF4A 0.017 0 -10000 0 -10000 0 0
MEF2C -0.024 0.085 -10000 0 -0.22 53 53
SMAD2-3/SMAD4 -0.058 0.14 -10000 0 -0.27 120 120
Cbp/p300/Src-1 0.022 0.017 -10000 0 -10000 0 0
IGHV3OR16-13 -0.012 0.026 -10000 0 -10000 0 0
TGIF2/HDAC complex 0.011 0.052 -10000 0 -0.41 8 8
CREBBP 0.011 0.008 -10000 0 -10000 0 0
SKIL 0.017 0 -10000 0 -10000 0 0
HDAC1 -0.036 0.14 -10000 0 -0.41 66 66
HDAC2 0.014 0.042 -10000 0 -0.41 5 5
SNIP1 0.018 0.002 -10000 0 -10000 0 0
GCN5L2 0.01 0.009 -10000 0 -10000 0 0
SMAD3/SMAD4/TFE3 -0.11 0.18 -10000 0 -0.29 247 247
MSG1/HSC70 0.013 0.066 -10000 0 -0.28 25 25
SMAD2 0.018 0.008 -10000 0 -10000 0 0
SMAD3 -0.023 0.062 -10000 0 -0.16 12 12
SMAD3/E2F4-5/DP1/p107/SMAD4 -0.026 0.085 -10000 0 -0.16 122 122
SMAD2/SMAD2/SMAD4 -0.028 0.076 0.15 1 -0.15 116 117
NCOR1 0.018 0.001 -10000 0 -10000 0 0
NCOA2 0.017 0 -10000 0 -10000 0 0
NCOA1 0.017 0.003 -10000 0 -10000 0 0
MYOD/E2A 0.025 0 -10000 0 -10000 0 0
SMAD2-3/SMAD4/SP1/MIZ-1 -0.069 0.14 -10000 0 -0.3 94 94
IFNB1 -0.054 0.12 -10000 0 -0.28 85 85
SMAD3/SMAD4/MEF2C -0.024 0.11 -10000 0 -0.26 54 54
CITED1 -0.003 0.091 -10000 0 -0.41 25 25
SMAD2-3/SMAD4/ARC105 -0.041 0.12 -10000 0 -0.26 83 83
RBL1 0 0 -10000 0 -10000 0 0
SMAD2-3/SMAD4/FOXO1-3a-4/CEBPB 0.005 0.07 -10000 0 -0.26 6 6
RUNX1-3/PEBPB2 0.031 0.031 -10000 0 -0.23 7 7
SMAD7 -0.083 0.15 -10000 0 -0.3 136 136
MYC/MIZ-1 -0.06 0.14 -10000 0 -0.29 137 137
SMAD3/SMAD4 -0.17 0.14 -10000 0 -0.28 281 281
IL10 -0.048 0.12 -10000 0 -0.28 79 79
PIASy/HDAC complex 0.022 0.006 -10000 0 -10000 0 0
PIAS3 0.013 0.027 -10000 0 -0.42 2 2
CDK2 -0.01 0.094 -10000 0 -0.41 27 27
IL5 -0.048 0.12 -10000 0 -0.29 73 73
CDK4 -0.27 0.2 -10000 0 -0.42 343 343
PIAS4 0.022 0.006 -10000 0 -10000 0 0
ATF3 -0.071 0.17 -10000 0 -0.41 108 108
SMAD3/SMAD4/SP1 -0.11 0.16 -10000 0 -0.31 155 155
FOXG1 0.016 0.006 -10000 0 -10000 0 0
FOXO3 0.018 0.026 -10000 0 -0.28 4 4
FOXO1 0.012 0.053 -10000 0 -0.3 14 14
FOXO4 0.018 0.026 -10000 0 -0.28 4 4
heart looping -0.024 0.085 -10000 0 -0.22 53 53
CEBPB 0.009 0.061 -10000 0 -0.41 11 11
SMAD3/SMAD4/DLX1 -0.066 0.14 -10000 0 -0.26 141 141
MYOD1 0.017 0 -10000 0 -10000 0 0
SMAD3/SMAD4/HNF4 -0.058 0.14 -10000 0 -0.26 133 133
SMAD3/SMAD4/GATA3 -0.05 0.15 -10000 0 -0.28 121 121
SnoN/SIN3/HDAC complex/NCoR1 0.017 0 -10000 0 -10000 0 0
SMAD3/SMAD4/RUNX1-3/PEBPB2 -0.03 0.13 -10000 0 -0.25 91 91
SMAD3/SMAD4/SP1-3 -0.12 0.2 -10000 0 -0.39 133 133
MED15 0.017 0 -10000 0 -10000 0 0
SP1 -0.029 0.053 -10000 0 -0.17 1 1
SIN3B 0.018 0.001 -10000 0 -10000 0 0
SIN3A 0.001 0.001 -10000 0 -10000 0 0
SMAD2/SMAD2/SMAD4/FOXH1/NKX2-5 -0.014 0.1 -10000 0 -0.2 111 111
ITGB5 -0.12 0.18 -10000 0 -0.38 125 125
TGIF/SIN3/HDAC complex/CtBP -0.073 0.086 -10000 0 -0.19 139 139
SMAD3/SMAD4/AR -0.062 0.14 -10000 0 -0.27 141 141
AR 0.011 0.052 -10000 0 -0.41 8 8
negative regulation of cell growth -0.043 0.1 -10000 0 -0.2 127 127
SMAD3/SMAD4/MYOD -0.058 0.14 -10000 0 -0.26 131 131
E2F5 0.017 0 -10000 0 -10000 0 0
E2F4 0.017 0 -10000 0 -10000 0 0
SMAD2/SMAD2/SMAD4/FOXH1/SMIF -0.017 0.097 -10000 0 -0.21 80 80
SMAD2-3/SMAD4/FOXO1-3a-4 0.001 0.074 -10000 0 -0.22 19 19
TFDP1 0.005 0.071 -10000 0 -0.41 15 15
SMAD3/SMAD4/AP1 -0.066 0.15 -10000 0 -0.29 124 124
SMAD3/SMAD4/RUNX2 -0.058 0.14 -10000 0 -0.26 133 133
TGIF2 0.011 0.052 -10000 0 -0.41 8 8
TGIF1 -0.28 0.2 -10000 0 -0.41 372 372
ATF2 0.017 0 -10000 0 -10000 0 0
PDGFR-alpha signaling pathway

Figure S22.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S22.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
PDGFRA -0.032 0.13 -9999 0 -0.42 51 51
PDGF/PDGFRA/CRKL -0.007 0.089 -9999 0 -0.28 51 51
positive regulation of JUN kinase activity -0.014 0.092 -9999 0 -0.21 93 93
CRKL 0.017 0 -9999 0 -10000 0 0
PDGF/PDGFRA/Caveolin-3 -0.007 0.089 -9999 0 -0.28 51 51
AP1 -0.089 0.19 -9999 0 -0.35 164 164
mol:IP3 -0.021 0.091 -9999 0 -0.29 51 51
PLCG1 -0.021 0.091 -9999 0 -0.29 51 51
PDGF/PDGFRA/alphaV Integrin -0.016 0.1 -9999 0 -0.28 67 67
RAPGEF1 0.017 0 -9999 0 -10000 0 0
CRK 0.017 0 -9999 0 -10000 0 0
mol:Ca2+ -0.021 0.091 -9999 0 -0.29 51 51
CAV3 0.017 0 -9999 0 -10000 0 0
CAV1 -0.25 0.21 -9999 0 -0.41 325 325
SHC/Grb2/SOS1 -0.013 0.093 -9999 0 -0.21 93 93
PDGF/PDGFRA/Shf -0.021 0.086 -9999 0 -0.28 51 51
FOS -0.091 0.18 -9999 0 -0.35 164 164
JUN -0.011 0.027 -9999 0 -0.34 1 1
oligodendrocyte development -0.016 0.1 -9999 0 -0.28 67 67
GRB2 0.017 0.002 -9999 0 -10000 0 0
PIK3R1 0.016 0.004 -9999 0 -10000 0 0
mol:DAG -0.021 0.091 -9999 0 -0.29 51 51
PDGF/PDGFRA -0.032 0.13 -9999 0 -0.42 51 51
actin cytoskeleton reorganization -0.007 0.089 -9999 0 -0.28 51 51
SRF 0.02 0.007 -9999 0 -10000 0 0
SHC1 -0.021 0.12 -9999 0 -0.41 47 47
PI3K -0.006 0.093 -9999 0 -0.24 69 69
PDGF/PDGFRA/Crk/C3G 0.007 0.077 -9999 0 -0.23 51 51
JAK1 -0.016 0.086 -9999 0 -0.28 51 51
ELK1/SRF -0.004 0.062 -9999 0 -0.18 51 51
SHB 0.017 0 -9999 0 -10000 0 0
SHF 0 0 -9999 0 -10000 0 0
CSNK2A1 0.023 0.014 -9999 0 -10000 0 0
GO:0007205 -0.022 0.086 -9999 0 -0.28 51 51
SOS1 0 0 -9999 0 -10000 0 0
Ras protein signal transduction -0.014 0.092 -9999 0 -0.21 93 93
PDGF/PDGFRA/SHB -0.007 0.089 -9999 0 -0.28 51 51
PDGF/PDGFRA/Caveolin-1 -0.2 0.17 -9999 0 -0.31 348 348
ITGAV 0.004 0.073 -9999 0 -0.41 16 16
ELK1 -0.02 0.077 -9999 0 -0.24 51 51
PIK3CA -0.003 0.091 -9999 0 -0.41 25 25
PDGF/PDGFRA/Crk -0.007 0.089 -9999 0 -0.28 51 51
JAK-STAT cascade -0.016 0.086 -9999 0 -0.28 51 51
cell proliferation -0.021 0.086 -9999 0 -0.28 51 51
FAS signaling pathway (CD95)

Figure S23.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S23.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
SPTAN1 -0.024 0.057 -10000 0 -0.14 101 101
RFC1 -0.024 0.057 -10000 0 -0.14 103 103
PRKDC -0.034 0.077 -10000 0 -0.17 117 117
RIPK1 0.01 0.055 -10000 0 -0.41 9 9
CASP7 -0.009 0.071 -10000 0 -0.23 31 31
FASLG/FAS/FADD/FAF1 -0.002 0.062 0.14 25 -0.15 65 90
MAP2K4 0.002 0.078 -10000 0 -0.22 36 36
mol:ceramide 0.01 0.069 -10000 0 -0.22 23 23
GSN -0.031 0.068 -10000 0 -0.15 116 116
FASLG/FAS/FADD/FAF1/Caspase 8 0.007 0.063 0.13 24 -0.19 25 49
FAS -0.039 0.14 -10000 0 -0.42 68 68
BID -0.004 0.043 0.14 1 -0.25 16 17
MAP3K1 -0.013 0.077 -10000 0 -0.22 42 42
MAP3K7 0.016 0.019 -10000 0 -0.41 1 1
RB1 -0.024 0.057 -10000 0 -0.14 103 103
CFLAR 0.013 0.041 -10000 0 -0.41 5 5
HGF/MET 0.014 0.074 -10000 0 -0.24 41 41
ARHGDIB -0.045 0.088 -10000 0 -0.18 139 139
FADD 0.015 0.027 -10000 0 -0.41 2 2
actin filament polymerization 0.031 0.068 0.15 116 -10000 0 116
NFKB1 0.007 0.045 -10000 0 -0.24 2 2
MAPK8 0.001 0.093 -10000 0 -0.24 53 53
DFFA -0.024 0.057 -10000 0 -0.14 103 103
DNA fragmentation during apoptosis -0.024 0.057 -10000 0 -0.14 103 103
FAS/FADD/MET -0.006 0.099 -10000 0 -0.24 79 79
CFLAR/RIP1 0.018 0.049 -10000 0 -0.28 14 14
FAIM3 0.016 0.019 -10000 0 -0.41 1 1
FAF1 0.016 0.007 -10000 0 -10000 0 0
PARP1 -0.024 0.057 -10000 0 -0.14 103 103
DFFB -0.024 0.057 -10000 0 -0.14 103 103
CHUK 0.009 0.042 -10000 0 -0.23 1 1
FASLG 0.016 0.007 -10000 0 -10000 0 0
FAS/FADD -0.017 0.11 -10000 0 -0.29 70 70
HGF 0.015 0.026 -10000 0 -0.41 2 2
LMNA -0.032 0.081 -10000 0 -0.16 119 119
CASP6 -0.035 0.079 -10000 0 -0.17 118 118
CASP10 0.017 0.004 -10000 0 -10000 0 0
CASP3 -0.032 0.066 -10000 0 -0.16 103 103
PTPN13 -0.007 0.099 -10000 0 -0.41 30 30
CASP8 -0.009 0.039 0.22 1 -0.3 9 10
IL6 -0.011 0.13 -10000 0 -0.39 52 52
MET 0.009 0.058 -10000 0 -0.41 10 10
ICAD/CAD -0.019 0.053 -10000 0 -0.13 98 98
FASLG/FAS/FADD/FAF1/Caspase 10 0.01 0.069 -10000 0 -0.22 23 23
activation of caspase activity by cytochrome c -0.004 0.043 0.14 1 -0.24 16 17
PAK2 -0.034 0.079 -10000 0 -0.17 115 115
BCL2 0.017 0 -10000 0 -10000 0 0
Stabilization and expansion of the E-cadherin adherens junction

Figure S24.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S24.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
adherens junction organization -0.11 0.059 -10000 0 -0.13 456 456
epithelial cell differentiation 0.029 0.042 -10000 0 -0.19 18 18
CYFIP2 0.01 0.008 -10000 0 -10000 0 0
ENAH 0.008 0.072 -10000 0 -0.26 21 21
EGFR -0.14 0.21 -10000 0 -0.41 194 194
EPHA2 0.006 0.069 -10000 0 -0.41 14 14
MYO6 0.018 0.037 -10000 0 -0.18 18 18
CTNNB1 0.017 0 -10000 0 -10000 0 0
ABI1/Sra1/Nap1 0.02 0.017 -10000 0 -10000 0 0
AQP5 0.027 0.033 -10000 0 -0.15 18 18
CTNND1 0.009 0.058 -10000 0 -0.41 10 10
mol:PI-4-5-P2 0.017 0.036 -10000 0 -0.18 17 17
regulation of calcium-dependent cell-cell adhesion 0.018 0.037 -10000 0 -0.18 18 18
EGF 0.015 0.026 -10000 0 -0.41 2 2
NCKAP1 0.017 0 -10000 0 -10000 0 0
AQP3 0.024 0.045 -10000 0 -0.32 3 3
cortical microtubule organization 0.029 0.042 -10000 0 -0.19 18 18
GO:0000145 0.012 0.033 -10000 0 -0.17 17 17
E-cadherin/Ca2+/beta catenin/alpha catenin/p120 catenin 0.033 0.043 -10000 0 -0.19 18 18
MLLT4 0.017 0 -10000 0 -10000 0 0
ARF6/GDP -0.019 0.068 -10000 0 -0.35 15 15
ARF6 0.017 0 -10000 0 -10000 0 0
Ephrin A1/EPHA2/NCK1/GIT1 0.022 0.084 -10000 0 -0.26 38 38
mol:Ca2+ 0 0 -10000 0 -10000 0 0
VASP -0.015 0.078 -10000 0 -0.22 39 39
PVRL2 0.017 0 -10000 0 -10000 0 0
ZYX -0.032 0.098 -10000 0 -0.19 140 140
ARF6/GTP 0.028 0.08 -10000 0 -0.24 38 38
CDH1 0.011 0.052 -10000 0 -0.41 8 8
EGFR/EGFR/EGF/EGF -0.05 0.11 -10000 0 -0.18 207 207
RhoA/GDP 0.03 0.039 -10000 0 -0.18 18 18
actin cytoskeleton organization 0.019 0.035 -10000 0 -0.17 18 18
IGF-1R heterotetramer 0.017 0 -10000 0 -10000 0 0
GIT1 0.017 0 -10000 0 -10000 0 0
IGF1R 0.017 0 -10000 0 -10000 0 0
IGF1 0.014 0.037 -10000 0 -0.41 4 4
DIAPH1 -0.13 0.2 -10000 0 -0.36 226 226
Wnt receptor signaling pathway -0.029 0.042 0.19 18 -10000 0 18
RHOA 0.017 0.001 -10000 0 -10000 0 0
RhoA/GTP -0.019 0.068 -10000 0 -0.35 15 15
CTNNA1 0.017 0 -10000 0 -10000 0 0
VCL 0.019 0.036 -10000 0 -0.17 18 18
EFNA1 -0.002 0.088 -10000 0 -0.41 23 23
LPP 0.003 0.068 -10000 0 -0.19 55 55
Ephrin A1/EPHA2 0.012 0.071 -10000 0 -0.2 47 47
SEC6/SEC8 -0.005 0.029 -10000 0 -0.16 18 18
MGAT3 0.018 0.037 -10000 0 -0.18 18 18
HGF/MET 0.022 0.052 -10000 0 -0.19 27 27
HGF 0.015 0.026 -10000 0 -0.41 2 2
E-cadherin/Ca2+/beta catenin/alpha catenin/p120 catenin/EPLIN -0.11 0.059 -10000 0 -0.13 456 456
actin cable formation -0.006 0.07 -10000 0 -0.23 27 27
KIAA1543 0.007 0.034 -10000 0 -0.18 18 18
KIFC3 0.018 0.037 -10000 0 -0.18 18 18
NCK1 0.008 0.061 -10000 0 -0.41 11 11
EXOC3 0.017 0 -10000 0 -10000 0 0
ACTN1 0.002 0.072 -10000 0 -0.2 54 54
NCK1/GIT1 0.019 0.044 -10000 0 -0.28 11 11
mol:GDP 0.029 0.042 -10000 0 -0.19 18 18
EXOC4 0 0 -10000 0 -10000 0 0
STX4 0.018 0.037 -10000 0 -0.18 18 18
PIP5K1C 0.018 0.036 -10000 0 -0.18 17 17
LIMA1 -0.35 0.15 -10000 0 -0.41 454 454
ABI1 0.017 0 -10000 0 -10000 0 0
ROCK1 0.015 0.069 -10000 0 -0.31 15 15
adherens junction assembly 0.015 0.037 -10000 0 -0.16 18 18
IGF-1R heterotetramer/IGF1 0.025 0.044 -10000 0 -0.19 20 20
nectin-2(dimer)/I-afadin/I-afadin/nectin-2(dimer/I-afadin/I-afadin 0.025 0 -10000 0 -10000 0 0
MET 0.009 0.058 -10000 0 -0.41 10 10
PLEKHA7 0.007 0.036 -10000 0 -0.18 18 18
mol:GTP 0.021 0.084 -10000 0 -0.26 38 38
establishment of epithelial cell apical/basal polarity 0.026 0.033 -10000 0 -10000 0 0
cortical actin cytoskeleton stabilization -0.11 0.059 -10000 0 -0.13 456 456
regulation of cell-cell adhesion 0.019 0.035 -10000 0 -0.17 18 18
E-cadherin/Ca2+/beta catenin/alpha catenin/p120 catenin/EPLIN/cortical actin cytoskeleton -0.11 0.059 -10000 0 -0.13 456 456
Noncanonical Wnt signaling pathway

Figure S25.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S25.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
NFATC2 0 0 -9999 0 -10000 0 0
GNB1/GNG2 -0.035 0.096 -9999 0 -0.25 51 51
mol:DAG -0.032 0.088 -9999 0 -0.23 51 51
PLCG1 -0.032 0.09 -9999 0 -0.23 51 51
YES1 -0.072 0.13 -9999 0 -0.28 116 116
FZD3 0.014 0.032 -9999 0 -0.41 3 3
FZD6 -0.065 0.17 -9999 0 -0.41 101 101
G protein -0.031 0.091 -9999 0 -0.24 51 51
MAP3K7 -0.02 0.074 -9999 0 -0.19 48 48
mol:Ca2+ -0.031 0.086 -9999 0 -0.22 51 51
mol:IP3 -0.032 0.088 -9999 0 -0.23 51 51
NLK 0.016 0.056 -9999 0 -0.71 3 3
GNB1 0.017 0.002 -9999 0 -10000 0 0
CAMK2A -0.024 0.078 -9999 0 -0.21 47 47
MAP3K7IP1 0.017 0 -9999 0 -10000 0 0
Noncanonical Wnts/FZD -0.047 0.1 -9999 0 -0.16 221 221
CSNK1A1 0.017 0 -9999 0 -10000 0 0
GNAS -0.041 0.096 -9999 0 -0.26 51 51
GO:0007205 -0.032 0.084 -9999 0 -0.22 51 51
WNT6 0.017 0 -9999 0 -10000 0 0
WNT4 0.015 0.026 -9999 0 -0.41 2 2
NFAT1/CK1 alpha -0.055 0.12 -9999 0 -0.25 111 111
GNG2 0 0 -9999 0 -10000 0 0
WNT5A -0.12 0.2 -9999 0 -0.41 168 168
WNT11 0.015 0.026 -9999 0 -0.41 2 2
CDC42 -0.066 0.13 -9999 0 -0.27 111 111
Paxillin-independent events mediated by a4b1 and a4b7

Figure S26.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S26.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
PTK2 0.023 0.031 -9999 0 -0.28 5 5
CRKL 0.017 0 -9999 0 -10000 0 0
Rac1/GDP 0.013 0 -9999 0 -10000 0 0
DOCK1 0.017 0 -9999 0 -10000 0 0
ITGA4 0.013 0.042 -9999 0 -0.41 5 5
alpha4/beta7 Integrin/MAdCAM1 0.041 0.034 -9999 0 -0.29 5 5
EPO 0.017 0 -9999 0 -10000 0 0
alpha4/beta7 Integrin 0.022 0.041 -9999 0 -0.38 5 5
mol:GTP 0 0 -9999 0 -10000 0 0
CRK 0.017 0 -9999 0 -10000 0 0
alpha4/beta1 Integrin 0.023 0.03 -9999 0 -0.28 5 5
EPO/EPOR (dimer) 0.025 0 -9999 0 -10000 0 0
lamellipodium assembly 0.01 0.037 -9999 0 -0.15 25 25
PIK3CA -0.003 0.091 -9999 0 -0.41 25 25
PI3K 0.009 0.065 -9999 0 -0.28 25 25
ARF6 0.017 0 -9999 0 -10000 0 0
JAK2 0.028 0.016 -9999 0 -0.14 5 5
PXN 0.017 0 -9999 0 -10000 0 0
PIK3R1 0.016 0.004 -9999 0 -10000 0 0
MADCAM1 0.017 0 -9999 0 -10000 0 0
cell adhesion 0.039 0.034 -9999 0 -0.29 5 5
CRKL/CBL 0.025 0 -9999 0 -10000 0 0
ITGB1 0.017 0 -9999 0 -10000 0 0
SRC -0.13 0.11 -9999 0 -0.21 353 353
ITGB7 0.015 0.026 -9999 0 -0.41 2 2
RAC1 0.017 0 -9999 0 -10000 0 0
alpha4/beta1 Integrin/VCAM1 -0.15 0.13 -9999 0 -0.24 353 353
p130Cas/Crk/Dock1 -0.1 0.099 -9999 0 -0.17 353 353
VCAM1 -0.27 0.2 -9999 0 -0.41 351 351
RHOA 0.017 0.001 -9999 0 -10000 0 0
alpha4/beta1 Integrin/Paxillin/GIT1 0.042 0.024 -9999 0 -0.21 5 5
BCAR1 -0.12 0.1 -9999 0 -0.19 353 353
EPOR 0.017 0 -9999 0 -10000 0 0
mol:GDP 0 0 -9999 0 -10000 0 0
CBL 0.017 0 -9999 0 -10000 0 0
GIT1 0.017 0 -9999 0 -10000 0 0
Rac1/GTP 0.01 0.038 -9999 0 -0.16 25 25
S1P1 pathway

Figure S27.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S27.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
VEGFR2 homodimer/VEGFA homodimer -0.14 0.16 -9999 0 -0.29 289 289
PDGFRB 0.014 0.032 -9999 0 -0.41 3 3
SPHK1 -0.006 0.041 -9999 0 -0.21 14 14
mol:S1P -0.005 0.051 -9999 0 -0.22 20 20
S1P1/S1P/Gi -0.08 0.1 -9999 0 -0.27 83 83
GNAO1 0.002 0.005 -9999 0 -10000 0 0
PDGFB-D/PDGFRB/PLCgamma1 -0.064 0.088 -9999 0 -0.24 74 74
PLCG1 -0.068 0.093 -9999 0 -0.25 77 77
mol:GTP 0 0 -9999 0 -10000 0 0
PDGFB-D/PDGFRB 0.014 0.032 -9999 0 -0.41 3 3
GNAI2 0.022 0.004 -9999 0 -10000 0 0
GNAI3 -0.036 0.14 -9999 0 -0.41 65 65
GNAI1 0.013 0.019 -9999 0 -0.41 1 1
mol:GDP 0 0 -9999 0 -10000 0 0
EDG1 -0.11 0.14 -9999 0 -0.23 289 289
S1P1/S1P -0.074 0.11 -9999 0 -0.29 38 38
negative regulation of cAMP metabolic process -0.079 0.099 -9999 0 -0.26 83 83
MAPK3 -0.076 0.11 -9999 0 -0.3 69 69
calcium-dependent phospholipase C activity 0 0.002 -9999 0 -10000 0 0
Rac1/GDP 0.013 0 -9999 0 -10000 0 0
RhoA/GDP 0.013 0.001 -9999 0 -10000 0 0
KDR 0.007 0.076 -9999 0 -0.41 17 17
PLCB2 -0.067 0.1 -9999 0 -0.26 38 38
RAC1 0.017 0 -9999 0 -10000 0 0
RhoA/GTP -0.068 0.092 -9999 0 -0.25 38 38
receptor internalization -0.071 0.1 -9999 0 -0.28 38 38
PTGS2 -0.084 0.12 -9999 0 -0.43 40 40
Rac1/GTP -0.068 0.092 -9999 0 -0.25 38 38
RHOA 0.017 0.001 -9999 0 -10000 0 0
VEGFA -0.21 0.21 -9999 0 -0.4 286 286
negative regulation of T cell proliferation -0.079 0.099 -9999 0 -0.26 83 83
GO:0007205 0 0 -9999 0 -10000 0 0
GNAZ 0.015 0.006 -9999 0 -10000 0 0
MAPK1 -0.074 0.11 -9999 0 -0.3 67 67
S1P1/S1P/PDGFB-D/PDGFRB -0.07 0.12 -9999 0 -0.3 42 42
ABCC1 0.01 0.056 -9999 0 -0.41 9 9
Class I PI3K signaling events

Figure S28.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S28.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
ARF5/GTP -0.028 0.078 -9999 0 -0.16 132 132
DAPP1 -0.015 0.088 -9999 0 -0.2 71 71
Src family/SYK family/BLNK-LAT/BTK-ITK -0.036 0.14 -9999 0 -0.3 86 86
mol:DAG -0.019 0.078 -9999 0 -0.16 79 79
HRAS 0.01 0.021 -9999 0 -0.41 1 1
RAP1A 0.015 0.004 -9999 0 -10000 0 0
ARF5/GDP 0.003 0.053 -9999 0 -0.19 25 25
PLCG2 0.009 0.058 -9999 0 -0.41 10 10
PLCG1 0.017 0 -9999 0 -10000 0 0
ARF5 0.017 0 -9999 0 -10000 0 0
mol:GTP -0.039 0.078 -9999 0 -0.17 132 132
ARF1/GTP -0.033 0.073 -9999 0 -0.16 132 132
RHOA 0.017 0.001 -9999 0 -10000 0 0
YES1 -0.048 0.15 -9999 0 -0.41 80 80
RAP1A/GTP -0.032 0.082 -9999 0 -0.17 132 132
ADAP1 -0.037 0.075 -9999 0 -0.17 132 132
ARAP3 -0.038 0.077 -9999 0 -0.17 132 132
INPPL1 0.017 0 -9999 0 -10000 0 0
PREX1 0 0 -9999 0 -10000 0 0
ARHGEF6 0.01 0.052 -9999 0 -0.41 8 8
ARHGEF7 0.016 0.019 -9999 0 -0.41 1 1
ARF1 0.017 0.001 -9999 0 -10000 0 0
NRAS -0.094 0.19 -9999 0 -0.41 137 137
FYN 0.015 0.026 -9999 0 -0.41 2 2
ARF6 0.017 0 -9999 0 -10000 0 0
FGR 0.003 0.076 -9999 0 -0.41 17 17
mol:Ca2+ -0.006 0.042 -9999 0 -0.12 17 17
mol:IP4 0 0 -9999 0 -10000 0 0
TIAM1 0.016 0.003 -9999 0 -10000 0 0
ZAP70 0.017 0 -9999 0 -10000 0 0
mol:IP3 -0.01 0.057 -9999 0 -0.13 55 55
LYN -0.035 0.14 -9999 0 -0.41 64 64
ARF1/GDP 0.003 0.053 -9999 0 -0.19 25 25
RhoA/GDP -0.018 0.08 -9999 0 -0.15 133 133
PDK1/Src/Hsp90 0.035 0 -9999 0 -10000 0 0
BLNK -0.038 0.14 -9999 0 -0.41 68 68
actin cytoskeleton reorganization -0.012 0.069 -9999 0 -0.13 133 133
SRC 0.017 0 -9999 0 -10000 0 0
PLEKHA2 0.011 0.011 -9999 0 -0.24 1 1
RAC1 0.017 0 -9999 0 -10000 0 0
PTEN 0.019 0.027 -9999 0 -0.4 2 2
HSP90AA1 0.017 0 -9999 0 -10000 0 0
ARF6/GTP -0.028 0.078 -9999 0 -0.16 132 132
RhoA/GTP -0.028 0.079 -9999 0 -0.16 132 132
Src family/SYK family/BLNK-LAT -0.032 0.13 -9999 0 -0.28 91 91
BLK 0.017 0 -9999 0 -10000 0 0
PDPK1 0.017 0 -9999 0 -10000 0 0
CYTH1 -0.037 0.075 -9999 0 -0.17 132 132
HCK -0.053 0.16 -9999 0 -0.41 86 86
CYTH3 -0.037 0.075 -9999 0 -0.17 132 132
CYTH2 -0.037 0.075 -9999 0 -0.17 132 132
KRAS 0.011 0.011 -9999 0 -10000 0 0
GO:0030676 0 0 -9999 0 -10000 0 0
FOXO3 -0.005 0.044 -9999 0 -10000 0 0
SGK1 -0.008 0.047 -9999 0 -10000 0 0
INPP5D 0 0 -9999 0 -10000 0 0
mol:GDP -0.006 0.053 -9999 0 -0.21 25 25
SOS1 0 0 -9999 0 -10000 0 0
SYK -0.012 0.11 -9999 0 -0.41 36 36
ARF6/GDP -0.021 0.076 -9999 0 -0.15 133 133
mol:PI-3-4-5-P3 -0.038 0.079 -9999 0 -0.17 132 132
ARAP3/RAP1A/GTP -0.032 0.083 -9999 0 -0.17 134 134
VAV1 0.016 0.019 -9999 0 -0.41 1 1
mol:PI-3-4-P2 0.009 0 -9999 0 -10000 0 0
RAS family/GTP/PI3K Class I -0.024 0.089 -9999 0 -0.18 134 134
PLEKHA1 0.01 0.004 -9999 0 -10000 0 0
Rac1/GDP 0.003 0.053 -9999 0 -0.19 25 25
LAT 0.016 0.019 -9999 0 -0.41 1 1
Rac1/GTP 0.011 0.041 -9999 0 -0.15 24 24
ITK -0.034 0.08 -9999 0 -0.17 134 134
Src family/SYK family/BLNK-LAT/BTK-ITK/PLC-gamma -0.03 0.1 -9999 0 -0.21 93 93
LCK 0.014 0.037 -9999 0 -0.41 4 4
BTK -0.032 0.077 -9999 0 -0.16 133 133
Circadian rhythm pathway

Figure S29.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S29.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
chromatin modification -0.046 0.19 -10000 0 -0.42 100 100
CLOCK 0.009 0.038 -10000 0 -0.44 3 3
TIMELESS/CRY2 -0.035 0.15 -10000 0 -0.35 100 100
DEC1/BMAL1 0.024 0.007 -10000 0 -10000 0 0
ATR 0.017 0 -10000 0 -10000 0 0
NR1D1 -0.007 0.08 -10000 0 -0.17 100 100
ARNTL 0.012 0.016 -10000 0 -10000 0 0
TIMELESS -0.046 0.16 -10000 0 -0.38 100 100
NPAS2 0.011 0.024 -10000 0 -0.41 1 1
CRY2 0.017 0 -10000 0 -10000 0 0
mol:CO 0.006 0.034 0.077 100 -10000 0 100
CHEK1 -0.032 0.14 -10000 0 -0.41 60 60
mol:HEME -0.006 0.034 -10000 0 -0.077 100 100
PER1 0.015 0.032 -10000 0 -0.41 3 3
BMAL/CLOCK/NPAS2 0.026 0.05 -10000 0 -0.29 4 4
BMAL1/CLOCK -0.003 0.1 -10000 0 -0.34 4 4
S phase of mitotic cell cycle -0.046 0.19 -10000 0 -0.42 100 100
TIMELESS/CHEK1/ATR -0.046 0.19 -10000 0 -0.43 100 100
mol:NADPH -0.006 0.034 -10000 0 -0.077 100 100
PER1/TIMELESS -0.036 0.15 -10000 0 -0.35 100 100
PER1-2 / CRY1-2 0 0 -10000 0 -10000 0 0
DEC1 0.017 0 -10000 0 -10000 0 0
Aurora A signaling

Figure S30.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S30.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
Aurora A/GADD45A 0.002 0.077 -9999 0 -0.23 47 47
BIRC5 -0.16 0.21 -9999 0 -0.41 212 212
NFKBIA 0.017 0.031 -9999 0 -0.13 17 17
CPEB1 0.013 0.007 -9999 0 -10000 0 0
AKT1 0.016 0.036 -9999 0 -0.14 20 20
NDEL1 0.016 0.004 -9999 0 -10000 0 0
Aurora A/BRCA1 0.02 0.036 -9999 0 -0.14 22 22
NDEL1/TACC3 -0.009 0.093 -9999 0 -0.2 92 92
GADD45A -0.02 0.12 -9999 0 -0.41 46 46
GSK3B 0.019 0.007 -9999 0 -10000 0 0
PAK1/Aurora A 0.024 0.03 -9999 0 -0.12 19 19
MDM2 0.002 0.078 -9999 0 -0.41 18 18
JUB 0 0 -9999 0 -10000 0 0
TPX2 -0.15 0.15 -9999 0 -0.28 296 296
TP53 -0.001 0.065 -9999 0 -0.14 81 81
DLG7 -0.091 0.13 -9999 0 -0.24 230 230
AURKAIP1 0.017 0 -9999 0 -10000 0 0
ARHGEF7 0.016 0.019 -9999 0 -0.41 1 1
G2 phase of mitotic cell cycle 0 0 -9999 0 -10000 0 0
Aurora A/NDEL1/TACC3 -0.01 0.099 -9999 0 -0.22 92 92
G2/M transition of mitotic cell cycle 0.02 0.036 -9999 0 -0.14 22 22
AURKA 0.018 0.036 -9999 0 -0.15 19 19
AURKB -0.002 0.047 -9999 0 -0.18 30 30
CDC25B 0.015 0.04 -9999 0 -0.13 31 31
G2/M transition checkpoint 0.01 0.025 -9999 0 -0.11 19 19
mRNA polyadenylation 0.017 0.022 -9999 0 -0.1 10 10
Aurora A/CPEB 0.017 0.022 -9999 0 -0.1 10 10
Aurora A/TACC1/TRAP/chTOG 0.042 0.027 -9999 0 -10000 0 0
BRCA1 0.013 0.042 -9999 0 -0.41 5 5
centrosome duplication 0.024 0.03 -9999 0 -0.12 19 19
regulation of centrosome cycle -0.009 0.091 -9999 0 -0.2 92 92
spindle assembly 0.041 0.027 -9999 0 -10000 0 0
TDRD7 0.017 0.001 -9999 0 -10000 0 0
Aurora A/RasGAP/Survivin -0.05 0.12 -9999 0 -0.19 208 208
CENPA -0.004 0.054 -9999 0 -0.11 86 86
Aurora A/PP2A 0.024 0.03 -9999 0 -0.12 16 16
meiosis 0 0 -9999 0 -10000 0 0
protein catabolic process -0.051 0.091 -9999 0 -0.16 190 190
negative regulation of DNA binding -0.001 0.064 -9999 0 -0.14 80 80
prophase 0 0 -9999 0 -10000 0 0
GIT1/beta-PIX 0.025 0.013 -9999 0 -0.28 1 1
RASA1 0.017 0.002 -9999 0 -10000 0 0
Ajuba/Aurora A 0.011 0.025 -9999 0 -0.11 19 19
mitotic prometaphase 0 0.009 -9999 0 -10000 0 0
proteasomal ubiquitin-dependent protein catabolic process 0.018 0.036 -9999 0 -0.15 19 19
TACC1 0.017 0.001 -9999 0 -10000 0 0
TACC3 -0.061 0.16 -9999 0 -0.41 96 96
Aurora A/Antizyme1 0.033 0.028 -9999 0 -0.12 1 1
Aurora A/RasGAP 0.024 0.03 -9999 0 -0.12 16 16
OAZ1 0.017 0 -9999 0 -10000 0 0
RAN 0.017 0.001 -9999 0 -10000 0 0
mitosis 0 0 -9999 0 -10000 0 0
PRKACA 0.019 0.007 -9999 0 -10000 0 0
GIT1 0.017 0 -9999 0 -10000 0 0
GIT1/beta-PIX/PAK1 0.034 0.012 -9999 0 -0.23 1 1
Importin alpha/Importin beta/TPX2 -0.15 0.15 -9999 0 -0.28 296 296
PPP2R5D 0.017 0 -9999 0 -10000 0 0
Aurora A/TPX2 -0.1 0.12 -9999 0 -0.21 296 296
PAK1 0.017 0 -9999 0 -10000 0 0
CKAP5 0.017 0 -9999 0 -10000 0 0
Ras signaling in the CD4+ TCR pathway

Figure S31.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S31.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
ERK1-2/ELK1 -0.021 0.11 -10000 0 -0.2 127 127
MAP3K8 -0.018 0.12 -10000 0 -0.42 42 42
FOS -0.012 0.069 -10000 0 -0.18 20 20
PRKCA 0.013 0.009 -10000 0 -10000 0 0
PTPN7 0.011 0.022 -10000 0 -0.41 1 1
HRAS 0.016 0.019 -10000 0 -0.41 1 1
PRKCB -0.002 0.006 0.01 2 -0.012 125 127
NRAS -0.095 0.19 -10000 0 -0.41 137 137
RAS family/GTP -0.034 0.1 -10000 0 -0.21 138 138
MAPK3 0.004 0.038 -10000 0 -0.19 1 1
MAP2K1 -0.009 0.048 -10000 0 -0.12 52 52
ELK1 0.011 0.013 -10000 0 -10000 0 0
BRAF -0.003 0.028 -10000 0 -10000 0 0
mol:GTP -0.001 0.002 0.002 1 -0.004 125 126
MAPK1 -0.005 0.062 -10000 0 -0.27 18 18
RAF1 -0.003 0.029 -10000 0 -0.17 1 1
KRAS 0.016 0.002 -10000 0 -10000 0 0
E-cadherin signaling in keratinocytes

Figure S32.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S32.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
keratinocyte differentiation 0.02 0.048 -10000 0 -0.16 31 31
adherens junction organization 0.02 0.038 -10000 0 -0.14 21 21
mol:GTP 0 0 -10000 0 -10000 0 0
Rac1/GDP -0.041 0.1 -10000 0 -0.16 196 196
FMN1 0.019 0.038 -10000 0 -0.14 20 20
mol:IP3 0.017 0.047 -10000 0 -0.16 27 27
E-cadherin/Ca2+/beta catenin-gamma catenin/alpha catenin/p120 catenin 0.02 0.04 -10000 0 -0.15 20 20
CTNNB1 0.017 0.002 -10000 0 -10000 0 0
AKT1 0.02 0.051 -10000 0 -0.16 30 30
E-cadherin/beta catenin-gamma catenin/alpha catenin/p120 catenin 0.028 0.041 -10000 0 -0.19 12 12
CTNND1 0.009 0.059 -10000 0 -0.41 10 10
mol:PI-4-5-P2 0.022 0.04 -10000 0 -0.19 11 11
VASP 0.022 0.04 -10000 0 -0.19 11 11
ZYX -0.026 0.094 -10000 0 -0.18 137 137
JUB 0.019 0.038 -10000 0 -0.14 20 20
EGFR(dimer) -0.046 0.11 -10000 0 -0.18 202 202
E-cadherin/beta catenin-gamma catenin 0.022 0.063 -10000 0 -0.29 19 19
mol:PI-3-4-5-P3 0.024 0.052 -10000 0 -0.16 31 31
PIK3CA -0.003 0.091 -10000 0 -0.41 25 25
PI3K 0.024 0.053 -10000 0 -0.17 31 31
FYN 0.023 0.044 -10000 0 -0.14 27 27
mol:Ca2+ 0.017 0.047 -10000 0 -0.16 27 27
JUP 0.004 0.073 -10000 0 -0.41 16 16
PIK3R1 0.016 0.005 -10000 0 -10000 0 0
mol:DAG 0.017 0.047 -10000 0 -0.16 27 27
CDH1 0.011 0.052 -10000 0 -0.41 8 8
RhoA/GDP -0.041 0.1 -10000 0 -0.16 207 207
establishment of polarity of embryonic epithelium 0.022 0.039 -10000 0 -0.19 11 11
SRC 0.017 0 -10000 0 -10000 0 0
RAC1 0.017 0 -10000 0 -10000 0 0
RHOA 0.017 0.001 -10000 0 -10000 0 0
EGFR -0.14 0.21 -10000 0 -0.41 194 194
CASR 0.018 0.044 -10000 0 -0.15 26 26
RhoA/GTP 0.023 0.045 -10000 0 -0.15 26 26
AKT2 0.022 0.048 -10000 0 -0.16 26 26
actin cable formation 0.021 0.039 -10000 0 -0.18 11 11
apoptosis -0.019 0.048 0.15 31 -10000 0 31
CTNNA1 0.018 0.002 -10000 0 -10000 0 0
mol:GDP -0.051 0.1 -10000 0 -0.17 207 207
PIP5K1A 0.022 0.04 -10000 0 -0.19 11 11
PLCG1 0.017 0.048 -10000 0 -0.17 27 27
Rac1/GTP -0.037 0.1 -10000 0 -0.16 202 202
homophilic cell adhesion 0 0.002 -10000 0 -10000 0 0
Plasma membrane estrogen receptor signaling

Figure S33.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S33.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
GNB1/GNG2 0.03 0.003 -10000 0 -10000 0 0
ER alpha/Gai/GDP/Gbeta gamma -0.063 0.064 -10000 0 -0.2 63 63
AKT1 0.007 0.03 -10000 0 -10000 0 0
PIK3CA -0.003 0.091 -10000 0 -0.41 25 25
E2/ER alpha (dimer)/PELP1/Src/PI3K 0.005 0.03 -10000 0 -10000 0 0
mol:Ca2+ 0.029 0.018 -10000 0 -10000 0 0
IGF1R 0.017 0 -10000 0 -10000 0 0
E2/ER alpha (dimer)/Striatin 0.023 0 -10000 0 -10000 0 0
SHC1 -0.021 0.12 -10000 0 -0.41 47 47
apoptosis -0.007 0.03 -10000 0 -10000 0 0
RhoA/GTP -0.044 0.074 -10000 0 -0.17 135 135
E2/ER alpha (dimer)/PELP1/Src/p130 Cas -0.047 0.046 -10000 0 -0.18 14 14
regulation of stress fiber formation 0.13 0.11 0.19 363 -0.21 1 364
E2/ERA-ERB (dimer) 0.023 0 -10000 0 -10000 0 0
KRAS 0.017 0.002 -10000 0 -10000 0 0
G13/GTP 0.021 0.015 -10000 0 -0.22 2 2
pseudopodium formation -0.13 0.11 0.21 1 -0.19 363 364
E2/ER alpha (dimer)/PELP1 0.023 0 -10000 0 -10000 0 0
GRB2 0.017 0.002 -10000 0 -10000 0 0
GNG2 0 0 -10000 0 -10000 0 0
GNAO1 0.002 0.005 -10000 0 -10000 0 0
HRAS 0.016 0.019 -10000 0 -0.41 1 1
mol:GTP 0 0 -10000 0 -10000 0 0
mol:NO -0.03 0.037 -10000 0 -0.16 8 8
E2/ER beta (dimer) 0.013 0 -10000 0 -10000 0 0
mol:GDP -0.006 0.052 -10000 0 -0.2 2 2
mol:NADP -0.03 0.037 -10000 0 -0.16 8 8
PIK3R1 0.016 0.004 -10000 0 -10000 0 0
mol:IP3 0.03 0.018 -10000 0 -10000 0 0
IGF-1R heterotetramer 0.017 0 -10000 0 -10000 0 0
PLCB1 0.028 0.019 -10000 0 -0.15 2 2
PLCB2 0.028 0.019 -10000 0 -0.15 2 2
IGF1 0.014 0.037 -10000 0 -0.41 4 4
mol:L-citrulline -0.03 0.037 -10000 0 -0.16 8 8
RHOA 0.017 0.001 -10000 0 -10000 0 0
Gai/GDP -0.42 0.15 -10000 0 -0.46 481 481
JNK cascade 0.013 0 -10000 0 -10000 0 0
BCAR1 0 0 -10000 0 -10000 0 0
ESR2 0.017 0 -10000 0 -10000 0 0
GNAQ 0.017 0 -10000 0 -10000 0 0
ESR1 0.017 0 -10000 0 -10000 0 0
Gq family/GDP/Gbeta gamma 0.026 0.026 -10000 0 -0.15 7 7
E2/ER alpha (dimer)/PELP1/Src/p52 SHC/GRB2/SOS1 -0.008 0.067 -10000 0 -0.48 5 5
E2/ER alpha (dimer)/PELP1/Src/p52 SHC -0.059 0.074 -10000 0 -0.24 55 55
GNAZ 0.015 0.006 -10000 0 -10000 0 0
E2/ER alpha (dimer) 0.013 0 -10000 0 -10000 0 0
STRN 0.017 0 -10000 0 -10000 0 0
GNAL 0.017 0 -10000 0 -10000 0 0
PELP1 0.017 0 -10000 0 -10000 0 0
MAPK11 0.016 0 -10000 0 -10000 0 0
GNAI2 0.017 0.001 -10000 0 -10000 0 0
GNAI3 -0.036 0.14 -10000 0 -0.41 65 65
GNAI1 0.014 0.02 -10000 0 -0.41 1 1
HBEGF -0.16 0.1 -10000 0 -0.22 327 327
cAMP biosynthetic process 0.02 0 -10000 0 -10000 0 0
SRC -0.059 0.062 -10000 0 -0.19 66 66
PI3K 0.009 0.065 -10000 0 -0.28 25 25
GNB1 0.017 0.002 -10000 0 -10000 0 0
G13/GDP/Gbeta gamma 0.002 0.05 -10000 0 -0.21 2 2
SOS1 0 0 -10000 0 -10000 0 0
IGF-1R heterotetramer/IGF1 -0.05 0.061 -10000 0 -0.2 52 52
Gs family/GTP 0.025 0 -10000 0 -10000 0 0
EntrezGene:2778 0 0 -10000 0 -10000 0 0
RAS family/GTP -0.03 0.11 -10000 0 -0.21 138 138
vasodilation -0.03 0.036 -10000 0 -0.15 8 8
mol:DAG 0.03 0.018 -10000 0 -10000 0 0
Gs family/GDP/Gbeta gamma -0.02 0.034 -10000 0 -0.22 1 1
MSN -0.14 0.11 0.21 1 -0.2 363 364
Gq family/GTP 0.028 0.02 -10000 0 -0.16 2 2
mol:PI-3-4-5-P3 0.005 0.03 -10000 0 -10000 0 0
NRAS -0.094 0.19 -10000 0 -0.41 137 137
mol:E2 0 0 -10000 0 -10000 0 0
cell adhesion 0.03 0.036 0.15 8 -10000 0 8
GRB2/SOS1 0.013 0.001 -10000 0 -10000 0 0
RhoA/GDP 0.002 0.053 -10000 0 -0.18 2 2
NOS3 -0.031 0.038 -10000 0 -0.16 8 8
GNA11 0.017 0 -10000 0 -10000 0 0
MAPKKK cascade -0.015 0.047 -10000 0 -0.2 9 9
E2/ER alpha (dimer)/PELP1/Src -0.048 0.048 -10000 0 -0.19 14 14
ruffle organization -0.13 0.11 0.21 1 -0.19 363 364
ROCK2 -0.018 0.083 0.22 1 -0.16 135 136
GNA14 0.015 0.026 -10000 0 -0.41 2 2
GNA15 0.011 0.049 -10000 0 -0.41 7 7
GNA13 0.015 0.026 -10000 0 -0.41 2 2
MMP9 -0.13 0.11 -10000 0 -0.25 224 224
MMP2 -0.15 0.12 -10000 0 -0.25 286 286
IL1-mediated signaling events

Figure S34.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S34.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
UBC13/UEV1A 0.013 0.001 -9999 0 -10000 0 0
PRKCZ 0 0 -9999 0 -10000 0 0
MAP3K7IP2 0.017 0 -9999 0 -10000 0 0
ERC1 0.016 0.019 -9999 0 -0.41 1 1
IL1 beta fragment/IL1R1/IL1RAP/MYD88/IRAK4 -0.047 0.1 -9999 0 -0.23 95 95
IRAK/TOLLIP 0.025 0.002 -9999 0 -10000 0 0
IKBKB 0.017 0 -9999 0 -10000 0 0
IKBKG 0.017 0 -9999 0 -10000 0 0
IL1 alpha/IL1R2 0 0.085 -9999 0 -0.28 43 43
IL1A 0.015 0.032 -9999 0 -0.41 3 3
IL1B -0.088 0.15 -9999 0 -0.3 178 178
IRAK/TRAF6/p62/Atypical PKCs 0.038 0.013 -9999 0 -0.18 2 2
IL1R2 -0.015 0.11 -9999 0 -0.41 40 40
IL1R1 0.015 0.032 -9999 0 -0.41 3 3
IL1 beta fragment/IL1R1/IL1RAP/MYD88/IRAK4/IRAK/TOLLIP -0.035 0.09 -9999 0 -0.22 71 71
TOLLIP 0.017 0 -9999 0 -10000 0 0
TICAM2 0 0 -9999 0 -10000 0 0
MAP3K3 0.017 0 -9999 0 -10000 0 0
TAK1/TAB1/TAB2 0.034 0.012 -9999 0 -0.23 1 1
IKK complex/ELKS 0.049 0.015 -9999 0 -0.25 1 1
JUN 0.027 0.012 -9999 0 -10000 0 0
MAP3K7 0.016 0.019 -9999 0 -0.41 1 1
IL1 beta fragment/IL1R1/IL1RAP/PI3K -0.056 0.14 -9999 0 -0.22 196 196
IL1 alpha/IL1R1/IL1RAP/MYD88 -0.013 0.12 -9999 0 -0.23 112 112
PIK3R1 0.016 0.004 -9999 0 -10000 0 0
IL1 alpha/IL1R1/IL1RAP/MYD88/IRAK4 -0.005 0.11 -9999 0 -0.21 113 113
IL1 beta fragment/IL1R1/IL1RAP -0.069 0.15 -9999 0 -0.24 198 198
NFKB1 0.014 0.037 -9999 0 -0.41 4 4
MAPK8 0.027 0.009 -9999 0 -10000 0 0
IRAK1 0.016 0.001 -9999 0 -10000 0 0
IL1RN/IL1R1 0.024 0.023 -9999 0 -0.28 3 3
IRAK4 0.016 0.019 -9999 0 -0.41 1 1
PRKCI 0.016 0.019 -9999 0 -0.41 1 1
TRAF6 0.017 0 -9999 0 -10000 0 0
PI3K 0.009 0.065 -9999 0 -0.28 25 25
IL1 beta fragment/IL1R1/IL1RAP/MYD88/IRAK4/TOLLIP -0.043 0.1 -9999 0 -0.26 72 72
CHUK 0.016 0.019 -9999 0 -0.41 1 1
IL1 beta fragment/IL1R1/IL1RAP/MYD88s -0.069 0.15 -9999 0 -0.24 198 198
IL1 beta/IL1R2 -0.082 0.15 -9999 0 -0.26 201 201
IRAK/TRAF6/TAK1/TAB1/TAB2 0.048 0.01 -9999 0 -0.17 1 1
NF kappa B1 p50/RelA -0.056 0.13 -9999 0 -0.37 41 41
IRAK3 0.015 0.026 -9999 0 -0.41 2 2
IL1 beta fragment/IL1R1/IL1RAP/TICAM2/IRAK4 -0.056 0.14 -9999 0 -0.22 198 198
IL1 alpha/IL1R1/IL1RAP/MYD88/IRAK4/TOLLIP -0.003 0.071 -9999 0 -0.13 113 113
IL1 alpha/IL1R1/IL1RAP 0.009 0.081 -9999 0 -0.24 50 50
RELA 0.017 0 -9999 0 -10000 0 0
MAP3K7IP1 0.017 0 -9999 0 -10000 0 0
SQSTM1 0.016 0.019 -9999 0 -0.41 1 1
MYD88 -0.041 0.15 -9999 0 -0.41 72 72
IRAK/TRAF6/MEKK3 0.035 0.002 -9999 0 -10000 0 0
IL1RAP -0.019 0.12 -9999 0 -0.41 45 45
UBE2N 0.017 0.001 -9999 0 -10000 0 0
IRAK/TRAF6 -0.053 0.11 -9999 0 -0.34 33 33
CASP1 -0.12 0.2 -9999 0 -0.41 172 172
IL1RN/IL1R2 0.002 0.082 -9999 0 -0.28 40 40
IL1 beta fragment/IL1R1/IL1RAP/MYD88 -0.085 0.17 -9999 0 -0.27 221 221
TMEM189-UBE2V1 0 0 -9999 0 -10000 0 0
IL1 alpha/IL1R1/IL1RAP/MYD88/IRAK4/IRAK/TOLLIP 0.004 0.063 -9999 0 -0.22 11 11
PIK3CA -0.003 0.091 -9999 0 -0.41 25 25
IL1RN 0.017 0 -9999 0 -10000 0 0
TRAF6/TAK1/TAB1/TAB2 0.042 0.01 -9999 0 -0.18 1 1
MAP2K6 0.027 0.01 -9999 0 -0.17 1 1
Signaling events mediated by Stem cell factor receptor (c-Kit)

Figure S35.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S35.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
MAP4K1 0.004 0.085 -10000 0 -0.23 53 53
CRKL 0.001 0.089 -10000 0 -0.24 53 53
HRAS 0.007 0.097 -10000 0 -0.23 54 54
mol:PIP3 -0.008 0.086 0.18 3 -0.24 52 55
SPRED1 0 0 -10000 0 -10000 0 0
SPRED2 0.017 0 -10000 0 -10000 0 0
GAB1 -0.002 0.093 -10000 0 -0.25 62 62
FOXO3 0.004 0.089 -10000 0 -0.24 52 52
AKT1 0 0.095 -10000 0 -0.26 52 52
BAD 0.004 0.089 -10000 0 -0.24 52 52
megakaryocyte differentiation 0.001 0.088 0.16 1 -0.24 58 59
GSK3B 0.005 0.09 -10000 0 -0.24 52 52
RAF1 0.01 0.083 -10000 0 -0.19 53 53
SHC1 -0.021 0.12 -10000 0 -0.41 47 47
STAT3 -0.004 0.095 -10000 0 -0.24 66 66
STAT1 -0.004 0.16 -10000 0 -0.42 62 62
HRAS/SPRED1 0.006 0.082 -10000 0 -0.2 54 54
cell proliferation 0 0.091 -10000 0 -0.24 62 62
PIK3CA -0.003 0.091 -10000 0 -0.41 25 25
TEC 0.017 0 -10000 0 -10000 0 0
RPS6KB1 0.002 0.095 -10000 0 -0.26 53 53
HRAS/SPRED2 0.015 0.085 -10000 0 -0.19 52 52
LYN/TEC/p62DOK -0.004 0.11 -10000 0 -0.24 57 57
MAPK3 0.017 0.064 -10000 0 -0.2 12 12
STAP1 -0.001 0.093 -10000 0 -0.25 62 62
GRAP2 0.017 0 -10000 0 -10000 0 0
JAK2 -0.001 0.14 -10000 0 -0.39 62 62
STAT1 (dimer) -0.003 0.15 -10000 0 -0.41 62 62
mol:Gleevec -0.001 0.004 -10000 0 -10000 0 0
GRB2/SOCS1/VAV1 0.02 0.093 -10000 0 -0.24 53 53
actin filament polymerization -0.004 0.09 -10000 0 -0.25 62 62
LYN -0.035 0.14 -10000 0 -0.41 64 64
STAP1/STAT5A (dimer) 0.004 0.12 -10000 0 -0.33 53 53
PIK3R1 0.016 0.004 -10000 0 -10000 0 0
CBL/CRKL/GRB2 0.018 0.087 -10000 0 -0.22 53 53
PI3K 0.007 0.097 -10000 0 -0.25 48 48
PTEN 0.015 0.026 -10000 0 -0.41 2 2
SCF/KIT/EPO/EPOR 0.008 0.17 -10000 0 -0.47 53 53
MAPK8 -0.001 0.092 -10000 0 -0.25 62 62
STAT3 (dimer) -0.004 0.093 -10000 0 -0.24 66 66
positive regulation of transcription 0.017 0.055 -10000 0 -0.17 12 12
mol:GDP 0.006 0.1 -10000 0 -0.24 55 55
PIK3C2B -0.004 0.095 -10000 0 -0.25 65 65
CBL/CRKL 0.01 0.087 -10000 0 -0.23 53 53
FER -0.001 0.092 -10000 0 -0.25 62 62
SH2B3 -0.004 0.097 -10000 0 -0.26 63 63
PDPK1 -0.004 0.081 0.18 3 -0.22 52 55
SNAI2 -0.047 0.12 -10000 0 -0.22 164 164
positive regulation of cell proliferation -0.002 0.14 -10000 0 -0.37 62 62
KITLG 0.018 0.011 -10000 0 -10000 0 0
cell motility -0.002 0.14 -10000 0 -0.37 62 62
PTPN6 0.008 0.062 -10000 0 -0.41 11 11
EPOR 0.024 0.065 -10000 0 -10000 0 0
STAT5A (dimer) 0.003 0.12 -10000 0 -0.32 62 62
SOCS1 0.017 0 -10000 0 -10000 0 0
cell migration 0 0.091 0.24 62 -10000 0 62
SOS1 0 0 -10000 0 -10000 0 0
EPO 0.018 0.005 -10000 0 -10000 0 0
VAV1 0.016 0.019 -10000 0 -0.41 1 1
GRB10 -0.007 0.1 -10000 0 -0.27 62 62
PTPN11 0.017 0.004 -10000 0 -10000 0 0
SCF/KIT -0.004 0.097 -10000 0 -0.26 62 62
GO:0007205 0 0.006 -10000 0 -10000 0 0
MAP2K1 0.013 0.068 -10000 0 -0.22 14 14
CBL 0.017 0 -10000 0 -10000 0 0
KIT 0.032 0.071 -10000 0 -0.41 12 12
MAP2K2 0.013 0.069 -10000 0 -0.22 14 14
SHC/Grb2/SOS1 -0.006 0.11 -10000 0 -0.28 54 54
STAT5A 0.003 0.12 -10000 0 -0.32 62 62
GRB2 0.017 0.002 -10000 0 -10000 0 0
response to radiation -0.046 0.12 -10000 0 -0.21 164 164
SHC/GRAP2 -0.002 0.088 -10000 0 -0.28 47 47
PTPRO 0 0.089 -10000 0 -0.25 58 58
SH2B2 -0.004 0.092 -10000 0 -0.25 62 62
DOK1 0.017 0 -10000 0 -10000 0 0
MATK -0.001 0.092 -10000 0 -0.25 62 62
CREBBP 0.026 0.03 -10000 0 -10000 0 0
BCL2 0.024 0.064 -10000 0 -10000 0 0
Integrins in angiogenesis

Figure S36.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S36.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
VEGFR2 homodimer/VEGFA homodimer -0.15 0.16 -9999 0 -0.3 291 291
alphaV beta3 Integrin 0.026 0.049 -9999 0 -0.23 18 18
PTK2 -0.058 0.095 -9999 0 -0.28 28 28
IGF1R 0.017 0 -9999 0 -10000 0 0
PI4KB 0.016 0.019 -9999 0 -0.41 1 1
MFGE8 0.015 0.032 -9999 0 -0.41 3 3
SRC 0.017 0 -9999 0 -10000 0 0
CDKN1B 0.022 0.023 -9999 0 -0.19 2 2
VEGFA -0.22 0.21 -9999 0 -0.41 286 286
ILK 0.022 0.023 -9999 0 -0.19 2 2
ROCK1 0.017 0 -9999 0 -10000 0 0
AKT1 0.021 0.028 -9999 0 -0.18 6 6
PTK2B -0.1 0.12 -9999 0 -0.2 297 297
alphaV/beta3 Integrin/JAM-A 0.021 0.071 -9999 0 -0.19 53 53
CBL 0.017 0 -9999 0 -10000 0 0
mol:GTP 0 0 -9999 0 -10000 0 0
alphaV beta3 Integrin/ANGPTL3 0.027 0.046 -9999 0 -0.23 16 16
IGF-1R heterotetramer/IGF1/IRS1/Shp2 0.04 0.033 -9999 0 -0.21 9 9
VEGF/Rho/ROCK/alphaV/beta3 Integrin -0.04 0.07 -9999 0 -0.21 21 21
alphaV/beta3 Integrin/Syndecan-1 0.003 0.092 -9999 0 -0.25 60 60
PI4KA 0.006 0.008 -9999 0 -10000 0 0
IGF-1R heterotetramer/IGF1/IRS1 -0.011 0.1 -9999 0 -0.19 114 114
PI4 Kinase 0.009 0.014 -9999 0 -0.14 1 1
PIK3CA -0.003 0.091 -9999 0 -0.41 25 25
alphaV/beta3 Integrin/Osteopontin -0.065 0.14 -9999 0 -0.25 185 185
RPS6KB1 -0.013 0.095 -9999 0 -0.36 13 13
TLN1 -0.02 0.12 -9999 0 -0.41 46 46
MAPK3 0.003 0.069 -9999 0 -0.19 39 39
GPR124 0.014 0.037 -9999 0 -0.41 4 4
MAPK1 0.003 0.068 -9999 0 -0.24 18 18
PXN 0.017 0 -9999 0 -10000 0 0
PIK3R1 0.016 0.004 -9999 0 -10000 0 0
alphaV/beta3 Integrin/Tumstatin 0.027 0.046 -9999 0 -0.23 16 16
cell adhesion 0.029 0.045 -9999 0 -0.2 20 20
ANGPTL3 0.017 0 -9999 0 -10000 0 0
VEGFR2 homodimer/VEGFA homodimer/Src -0.12 0.14 -9999 0 -0.24 291 291
IGF-1R heterotetramer 0.017 0 -9999 0 -10000 0 0
Rac1/GDP 0.013 0 -9999 0 -10000 0 0
TGFBR2 0.011 0.049 -9999 0 -0.41 7 7
ITGB3 0.017 0 -9999 0 -10000 0 0
IGF1 0.014 0.037 -9999 0 -0.41 4 4
RAC1 0.017 0 -9999 0 -10000 0 0
regulation of cell-matrix adhesion 0.024 0.051 -9999 0 -0.23 20 20
apoptosis 0.004 0.073 -9999 0 -0.41 16 16
CD47 0.015 0.026 -9999 0 -0.41 2 2
alphaV/beta3 Integrin/CD47 0.026 0.049 -9999 0 -0.23 18 18
VCL 0.017 0 -9999 0 -10000 0 0
alphaV/beta3 Integrin/Del1 0.027 0.046 -9999 0 -0.23 16 16
CSF1 0.017 0 -9999 0 -10000 0 0
PIK3C2A 0.012 0.023 -9999 0 -0.19 2 2
PI4 Kinase/Pyk2 -0.054 0.079 -9999 0 -0.28 23 23
VEGFR2 homodimer/VEGFA homodimer/alphaV beta3 Integrin -0.11 0.14 -9999 0 -0.22 297 297
FAK1/Vinculin -0.044 0.084 -9999 0 -0.23 28 28
alphaV beta3/Integrin/ppsTEM5 0.025 0.051 -9999 0 -0.23 20 20
RHOA 0.017 0.001 -9999 0 -10000 0 0
VTN 0.015 0.026 -9999 0 -0.41 2 2
BCAR1 0 0 -9999 0 -10000 0 0
FGF2 0.015 0.026 -9999 0 -0.41 2 2
F11R -0.002 0.075 -9999 0 -0.28 35 35
alphaV/beta3 Integrin/Lactadherin 0.025 0.05 -9999 0 -0.23 19 19
alphaV/beta3 Integrin/TGFBR2 0.023 0.055 -9999 0 -0.23 23 23
alphaV/beta3 Integrin/c-FMS/Cbl/Cas 0.026 0.042 -9999 0 -0.21 16 16
HSP90AA1 0.017 0 -9999 0 -10000 0 0
alphaV/beta3 Integrin/Talin 0.005 0.084 -9999 0 -0.23 57 57
mol:GDP 0 0 -9999 0 -10000 0 0
FN1 -0.065 0.17 -9999 0 -0.41 101 101
alphaV/beta3 Integrin/Pyk2 -0.097 0.13 -9999 0 -0.2 297 297
SDC1 -0.022 0.12 -9999 0 -0.41 48 48
VAV3 0.001 0.069 -9999 0 -0.21 48 48
PTPN11 0.017 0 -9999 0 -10000 0 0
IRS1 0.013 0.042 -9999 0 -0.41 5 5
FAK1/Paxillin -0.044 0.084 -9999 0 -0.23 28 28
cell migration -0.038 0.079 -9999 0 -0.21 28 28
ITGAV 0.004 0.073 -9999 0 -0.41 16 16
PI3K 0.022 0.072 -9999 0 -0.18 51 51
SPP1 -0.13 0.2 -9999 0 -0.41 181 181
KDR 0.003 0.076 -9999 0 -0.41 17 17
mol:PI-4-5-P2 0 0 -9999 0 -10000 0 0
alphaV/beta3 Integrin/Caspase 8 0.004 0.073 -9999 0 -0.41 16 16
COL4A3 0.017 0 -9999 0 -10000 0 0
angiogenesis 0.008 0.064 -9999 0 -0.22 18 18
Rac1/GTP 0.011 0.065 -9999 0 -0.19 48 48
EDIL3 0.017 0 -9999 0 -10000 0 0
cell proliferation 0.023 0.055 -9999 0 -0.23 23 23
BCR signaling pathway

Figure S37.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S37.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
JUN 0 0.077 -10000 0 -0.19 50 50
IKBKB 0.007 0.051 -10000 0 -0.16 22 22
AKT1 -0.013 0.069 0.18 1 -0.17 59 60
IKBKG 0.007 0.053 -10000 0 -0.16 24 24
CALM1 -0.011 0.079 -10000 0 -0.25 38 38
PIK3CA -0.003 0.091 -10000 0 -0.41 25 25
MAP3K1 -0.01 0.095 -10000 0 -0.24 57 57
MAP3K7 0.016 0.019 -10000 0 -0.41 1 1
mol:Ca2+ -0.015 0.086 -10000 0 -0.27 40 40
DOK1 0.017 0 -10000 0 -10000 0 0
AP-1 -0.011 0.071 -10000 0 -0.17 49 49
LYN -0.035 0.14 -10000 0 -0.41 64 64
BLNK -0.038 0.14 -10000 0 -0.41 68 68
SHC1 -0.021 0.12 -10000 0 -0.41 47 47
BCR complex 0.024 0.028 -10000 0 -0.41 2 2
CD22 -0.038 0.11 -10000 0 -0.24 94 94
CAMK2G -0.006 0.058 -10000 0 -0.23 24 24
CSNK2A1 0.017 0 -10000 0 -10000 0 0
INPP5D 0 0 -10000 0 -10000 0 0
SHC/GRB2/SOS1 -0.07 0.14 -10000 0 -0.46 49 49
GO:0007205 -0.016 0.087 -10000 0 -0.28 40 40
SYK -0.012 0.11 -10000 0 -0.41 36 36
ELK1 -0.012 0.083 -10000 0 -0.26 40 40
NFATC1 -0.019 0.093 0.14 1 -0.23 64 65
B-cell antigen/BCR complex 0.024 0.028 -10000 0 -0.41 2 2
PAG1/CSK 0.013 0 -10000 0 -10000 0 0
NFKBIB 0.013 0.021 -10000 0 -0.085 2 2
HRAS -0.016 0.093 -10000 0 -0.28 46 46
NFKBIA 0.013 0.021 -10000 0 -0.086 2 2
NF-kappa-B/RelA/I kappa B beta 0.017 0.02 -10000 0 -0.091 4 4
RasGAP/Csk -0.009 0.11 -10000 0 -0.19 126 126
mol:GDP -0.013 0.084 -10000 0 -0.26 40 40
PTEN 0.015 0.026 -10000 0 -0.41 2 2
CD79B 0.016 0.019 -10000 0 -0.41 1 1
NF-kappa-B/RelA/I kappa B alpha 0.017 0.02 -10000 0 -0.092 4 4
GRB2 0.017 0.002 -10000 0 -10000 0 0
PI3K/BCAP/CD19 -0.024 0.11 -10000 0 -0.29 60 60
PIK3R1 0.016 0.004 -10000 0 -10000 0 0
mol:IP3 -0.016 0.088 -10000 0 -0.28 40 40
CSK 0.017 0 -10000 0 -10000 0 0
FOS -0.051 0.12 -10000 0 -0.22 148 148
CHUK 0.007 0.053 -10000 0 -0.16 25 25
IBTK 0.017 0 -10000 0 -10000 0 0
CARD11/BCL10/MALT1/TAK1 -0.006 0.093 -10000 0 -0.25 45 45
PTPN6 -0.037 0.11 -10000 0 -0.25 94 94
RELA 0.017 0 -10000 0 -10000 0 0
BCL2A1 -0.001 0.037 -10000 0 -0.064 129 129
VAV2 -0.034 0.12 -10000 0 -0.29 68 68
ubiquitin-dependent protein catabolic process 0.016 0.02 -10000 0 -0.08 2 2
BTK 0.011 0.009 -10000 0 -10000 0 0
CD19 -0.038 0.11 -10000 0 -0.24 94 94
MAP4K1 0.016 0.019 -10000 0 -0.41 1 1
CD72 0.017 0 -10000 0 -10000 0 0
PAG1 0 0 -10000 0 -10000 0 0
MAPK14 -0.005 0.086 -10000 0 -0.21 59 59
SH3BP5 0.016 0.005 -10000 0 -10000 0 0
PIK3AP1 -0.018 0.09 -10000 0 -0.29 40 40
B-cell antigen/BCR complex/Btk/LYN/SYK/BLNK/PLCgamma2/CD72 -0.009 0.11 -10000 0 -0.34 40 40
RAF1 -0.012 0.089 -10000 0 -0.26 45 45
RasGAP/p62DOK/SHIP -0.013 0.099 -10000 0 -0.19 126 126
CD79A 0.015 0.026 -10000 0 -0.41 2 2
re-entry into mitotic cell cycle -0.011 0.071 -10000 0 -0.17 49 49
RASA1 0.017 0.002 -10000 0 -10000 0 0
MAPK3 -0.001 0.079 0.17 1 -0.23 40 41
MAPK1 -0.002 0.079 0.26 1 -0.23 40 41
CD72/SHP1 -0.027 0.11 -10000 0 -0.28 59 59
NFKB1 0.014 0.037 -10000 0 -0.41 4 4
MAPK8 -0.004 0.085 -10000 0 -0.21 57 57
actin cytoskeleton organization -0.027 0.1 -10000 0 -0.26 65 65
NF-kappa-B/RelA 0.037 0.035 -10000 0 -0.15 2 2
Calcineurin 0.006 0.069 -10000 0 -0.21 34 34
PI3K -0.061 0.11 -10000 0 -0.3 80 80
B-cell antigen/BCR complex/Btk/LYN/SYK/BLNK/PLCgamma2 -0.019 0.095 -10000 0 -0.24 61 61
SOS1 0 0 -10000 0 -10000 0 0
Bam32/HPK1 -0.011 0.094 -10000 0 -0.25 38 38
DAPP1 -0.022 0.095 -10000 0 -0.27 38 38
cytokine secretion -0.017 0.088 0.14 1 -0.22 64 65
mol:DAG -0.016 0.088 -10000 0 -0.28 40 40
PLCG2 0.009 0.058 -10000 0 -0.41 10 10
MAP2K1 -0.007 0.083 0.17 1 -0.25 40 41
B-cell antigen/BCR complex/FcgammaRIIB -0.032 0.12 -10000 0 -0.24 129 129
mol:PI-3-4-5-P3 -0.046 0.084 0.27 1 -0.23 73 74
ETS1 0.048 0.091 0.22 18 -0.22 24 42
B-cell antigen/BCR complex/LYN/SYK/BLNK -0.022 0.16 -10000 0 -0.3 111 111
B-cell antigen/BCR complex/LYN -0.043 0.11 -10000 0 -0.22 135 135
MALT1 -0.003 0.091 -10000 0 -0.41 25 25
TRAF6 0.017 0 -10000 0 -10000 0 0
RAC1 -0.029 0.11 -10000 0 -0.27 65 65
B-cell antigen/BCR complex/LYN/SYK -0.042 0.16 -10000 0 -0.4 66 66
CARD11 -0.015 0.083 -10000 0 -0.26 40 40
FCGR2B -0.088 0.18 -10000 0 -0.41 129 129
PPP3CA 0.014 0.007 -10000 0 -10000 0 0
BCL10 0.015 0.032 -10000 0 -0.41 3 3
IKK complex 0.011 0.025 -10000 0 -0.07 10 10
PTPRC -0.086 0.18 -10000 0 -0.41 127 127
PDPK1 -0.016 0.069 0.17 1 -0.16 66 67
PPP3CB 0.017 0.002 -10000 0 -10000 0 0
PPP3CC 0.017 0 -10000 0 -10000 0 0
POU2F2 0.016 0.013 -10000 0 -0.054 1 1
Angiopoietin receptor Tie2-mediated signaling

Figure S38.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S38.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
AKT1 -0.13 0.17 -10000 0 -0.44 52 52
NCK1/PAK1/Dok-R -0.083 0.075 -10000 0 -0.24 54 54
NCK1/Dok-R -0.011 0.11 -10000 0 -0.29 13 13
PIK3CA -0.003 0.091 -10000 0 -0.41 25 25
mol:beta2-estradiol 0.012 0.044 0.12 78 -10000 0 78
RELA 0.017 0 -10000 0 -10000 0 0
SHC1 -0.022 0.12 -10000 0 -0.41 47 47
Rac/GDP 0.013 0 -10000 0 -10000 0 0
F2 0.037 0.054 -10000 0 -0.42 2 2
TNIP2 0.008 0.061 -10000 0 -0.41 11 11
NF kappa B/RelA 0.005 0.11 -10000 0 -0.35 6 6
FN1 -0.065 0.17 -10000 0 -0.41 101 101
PLD2 -0.013 0.1 -10000 0 -0.27 46 46
PTPN11 0.017 0 -10000 0 -10000 0 0
GRB14 0.002 0.078 -10000 0 -0.41 18 18
ELK1 -0.003 0.098 -10000 0 -0.26 6 6
GRB7 0.016 0.019 -10000 0 -0.41 1 1
PAK1 0.017 0 -10000 0 -10000 0 0
Tie2/Ang1/alpha5/beta1 Integrin -0.055 0.17 -10000 0 -0.4 60 60
CDKN1A -0.16 0.2 -10000 0 -0.47 93 93
ITGA5 -0.043 0.15 -10000 0 -0.41 74 74
mol:GTP 0 0 -10000 0 -10000 0 0
RasGAP/Dok-R -0.007 0.1 -10000 0 -0.27 15 15
CRK 0.017 0 -10000 0 -10000 0 0
mol:NO -0.1 0.14 -10000 0 -0.36 52 52
PLG -0.013 0.1 -10000 0 -0.27 46 46
mol:GDP 0 0 -10000 0 -10000 0 0
chemokinesis -0.1 0.15 -10000 0 -0.4 51 51
GRB2 0.017 0.002 -10000 0 -10000 0 0
PIK3R1 0.015 0.004 -10000 0 -10000 0 0
ANGPT2 -0.2 0.21 -10000 0 -0.39 280 280
BMX -0.013 0.1 -10000 0 -0.27 46 46
ANGPT1 -0.038 0.13 -10000 0 -0.34 78 78
tube development -0.16 0.19 0.28 1 -0.41 102 103
ANGPT4 0.012 0.005 -10000 0 -10000 0 0
response to hypoxia -0.006 0.012 -10000 0 -10000 0 0
Tie2/Ang1/GRB14 -0.014 0.11 -10000 0 -0.3 16 16
alpha5/beta1 Integrin -0.018 0.11 -10000 0 -0.28 74 74
FGF2 0.02 0.027 -10000 0 -0.41 2 2
STAT5A (dimer) -0.17 0.22 -10000 0 -0.51 87 87
mol:L-citrulline -0.1 0.14 -10000 0 -0.36 52 52
AGTR1 0.002 0.029 -10000 0 -0.41 2 2
MAPK14 -0.047 0.12 -10000 0 -0.33 40 40
Tie2/SHP2 0.016 0.045 -10000 0 -0.21 1 1
TEK 0.009 0.05 -10000 0 -0.2 2 2
RPS6KB1 -0.1 0.15 -10000 0 -0.39 50 50
Angiotensin II/AT1 -0.006 0.026 -10000 0 -0.29 2 2
Tie2/Ang1/GRB2 -0.006 0.11 -10000 0 -0.27 40 40
MAPK3 -0.009 0.098 -10000 0 -0.25 46 46
MAPK1 -0.01 0.096 -10000 0 -0.27 11 11
Tie2/Ang1/GRB7 -0.007 0.11 -10000 0 -0.27 40 40
NFKB1 0.014 0.037 -10000 0 -0.41 4 4
MAPK8 -0.013 0.1 -10000 0 -0.27 46 46
PI3K -0.12 0.16 -10000 0 -0.41 57 57
FES -0.049 0.12 -10000 0 -0.33 40 40
Crk/Dok-R -0.007 0.1 -10000 0 -0.26 40 40
Tie2/Ang1/ABIN2 -0.011 0.11 -10000 0 -0.28 40 40
blood circulation 0 0 -10000 0 -10000 0 0
negative regulation of caspase activity -0.12 0.16 -10000 0 -0.41 52 52
STAT5A 0.016 0.019 -10000 0 -0.41 1 1
mol:ROS 0 0 -10000 0 -10000 0 0
PTK2 -0.1 0.15 -10000 0 -0.4 43 43
Tie2/Ang2 -0.19 0.23 -10000 0 -0.5 104 104
Tie2/Ang1 -0.016 0.11 -10000 0 -0.29 48 48
FOXO1 -0.14 0.18 -10000 0 -0.43 81 81
ELF1 0.016 0.049 -10000 0 -0.41 7 7
ELF2 -0.015 0.11 -10000 0 -0.28 46 46
mol:Choline -0.012 0.1 -10000 0 -0.27 46 46
cell migration -0.064 0.057 -10000 0 -0.16 95 95
FYN -0.17 0.2 -10000 0 -0.45 103 103
DOK2 0 0 -10000 0 -10000 0 0
negative regulation of cell cycle -0.14 0.19 -10000 0 -0.43 93 93
ETS1 0.008 0.047 -10000 0 -10000 0 0
PXN -0.089 0.14 -10000 0 -0.36 42 42
ITGB1 0.017 0 -10000 0 -10000 0 0
NOS3 -0.11 0.16 -10000 0 -0.4 52 52
RAC1 0.017 0 -10000 0 -10000 0 0
TNF 0.002 0.053 -10000 0 -0.41 2 2
MAPKKK cascade -0.012 0.1 -10000 0 -0.27 46 46
RASA1 0.017 0.002 -10000 0 -10000 0 0
Tie2/Ang1/Shc -0.031 0.12 -10000 0 -0.32 43 43
NCK1 0.008 0.061 -10000 0 -0.41 11 11
vasculogenesis -0.097 0.14 -10000 0 -0.33 52 52
mol:Phosphatidic acid -0.012 0.1 -10000 0 -0.27 46 46
mol:Angiotensin II -0.009 0.01 -10000 0 -10000 0 0
mol:NADP -0.1 0.14 -10000 0 -0.36 52 52
Rac1/GTP -0.099 0.14 -10000 0 -0.38 43 43
MMP2 -0.11 0.14 -10000 0 -0.36 62 62
Syndecan-2-mediated signaling events

Figure S39.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S39.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
Syndecan-2/Fibronectin -0.03 0.11 -9999 0 -0.24 105 105
EPHB2 0.015 0.026 -9999 0 -0.41 2 2
Syndecan-2/TACI 0.019 0.036 -9999 0 -0.25 8 8
LAMA1 0 0 -9999 0 -10000 0 0
Syndecan-2/alpha2 ITGB1 -0.009 0.1 -9999 0 -0.21 106 106
HRAS 0.016 0.019 -9999 0 -0.41 1 1
Syndecan-2/CASK 0.007 0.034 -9999 0 -0.2 13 13
ITGA5 -0.043 0.15 -9999 0 -0.41 74 74
BAX 0.018 0.056 -9999 0 -0.3 14 14
EPB41 0.017 0 -9999 0 -10000 0 0
positive regulation of cell-cell adhesion 0.017 0.032 -9999 0 -0.22 8 8
LAMA3 0.005 0.071 -9999 0 -0.41 15 15
EZR 0 0 -9999 0 -10000 0 0
mol:PI-4-5-P2 0 0 -9999 0 -10000 0 0
CAV2 -0.041 0.15 -9999 0 -0.41 72 72
Syndecan-2/MMP2 -0.1 0.13 -9999 0 -0.24 254 254
RP11-540L11.1 0 0 -9999 0 -10000 0 0
alpha2 ITGB1 -0.029 0.12 -9999 0 -0.28 93 93
dendrite morphogenesis 0.018 0.039 -9999 0 -0.24 10 10
Syndecan-2/GM-CSF 0.019 0.036 -9999 0 -0.25 8 8
determination of left/right symmetry 0.01 0.041 -9999 0 -0.23 13 13
Syndecan-2/PKC delta 0.019 0.036 -9999 0 -0.25 8 8
GNB2L1 0.017 0 -9999 0 -10000 0 0
MAPK3 0.019 0.032 -9999 0 -0.22 8 8
MAPK1 0.018 0.032 -9999 0 -0.22 8 8
Syndecan-2/RACK1 0.027 0.033 -9999 0 -0.2 9 9
NF1 0.017 0 -9999 0 -10000 0 0
FGFR/FGF/Syndecan-2 0.01 0.041 -9999 0 -0.23 13 13
ITGA2 -0.058 0.16 -9999 0 -0.41 93 93
MAPK8 0.017 0.042 -9999 0 -0.24 13 13
Syndecan-2/alpha2/beta1 Integrin -0.012 0.091 -9999 0 -0.2 99 99
Syndecan-2/Kininogen 0.018 0.037 -9999 0 -0.25 9 9
ITGB1 0.017 0 -9999 0 -10000 0 0
SRC 0.021 0.03 -9999 0 -0.19 9 9
Syndecan-2/CASK/Protein 4.1 0.017 0.032 -9999 0 -0.22 8 8
extracellular matrix organization 0.006 0.067 -9999 0 -0.24 34 34
actin cytoskeleton reorganization -0.03 0.11 -9999 0 -0.24 105 105
Syndecan-2/Caveolin-2/Ras -0.004 0.091 -9999 0 -0.22 76 76
Syndecan-2/Laminin alpha3 0.012 0.056 -9999 0 -0.24 23 23
Syndecan-2/RasGAP 0.034 0.033 -9999 0 -0.19 9 9
alpha5/beta1 Integrin -0.018 0.11 -9999 0 -0.28 74 74
PRKCD 0.017 0 -9999 0 -10000 0 0
Syndecan-2 dimer 0.018 0.039 -9999 0 -0.24 10 10
GO:0007205 0.002 0.01 -9999 0 -0.11 1 1
DNA mediated transformation 0 0 -9999 0 -10000 0 0
Syndecan-2/RasGAP/Src 0.033 0.031 -9999 0 -0.18 9 9
RHOA 0.017 0.001 -9999 0 -10000 0 0
SDCBP 0.017 0 -9999 0 -10000 0 0
TNFRSF13B 0.017 0 -9999 0 -10000 0 0
RASA1 0.017 0.002 -9999 0 -10000 0 0
alpha2/beta1 Integrin -0.029 0.12 -9999 0 -0.28 93 93
Syndecan-2/Synbindin 0.019 0.036 -9999 0 -0.25 8 8
TGFB1 -0.005 0.094 -9999 0 -0.41 27 27
CASP3 -0.023 0.093 -9999 0 -0.21 103 103
FN1 -0.065 0.17 -9999 0 -0.41 101 101
Syndecan-2/IL8 -0.037 0.11 -9999 0 -0.24 121 121
SDC2 0.01 0.041 -9999 0 -0.24 13 13
KNG1 0.016 0.019 -9999 0 -0.41 1 1
Syndecan-2/Neurofibromin 0.019 0.036 -9999 0 -0.25 8 8
TRAPPC4 0.017 0.001 -9999 0 -10000 0 0
CSF2 0.017 0 -9999 0 -10000 0 0
Syndecan-2/TGFB1 0.006 0.067 -9999 0 -0.24 34 34
Syndecan-2/Syntenin/PI-4-5-P2 0.017 0.032 -9999 0 -0.22 8 8
Syndecan-2/Ezrin 0.017 0.032 -9999 0 -0.22 8 8
PRKACA 0.019 0.032 -9999 0 -0.22 8 8
angiogenesis -0.037 0.11 -9999 0 -0.24 121 121
MMP2 -0.19 0.21 -9999 0 -0.41 251 251
IL8 -0.076 0.18 -9999 0 -0.41 115 115
calcineurin-NFAT signaling pathway 0.019 0.036 -9999 0 -0.25 8 8
Syndecan-3-mediated signaling events

Figure S40.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S40.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
CTTN 0.017 0 -9999 0 -10000 0 0
Syndecan-3/Src/Cortactin 0.023 0.063 -9999 0 -0.21 25 25
Syndecan-3/Neurocan 0.003 0.062 -9999 0 -0.2 37 37
POMC 0.017 0 -9999 0 -10000 0 0
EGFR -0.14 0.21 -9999 0 -0.41 194 194
Syndecan-3/EGFR -0.073 0.12 -9999 0 -0.21 219 219
AGRP 0.017 0 -9999 0 -10000 0 0
NCSTN -0.007 0.099 -9999 0 -0.41 30 30
PSENEN 0.017 0.001 -9999 0 -10000 0 0
RP11-540L11.1 0 0 -9999 0 -10000 0 0
APH1B 0.017 0 -9999 0 -10000 0 0
APH1A 0.008 0.061 -9999 0 -0.41 11 11
NCAN 0.013 0.027 -9999 0 -0.41 2 2
long-term memory 0.014 0.065 -9999 0 -0.21 37 37
Syndecan-3/IL8 -0.042 0.11 -9999 0 -0.21 145 145
PSEN1 0.016 0.019 -9999 0 -0.41 1 1
Src/Cortactin 0.025 0 -9999 0 -10000 0 0
FYN 0.015 0.026 -9999 0 -0.41 2 2
limb bud formation 0.001 0.058 -9999 0 -0.26 21 21
MC4R 0.016 0.019 -9999 0 -0.41 1 1
SRC 0.017 0 -9999 0 -10000 0 0
PTN 0.016 0.004 -9999 0 -10000 0 0
FGFR/FGF/Syndecan-3 0.001 0.059 -9999 0 -0.26 21 21
neuron projection morphogenesis 0.016 0.05 -9999 0 -0.22 13 13
Syndecan-3/AgRP 0.003 0.073 -9999 0 -0.25 36 36
Syndecan-3/AgRP/MC4R 0.013 0.073 -9999 0 -0.24 37 37
Fyn/Cortactin 0.023 0.02 -9999 0 -0.28 2 2
SDC3 0.001 0.059 -9999 0 -0.26 21 21
GO:0007205 0 0 -9999 0 -10000 0 0
positive regulation of leukocyte migration -0.041 0.11 -9999 0 -0.21 145 145
IL8 -0.076 0.18 -9999 0 -0.41 115 115
Syndecan-3/Fyn/Cortactin 0.014 0.066 -9999 0 -0.21 37 37
Syndecan-3/CASK -0.007 0.071 -9999 0 -0.25 36 36
alpha-MSH/MC4R 0.025 0.013 -9999 0 -0.28 1 1
Gamma Secretase 0.032 0.068 -9999 0 -0.2 40 40
Signaling events mediated by HDAC Class I

Figure S41.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S41.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
NF kappa B/RelA -0.032 0.11 -9999 0 -0.18 187 187
Ran/GTP/Exportin 1/HDAC1 -0.022 0.058 -9999 0 -0.17 66 66
NF kappa B1 p50/RelA/I kappa B alpha -0.02 0.086 -9999 0 -0.13 187 187
SUMO1 0.017 0 -9999 0 -10000 0 0
ZFPM1 0 0 -9999 0 -10000 0 0
NPC/RanGAP1/SUMO1/Ubc9 0.017 0.005 -9999 0 -0.11 1 1
FKBP3 0.017 0.001 -9999 0 -10000 0 0
Histones -0.032 0.092 -9999 0 -0.21 69 69
YY1/LSF 0.026 0 -9999 0 -10000 0 0
SMG5 0.017 0 -9999 0 -10000 0 0
RAN 0.017 0.001 -9999 0 -10000 0 0
I kappa B alpha/HDAC3 -0.03 0.081 -9999 0 -0.14 186 186
I kappa B alpha/HDAC1 -0.043 0.096 -9999 0 -0.24 67 67
SAP18 0.017 0 -9999 0 -10000 0 0
RELA -0.02 0.07 -9999 0 -0.12 185 185
HDAC1/Smad7 0.001 0.091 -9999 0 -0.24 66 66
RANGAP1 0.017 0 -9999 0 -10000 0 0
HDAC3/TR2 -0.014 0.063 -9999 0 -10000 0 0
NuRD/MBD3 Complex -0.009 0.068 -9999 0 -0.19 40 40
NF kappa B1 p50/RelA -0.013 0.069 -9999 0 -0.25 4 4
EntrezGene:23225 0 0 -9999 0 -10000 0 0
GATA2 0.016 0.019 -9999 0 -0.41 1 1
GATA1 0.017 0 -9999 0 -10000 0 0
Mad/Max 0.025 0 -9999 0 -10000 0 0
NuRD/MBD3 Complex/GATA1/Fog1 -0.007 0.073 -9999 0 -0.19 40 40
RBBP7 0.017 0 -9999 0 -10000 0 0
NPC 0.01 0.009 -9999 0 -0.2 1 1
RBBP4 -0.065 0.17 -9999 0 -0.41 101 101
MAX 0.017 0 -9999 0 -10000 0 0
EntrezGene:9972 0 0 -9999 0 -10000 0 0
FBXW11 0.017 0 -9999 0 -10000 0 0
NFKBIA -0.025 0.068 -9999 0 -0.12 186 186
KAT2B 0 0 -9999 0 -10000 0 0
mol:GTP 0 0 -9999 0 -10000 0 0
SIN3/HDAC complex -0.01 0.07 -9999 0 -0.23 21 21
SIN3 complex 0.033 0 -9999 0 -10000 0 0
SMURF1 0.017 0 -9999 0 -10000 0 0
CHD3 0.017 0 -9999 0 -10000 0 0
SAP30 0.017 0 -9999 0 -10000 0 0
EntrezGene:23636 0 0 -9999 0 -10000 0 0
NCOR1 0.017 0 -9999 0 -10000 0 0
YY1/HDAC3 -0.008 0.056 -9999 0 -10000 0 0
YY1/HDAC2 0.024 0.024 -9999 0 -0.22 5 5
YY1/HDAC1 -0.005 0.082 -9999 0 -0.22 66 66
NuRD/MBD2 Complex (MeCP1) -0.009 0.068 -9999 0 -0.19 40 40
PPARG -0.033 0.088 -9999 0 -0.15 189 189
HDAC8/hEST1B 0.023 0 -9999 0 -10000 0 0
UBE2I 0.017 0 -9999 0 -10000 0 0
beta TrCP1/SCF ubiquitin ligase complex 0.017 0 -9999 0 -10000 0 0
TNFRSF1A -0.13 0.2 -9999 0 -0.41 183 183
HDAC3/SMRT (N-CoR2) -0.014 0.063 -9999 0 -10000 0 0
MBD3L2 0 0 -9999 0 -10000 0 0
ubiquitin-dependent protein catabolic process 0.001 0.09 -9999 0 -0.24 66 66
CREBBP 0.017 0 -9999 0 -10000 0 0
NuRD/MBD3/MBD3L2 Complex -0.011 0.076 -9999 0 -0.2 40 40
HDAC1 -0.036 0.14 -9999 0 -0.41 66 66
HDAC3 -0.025 0.068 -9999 0 -0.12 185 185
HDAC2 0.013 0.042 -9999 0 -0.41 5 5
YY1 0.018 0 -9999 0 -10000 0 0
HDAC8 0 0 -9999 0 -10000 0 0
SMAD7 0.016 0.019 -9999 0 -0.41 1 1
NCOR2 0.017 0 -9999 0 -10000 0 0
MXD1 0.017 0 -9999 0 -10000 0 0
STAT3 0.019 0.027 -9999 0 -0.18 10 10
NFKB1 0.014 0.037 -9999 0 -0.41 4 4
EntrezGene:8021 0 0 -9999 0 -10000 0 0
RANBP2 0.016 0.019 -9999 0 -0.41 1 1
YY1/LSF/HDAC1 0.006 0.077 -9999 0 -0.2 66 66
YY1/SAP30/HDAC1 0.006 0.077 -9999 0 -0.2 66 66
EP300 0.017 0 -9999 0 -10000 0 0
STAT3 (dimer non-phopshorylated) 0.018 0.027 -9999 0 -0.18 10 10
proteasomal ubiquitin-dependent protein catabolic process -0.025 0.068 -9999 0 -0.12 186 186
histone deacetylation -0.009 0.068 -9999 0 -0.19 40 40
STAT3 (dimer non-phopshorylated)/HDAC3 -0.009 0.063 -9999 0 -0.22 10 10
nuclear export -0.023 0 -9999 0 -10000 0 0
PRKACA 0.017 0 -9999 0 -10000 0 0
GATAD2B 0 0 -9999 0 -10000 0 0
GATAD2A -0.023 0.12 -9999 0 -0.41 49 49
GATA2/HDAC3 -0.014 0.064 -9999 0 -0.2 1 1
GATA1/HDAC1 -0.013 0.1 -9999 0 -0.28 66 66
GATA1/HDAC3 -0.014 0.063 -9999 0 -10000 0 0
CHD4 0.017 0 -9999 0 -10000 0 0
TNF-alpha/TNFR1A -0.083 0.15 -9999 0 -0.28 185 185
SIN3/HDAC complex/Mad/Max 0.001 0.059 -9999 0 -0.18 21 21
NuRD Complex -0.007 0.076 -9999 0 -0.2 40 40
positive regulation of chromatin silencing -0.033 0.09 -9999 0 -0.21 69 69
SIN3B 0.017 0 -9999 0 -10000 0 0
MTA2 0.017 0 -9999 0 -10000 0 0
SIN3A 0 0 -9999 0 -10000 0 0
XPO1 0.017 0 -9999 0 -10000 0 0
SUMO1/HDAC1 0.006 0.071 -9999 0 -0.18 66 66
HDAC complex -0.036 0.13 -9999 0 -0.24 150 150
GATA1/Fog1 0.013 0 -9999 0 -10000 0 0
FKBP25/HDAC1/HDAC2 -0.001 0.094 -9999 0 -0.24 69 69
TNF 0.015 0.026 -9999 0 -0.41 2 2
negative regulation of cell growth 0.001 0.058 -9999 0 -0.18 21 21
NuRD/MBD2/PRMT5 Complex -0.009 0.068 -9999 0 -0.19 40 40
Ran/GTP/Exportin 1 0.034 0.006 -9999 0 -10000 0 0
NF kappa B/RelA/I kappa B alpha -0.027 0.084 -9999 0 -0.14 186 186
SIN3/HDAC complex/NCoR1 -0.005 0.064 -9999 0 -0.2 21 21
TFCP2 0.017 0 -9999 0 -10000 0 0
NR2C1 0.017 0 -9999 0 -10000 0 0
MBD3 0.017 0 -9999 0 -10000 0 0
MBD2 0.017 0 -9999 0 -10000 0 0
Glypican 1 network

Figure S42.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S42.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
GPC1/FGF2 dimer/FGFR1 dimer 0.029 0.04 -10000 0 -0.23 12 12
fibroblast growth factor receptor signaling pathway 0.028 0.04 -10000 0 -0.23 12 12
LAMA1 0 0 -10000 0 -10000 0 0
PRNP 0.016 0.004 -10000 0 -10000 0 0
GPC1/SLIT2 0.012 0.037 -10000 0 -0.28 6 6
SMAD2 0.018 0.038 -10000 0 -0.21 15 15
GPC1/PrPc/Cu2+ 0.018 0.032 -10000 0 -0.24 8 8
GPC1/Laminin alpha1 0.008 0.037 -10000 0 -0.29 8 8
TDGF1 0.015 0.026 -10000 0 -0.41 2 2
CRIPTO/GPC1 0.02 0.042 -10000 0 -0.28 10 10
APP/GPC1 0.021 0.038 -10000 0 -0.28 8 8
mol:NO 0 0 -10000 0 -10000 0 0
YES1 -0.022 0.1 -10000 0 -0.24 86 86
FLT1 0.017 0 -10000 0 -10000 0 0
GPC1/TGFB/TGFBR1/TGFBR2 0.027 0.045 -10000 0 -0.23 15 15
SERPINC1 0.016 0.019 -10000 0 -0.41 1 1
FYN 0.015 0.038 -10000 0 -0.23 12 12
FGR 0.009 0.056 -10000 0 -0.23 27 27
positive regulation of MAPKKK cascade -0.022 0.095 -10000 0 -0.22 77 77
SLIT2 0.009 0.033 -10000 0 -0.41 3 3
GPC1/NRG 0.021 0.038 -10000 0 -0.28 8 8
NRG1 0.017 0 -10000 0 -10000 0 0
GPC1/VEGF165 homodimer/VEGFR1 homodimer -0.11 0.14 -10000 0 -0.24 289 289
LYN -0.014 0.09 -10000 0 -0.24 73 73
mol:Spermine 0.004 0.036 -10000 0 -0.29 8 8
cell growth 0.028 0.04 -10000 0 -0.23 12 12
BMP signaling pathway -0.011 0.052 0.41 8 -10000 0 8
SRC 0.017 0.035 -10000 0 -0.23 10 10
TGFBR1 0.017 0 -10000 0 -10000 0 0
mol:Cu2+ 0 0 -10000 0 -10000 0 0
PLA2G2A -0.14 0.21 -10000 0 -0.41 191 191
GPC1 0.011 0.052 -10000 0 -0.41 8 8
TGFBR1 (dimer) 0.017 0 -10000 0 -10000 0 0
VEGFA -0.22 0.21 -10000 0 -0.41 286 286
BLK 0.017 0.035 -10000 0 -0.23 10 10
HCK -0.025 0.1 -10000 0 -0.24 95 95
FGF2 0.015 0.026 -10000 0 -0.41 2 2
FGFR1 0.015 0.026 -10000 0 -0.41 2 2
VEGFR1 homodimer 0.017 0 -10000 0 -10000 0 0
TGFBR2 0.011 0.049 -10000 0 -0.41 7 7
cell death 0.021 0.038 -10000 0 -0.28 8 8
ATIII/GPC1 0.02 0.04 -10000 0 -0.28 9 9
PLA2G2A/GPC1 -0.091 0.15 -10000 0 -0.29 196 196
LCK 0.015 0.043 -10000 0 -0.25 13 13
neuron differentiation 0.021 0.038 -10000 0 -0.28 8 8
PrPc/Cu2+ 0.012 0.003 -10000 0 -10000 0 0
APP 0.017 0.001 -10000 0 -10000 0 0
TGFBR2 (dimer) 0.011 0.049 -10000 0 -0.41 7 7
Regulation of cytoplasmic and nuclear SMAD2/3 signaling

Figure S43.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S43.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
SMAD4 -0.086 0.18 -9999 0 -0.41 127 127
SMAD2 0.013 0.02 -9999 0 -0.12 2 2
SMAD3 0.018 0.04 -9999 0 -0.12 37 37
SMAD3/SMAD4 0.001 0.068 -9999 0 -0.23 10 10
SMAD4/Ubc9/PIASy -0.03 0.12 -9999 0 -0.23 127 127
SMAD2/SMAD2/SMAD4 -0.01 0.1 -9999 0 -0.19 123 123
PPM1A 0.017 0 -9999 0 -10000 0 0
CALM1 0.016 0.004 -9999 0 -10000 0 0
SMAD2/SMAD4 -0.032 0.097 -9999 0 -0.2 127 127
MAP3K1 0.016 0.019 -9999 0 -0.41 1 1
TRAP-1/SMAD4 -0.049 0.13 -9999 0 -0.28 127 127
MAPK3 0.017 0 -9999 0 -10000 0 0
MAPK1 0.017 0.003 -9999 0 -10000 0 0
NUP214 0.017 0 -9999 0 -10000 0 0
CTDSP1 0.015 0.032 -9999 0 -0.41 3 3
CTDSP2 -0.013 0.11 -9999 0 -0.41 37 37
CTDSPL 0.017 0 -9999 0 -10000 0 0
KPNB1 0.017 0 -9999 0 -10000 0 0
TGFBRAP1 0.017 0 -9999 0 -10000 0 0
UBE2I 0.017 0 -9999 0 -10000 0 0
NUP153 0.015 0.026 -9999 0 -0.41 2 2
KPNA2 0.007 0.064 -9999 0 -0.41 12 12
PIAS4 0.017 0 -9999 0 -10000 0 0
Visual signal transduction: Cones

Figure S44.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S44.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
Cone Metarhodopsin II/Cone Transducin 0.02 0 -9999 0 -10000 0 0
RGS9BP 0 0 -9999 0 -10000 0 0
mol:GTP 0 0 -9999 0 -10000 0 0
GRK1 0 0 -9999 0 -10000 0 0
mol:Na + -0.068 0.12 -9999 0 -0.24 184 184
mol:ADP 0 0 -9999 0 -10000 0 0
GNAT2 0.017 0 -9999 0 -10000 0 0
RGS9-1/Gbeta5/R9AP 0.023 0.003 -9999 0 -10000 0 0
mol:GDP 0 0 -9999 0 -10000 0 0
PDE6H/GNAT2/GTP 0.023 0 -9999 0 -10000 0 0
GRK7 0 0 -9999 0 -10000 0 0
CNGB3 0.017 0 -9999 0 -10000 0 0
Cone Metarhodopsin II/X-Arrestin 0.013 0 -9999 0 -10000 0 0
mol:Ca2+ -0.06 0.11 -9999 0 -0.21 184 184
Cone PDE6 0.04 0.005 -9999 0 -10000 0 0
Cone Metarhodopsin II 0 0 -9999 0 -10000 0 0
Na + (4 Units) -0.052 0.12 -9999 0 -0.21 184 184
GNAT2/GDP 0.03 0.003 -9999 0 -10000 0 0
GNB5 0.017 0.002 -9999 0 -10000 0 0
mol:GMP (4 units) 0.02 0 -9999 0 -10000 0 0
Cone Transducin 0.022 0 -9999 0 -10000 0 0
SLC24A2 0.017 0 -9999 0 -10000 0 0
GNB3/GNGT2 0.013 0 -9999 0 -10000 0 0
GNB3 0.017 0 -9999 0 -10000 0 0
GNAT2/GTP 0.013 0 -9999 0 -10000 0 0
CNGA3 -0.13 0.2 -9999 0 -0.41 184 184
ARR3 0.017 0 -9999 0 -10000 0 0
absorption of light 0 0 -9999 0 -10000 0 0
cGMP/Cone CNG Channel -0.068 0.12 -9999 0 -0.24 184 184
mol:Pi 0.023 0.003 -9999 0 -10000 0 0
Cone CNG Channel -0.036 0.11 -9999 0 -0.18 184 184
mol:all-trans-retinal 0 0 -9999 0 -10000 0 0
mol:K + 0.017 0 -9999 0 -10000 0 0
RGS9 0.017 0 -9999 0 -10000 0 0
PDE6C 0.017 0 -9999 0 -10000 0 0
GNGT2 0 0 -9999 0 -10000 0 0
mol:cGMP (4 units) 0 0 -9999 0 -10000 0 0
PDE6H 0.017 0 -9999 0 -10000 0 0
Nongenotropic Androgen signaling

Figure S45.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S45.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
PTK2 0.009 0.001 -10000 0 -10000 0 0
GNB1/GNG2 0.018 0.029 -10000 0 -0.22 8 8
regulation of S phase of mitotic cell cycle 0.014 0.038 -10000 0 -0.13 32 32
GNAO1 0.002 0.005 -10000 0 -10000 0 0
HRAS 0.016 0.019 -10000 0 -0.41 1 1
SHBG/T-DHT 0.012 0 -10000 0 -10000 0 0
PELP1 0.017 0.001 -10000 0 -10000 0 0
AKT1 0.007 0.026 -10000 0 -0.29 4 4
MAP2K1 0.005 0.044 -10000 0 -0.18 10 10
T-DHT/AR 0.008 0.037 -10000 0 -0.29 8 8
G-protein coupled receptor activity 0 0 -10000 0 -10000 0 0
mol:GTP -0.001 0.002 -10000 0 -0.005 127 127
GNAI2 0.017 0.001 -10000 0 -10000 0 0
GNAI3 -0.036 0.14 -10000 0 -0.41 65 65
GNAI1 0.014 0.019 -10000 0 -0.41 1 1
mol:GDP -0.007 0.036 -10000 0 -0.14 31 31
cell proliferation -0.011 0.096 -10000 0 -0.19 55 55
PIK3CA -0.003 0.091 -10000 0 -0.41 25 25
FOS -0.046 0.15 -10000 0 -0.32 125 125
mol:Ca2+ 0 0.006 -10000 0 -0.047 8 8
MAPK3 -0.003 0.073 -10000 0 -0.24 5 5
MAPK1 -0.011 0.07 -10000 0 -0.22 22 22
PIK3R1 0.016 0.004 -10000 0 -10000 0 0
mol:IP3 -0.001 0.001 -10000 0 -0.003 127 127
cAMP biosynthetic process 0.001 0.005 -10000 0 -10000 0 0
GNG2 0 0 -10000 0 -10000 0 0
potassium channel inhibitor activity -0.001 0.001 -10000 0 -0.003 127 127
HRAS/GTP 0.018 0.037 -10000 0 -0.2 9 9
actin cytoskeleton reorganization 0.015 0.044 -10000 0 -0.18 24 24
SRC 0.017 0.001 -10000 0 -10000 0 0
voltage-gated calcium channel activity -0.001 0.001 -10000 0 -0.003 127 127
PI3K 0.01 0.055 -10000 0 -0.23 25 25
apoptosis 0.018 0.098 0.19 127 -10000 0 127
T-DHT/AR/PELP1 0.018 0.032 -10000 0 -0.24 8 8
HRAS/GDP 0.012 0.039 -10000 0 -0.13 32 32
CREB1 -0.019 0.1 -10000 0 -0.2 125 125
RAC1-CDC42/GTP 0.021 0.046 -10000 0 -0.18 24 24
AR 0.01 0.053 -10000 0 -0.41 8 8
GNB1 0.017 0.002 -10000 0 -10000 0 0
RAF1 0.009 0.04 -10000 0 -0.19 10 10
RAC1-CDC42/GDP 0.023 0.039 -10000 0 -0.19 8 8
T-DHT/AR/PELP1/Src 0.027 0.031 -10000 0 -0.22 8 8
MAP2K2 0.006 0.045 -10000 0 -0.18 10 10
T-DHT/AR/PELP1/Src/PI3K 0.014 0.038 -10000 0 -0.13 32 32
GNAZ 0.015 0.006 -10000 0 -10000 0 0
SHBG 0.017 0 -10000 0 -10000 0 0
Gi family/GNB1/GNG2/GDP -0.059 0.063 -10000 0 -0.19 65 65
mol:T-DHT 0 0.001 -10000 0 -0.002 124 124
RAC1 0.017 0 -10000 0 -10000 0 0
GNRH1 0.009 0 -10000 0 -10000 0 0
Gi family/GTP -0.001 0.021 -10000 0 -0.16 7 7
CDC42 0.017 0 -10000 0 -10000 0 0
Signaling mediated by p38-alpha and p38-beta

Figure S46.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S46.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
PTGS2 0.011 0.096 -9999 0 -0.38 29 29
MKNK1 0.017 0 -9999 0 -10000 0 0
MAPK14 0.015 0.049 -9999 0 -0.17 31 31
ATF2/c-Jun 0.027 0.034 -9999 0 -0.39 1 1
MAPK11 0.017 0.042 -9999 0 -0.16 29 29
MITF 0.021 0.046 -9999 0 -0.16 33 33
MAPKAPK5 0.022 0.044 -9999 0 -0.15 31 31
KRT8 0.011 0.069 -9999 0 -0.19 53 53
MAPKAPK3 0.015 0.026 -9999 0 -0.41 2 2
MAPKAPK2 0.017 0 -9999 0 -10000 0 0
p38alpha-beta/CK2 0.022 0.059 -9999 0 -0.21 31 31
CEBPB 0.018 0.06 -9999 0 -0.19 36 36
SLC9A1 0.022 0.044 -9999 0 -0.15 31 31
mol:GDP 0 0 -9999 0 -10000 0 0
ATF2 0.025 0.045 -9999 0 -0.15 31 31
p38alpha-beta/MNK1 0.033 0.048 -9999 0 -0.16 31 31
JUN 0.025 0.034 -9999 0 -0.39 1 1
PPARGC1A 0.021 0.048 -9999 0 -0.16 33 33
USF1 0.015 0.044 -9999 0 -0.16 31 31
RAB5/GDP/GDI1 0.021 0.033 -9999 0 -0.13 9 9
NOS2 0.014 0.044 -9999 0 -0.16 31 31
DDIT3 0.006 0.074 -9999 0 -0.18 67 67
RAB5A 0.017 0 -9999 0 -10000 0 0
HSPB1 0.016 0.05 -9999 0 -0.24 10 10
p38alpha-beta/HBP1 0.033 0.048 -9999 0 -0.16 31 31
CREB1 0.026 0.043 -9999 0 -0.14 31 31
RAB5/GDP 0.013 0 -9999 0 -10000 0 0
EIF4E 0.02 0.043 -9999 0 -0.2 6 6
RPS6KA4 0.022 0.044 -9999 0 -0.15 31 31
PLA2G4A -0.044 0.12 -9999 0 -0.23 144 144
GDI1 0.023 0.039 -9999 0 -0.16 23 23
TP53 -0.005 0.078 -9999 0 -0.17 95 95
RPS6KA5 0.022 0.044 -9999 0 -0.15 31 31
ESR1 0.022 0.044 -9999 0 -0.15 31 31
HBP1 0.017 0 -9999 0 -10000 0 0
MEF2C 0.02 0.039 -9999 0 -0.16 22 22
MEF2A 0.022 0.044 -9999 0 -0.15 31 31
EIF4EBP1 -0.009 0.057 -9999 0 -0.19 31 31
KRT19 0.011 0.068 -9999 0 -0.18 54 54
ELK4 0.022 0.044 -9999 0 -0.15 31 31
ATF6 0.022 0.044 -9999 0 -0.15 31 31
ATF1 0.022 0.047 -9999 0 -0.16 31 31
p38alpha-beta/MAPKAPK2 0.033 0.048 -9999 0 -0.16 31 31
p38alpha-beta/MAPKAPK3 0.032 0.051 -9999 0 -0.16 33 33
S1P3 pathway

Figure S47.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S47.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
PDGFRB 0.015 0.032 -9999 0 -0.41 3 3
mol:S1P 0.001 0.001 -9999 0 -0.015 1 1
S1P1/S1P/Gi -0.015 0.052 -9999 0 -0.15 62 62
GNAO1 0.002 0.005 -9999 0 -10000 0 0
S1P/S1P3/G12/G13 0.021 0.025 -9999 0 -0.21 6 6
AKT1 0 0.02 -9999 0 -0.16 7 7
AKT3 -0.058 0.065 -9999 0 -0.26 5 5
mol:GTP 0 0 -9999 0 -10000 0 0
PDGFB-D/PDGFRB 0.015 0.032 -9999 0 -0.41 3 3
GNAI2 0.018 0.002 -9999 0 -10000 0 0
GNAI3 -0.035 0.14 -9999 0 -0.41 65 65
GNAI1 0.015 0.02 -9999 0 -0.41 1 1
mol:GDP 0 0 -9999 0 -10000 0 0
S1PR3 0.001 0.001 -9999 0 -0.022 1 1
S1PR2 0 0 -9999 0 -10000 0 0
EDG1 0.017 0.001 -9999 0 -10000 0 0
mol:Ca2+ 0.002 0.016 -9999 0 -0.25 1 1
MAPK3 0.002 0.015 -9999 0 -0.23 1 1
MAPK1 0.002 0.015 -9999 0 -0.23 1 1
JAK2 -0.074 0.081 -9999 0 -0.19 115 115
CXCR4 -0.11 0.11 -9999 0 -0.21 273 273
FLT1 0.019 0.002 -9999 0 -10000 0 0
RhoA/GDP 0.013 0.001 -9999 0 -10000 0 0
Rac1/GDP 0.013 0 -9999 0 -10000 0 0
SRC 0.002 0.015 -9999 0 -0.23 1 1
S1P/S1P3/Gi 0.002 0.016 -9999 0 -0.25 1 1
RAC1 0.017 0 -9999 0 -10000 0 0
RhoA/GTP -0.011 0.039 -9999 0 -0.16 13 13
VEGFA -0.21 0.21 -9999 0 -0.41 286 286
S1P/S1P2/Gi 0.001 0.014 -9999 0 -0.19 1 1
VEGFR1 homodimer/VEGFA homodimer -0.14 0.16 -9999 0 -0.28 286 286
RHOA 0.017 0.001 -9999 0 -10000 0 0
S1P/S1P3/Gq 0.02 0.019 -9999 0 -0.13 9 9
GNAQ 0.017 0 -9999 0 -10000 0 0
GNAZ 0.016 0.006 -9999 0 -10000 0 0
G12/G13 0.022 0.033 -9999 0 -0.28 6 6
GNA14 0.015 0.026 -9999 0 -0.41 2 2
GNA15 0.011 0.049 -9999 0 -0.41 7 7
GNA12 0.014 0.037 -9999 0 -0.41 4 4
GNA13 0.015 0.026 -9999 0 -0.41 2 2
GNA11 0.017 0 -9999 0 -10000 0 0
Rac1/GTP -0.011 0.039 -9999 0 -0.16 13 13
Paxillin-dependent events mediated by a4b1

Figure S48.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S48.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
CRKL 0.017 0 -10000 0 -10000 0 0
Rac1/GDP 0.013 0.003 -10000 0 -10000 0 0
DOCK1 0.017 0 -10000 0 -10000 0 0
ITGA4 0.013 0.042 -10000 0 -0.41 5 5
RAC1 0.017 0 -10000 0 -10000 0 0
alpha4/beta7 Integrin 0.022 0.041 -10000 0 -0.38 5 5
mol:GTP 0 0 -10000 0 -10000 0 0
CRK 0.017 0 -10000 0 -10000 0 0
alpha4/beta1 Integrin 0.032 0.026 -10000 0 -0.23 5 5
alpha4/beta7 Integrin/Paxillin 0.032 0.033 -10000 0 -0.29 5 5
lamellipodium assembly 0.018 0.05 -10000 0 -0.26 1 1
PIK3CA -0.003 0.091 -10000 0 -0.41 25 25
PI3K 0.009 0.065 -10000 0 -0.28 25 25
ARF6 0.017 0 -10000 0 -10000 0 0
TLN1 -0.02 0.12 -10000 0 -0.41 46 46
PXN 0.018 0 -10000 0 -10000 0 0
PIK3R1 0.016 0.004 -10000 0 -10000 0 0
ARF6/GTP 0.04 0.021 -10000 0 -0.17 5 5
cell adhesion 0.021 0.07 -10000 0 -0.19 50 50
CRKL/CBL 0.025 0 -10000 0 -10000 0 0
alpha4/beta1 Integrin/Paxillin 0.033 0.023 -10000 0 -0.21 5 5
ITGB1 0.017 0 -10000 0 -10000 0 0
ITGB7 0.015 0.026 -10000 0 -0.41 2 2
ARF6/GDP 0.013 0.003 -10000 0 -10000 0 0
alpha4/beta1 Integrin/Paxillin/VCAM1 -0.11 0.11 -10000 0 -0.19 353 353
p130Cas/Crk/Dock1 0.023 0 -10000 0 -10000 0 0
VCAM1 -0.27 0.2 -10000 0 -0.41 351 351
alpha4/beta1 Integrin/Paxillin/Talin 0.022 0.071 -10000 0 -0.2 50 50
alpha4/beta1 Integrin/Paxillin/GIT1 0.042 0.023 -10000 0 -0.19 5 5
BCAR1 0 0 -10000 0 -10000 0 0
mol:GDP -0.041 0.022 0.19 5 -10000 0 5
CBL 0.017 0 -10000 0 -10000 0 0
PRKACA 0.017 0 -10000 0 -10000 0 0
GIT1 0.017 0 -10000 0 -10000 0 0
alpha4/beta1 Integrin/Paxillin/Talin/Actin Cytoskeleton 0.022 0.071 -10000 0 -0.2 50 50
Rac1/GTP 0.018 0.053 -10000 0 -0.28 1 1
ErbB2/ErbB3 signaling events

Figure S49.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S49.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
USP8 0.01 0.022 -10000 0 -0.24 4 4
RAS family/GTP -0.034 0.11 -10000 0 -0.19 135 135
NFATC4 0.015 0.04 -10000 0 -0.13 3 3
ERBB2IP -0.008 0.1 -10000 0 -0.41 31 31
HSP90 (dimer) 0.017 0 -10000 0 -10000 0 0
mammary gland morphogenesis 0.019 0.054 0.15 18 -0.15 34 52
JUN 0.015 0.047 -10000 0 -10000 0 0
HRAS 0.016 0.019 -10000 0 -0.41 1 1
DOCK7 0.009 0.046 -10000 0 -0.14 34 34
ErbB2/ErbB3/neuregulin 1 beta/SHC 0.005 0.085 0.16 26 -0.2 65 91
AKT1 0.007 0.026 -10000 0 -0.29 4 4
BAD 0.01 0.022 -10000 0 -0.24 4 4
MAPK10 0.01 0.025 -10000 0 -10000 0 0
mol:GTP 0 0.001 -10000 0 -0.003 3 3
ErbB2/ErbB3/neuregulin 1 beta 0.021 0.057 0.16 18 -0.16 34 52
RAF1 -0.032 0.1 -10000 0 -0.18 135 135
ErbB2/ErbB3/neuregulin 2 0.015 0.066 0.16 30 -0.21 32 62
STAT3 0.019 0.027 -10000 0 -10000 0 0
cell migration 0.011 0.029 -10000 0 -10000 0 0
mol:PI-3-4-5-P3 0 0.001 -10000 0 -0.003 34 34
cell proliferation -0.026 0.12 -10000 0 -0.36 14 14
FOS -0.039 0.13 -10000 0 -0.24 131 131
NRAS -0.094 0.19 -10000 0 -0.41 137 137
mol:Ca2+ 0.019 0.054 0.15 18 -0.15 34 52
MAPK3 -0.017 0.098 -10000 0 -0.33 8 8
MAPK1 -0.028 0.11 -10000 0 -0.38 15 15
JAK2 0.016 0.047 -10000 0 -0.15 5 5
NF2 0.012 0.007 -10000 0 -10000 0 0
ErbB2/ErbB3/neuregulin 1 beta/SHC/GRB2/SOS1 -0.004 0.061 -10000 0 -0.15 75 75
NRG1 0.017 0.001 -10000 0 -10000 0 0
GRB2/SOS1 0.013 0.001 -10000 0 -10000 0 0
MAPK8 0.022 0.042 -10000 0 -0.13 5 5
MAPK9 0.019 0.029 -10000 0 -10000 0 0
ERBB2 0.009 0.052 0.22 31 -10000 0 31
ERBB3 -0.01 0.1 -10000 0 -0.41 32 32
SHC1 -0.021 0.12 -10000 0 -0.41 47 47
RAC1 0.017 0 -10000 0 -10000 0 0
apoptosis -0.007 0.022 0.23 4 -10000 0 4
STAT3 (dimer) 0.019 0.027 -10000 0 -10000 0 0
RNF41 0.012 0.02 -10000 0 -0.21 4 4
FRAP1 0.01 0.024 -10000 0 -0.24 5 5
RAC1-CDC42/GTP -0.006 0.027 -10000 0 -0.12 4 4
ErbB2/ErbB2/HSP90 (dimer) 0.022 0.035 0.16 31 -10000 0 31
CHRNA1 -0.011 0.085 -10000 0 -0.24 15 15
myelination 0.021 0.042 -10000 0 -10000 0 0
PPP3CB 0.015 0.045 -10000 0 -0.13 34 34
KRAS 0.017 0.002 -10000 0 -10000 0 0
RAC1-CDC42/GDP 0.014 0.058 -10000 0 -0.18 9 9
NRG2 0.017 0 -10000 0 -10000 0 0
mol:GDP -0.004 0.061 -10000 0 -0.15 75 75
SOS1 0 0 -10000 0 -10000 0 0
MAP2K2 -0.027 0.096 -10000 0 -0.23 47 47
SRC 0.017 0 -10000 0 -10000 0 0
mol:cAMP 0 0.001 -10000 0 -10000 0 0
PTPN11 0.016 0.047 -10000 0 -0.16 4 4
MAP2K1 -0.028 0.12 -10000 0 -0.4 22 22
heart morphogenesis 0.019 0.054 0.15 18 -0.15 34 52
RAS family/GDP -0.033 0.11 -10000 0 -0.19 140 140
GRB2 0.017 0.002 -10000 0 -10000 0 0
PRKACA 0.01 0.006 -10000 0 -10000 0 0
CHRNE 0.01 0.013 -10000 0 -10000 0 0
HSP90AA1 0.017 0 -10000 0 -10000 0 0
activation of caspase activity -0.007 0.026 0.29 4 -10000 0 4
nervous system development 0.019 0.054 0.15 18 -0.15 34 52
CDC42 0.017 0 -10000 0 -10000 0 0
Signaling events mediated by PRL

Figure S50.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S50.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
CCNE1 0.011 0.049 -10000 0 -0.41 7 7
mol:Halofuginone 0.004 0.015 -10000 0 -0.17 4 4
ITGA1 0 0 -10000 0 -10000 0 0
CDKN1A 0.009 0.052 -10000 0 -0.14 54 54
PRL-3/alpha Tubulin 0.007 0.073 -10000 0 -0.28 31 31
mol:Ca2+ 0.009 0.052 0.22 31 -10000 0 31
AGT 0.016 0.005 -10000 0 -10000 0 0
CCNA2 -0.038 0.1 -10000 0 -0.2 148 148
TUBA1B 0.017 0 -10000 0 -10000 0 0
EGR1 0.011 0.051 -10000 0 -0.28 16 16
CDK2/Cyclin E1 0.012 0.076 -10000 0 -0.21 35 35
MAPK3 0 0.071 -10000 0 -0.28 31 31
PRL-2 /Rab GGTase beta 0.025 0.001 -10000 0 -10000 0 0
MAPK1 -0.001 0.071 -10000 0 -0.28 31 31
PTP4A1 0.015 0.044 -10000 0 -0.21 19 19
PTP4A3 -0.008 0.1 -10000 0 -0.41 31 31
PTP4A2 0.017 0.001 -10000 0 -10000 0 0
ITGB1 0 0.071 -10000 0 -0.28 31 31
SRC 0.017 0 -10000 0 -10000 0 0
RAC1 0.015 0.042 -10000 0 -0.14 32 32
Rab GGTase beta/Rab GGTase alpha 0.025 0 -10000 0 -10000 0 0
PRL-1/ATF-5 0.024 0.043 -10000 0 -0.19 20 20
RABGGTA 0.017 0 -10000 0 -10000 0 0
BCAR1 0.002 0.051 0.21 31 -10000 0 31
RHOC -0.032 0.081 -10000 0 -0.14 185 185
RHOA 0.015 0.042 -10000 0 -0.14 32 32
cell motility -0.004 0.055 -10000 0 -0.21 13 13
PRL-1/alpha Tubulin 0.024 0.042 -10000 0 -0.19 19 19
PRL-3/alpha1 Integrin -0.005 0.071 -10000 0 -0.29 31 31
ROCK1 -0.004 0.055 -10000 0 -0.2 14 14
RABGGTB 0.017 0 -10000 0 -10000 0 0
CDK2 -0.005 0.094 -10000 0 -0.41 27 27
mitosis 0.015 0.044 -10000 0 -0.21 19 19
ATF5 0.016 0.019 -10000 0 -0.41 1 1
Arf6 downstream pathway

Figure S51.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S51.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
PLAUR -0.006 0.12 -10000 0 -0.38 47 47
regulation of axonogenesis -0.013 0.029 0.13 3 -10000 0 3
myoblast fusion -0.002 0.062 0.2 47 -10000 0 47
mol:GTP 0.001 0.041 -10000 0 -0.13 47 47
regulation of calcium-dependent cell-cell adhesion -0.016 0.041 0.12 45 -10000 0 45
ARF1/GTP 0.014 0.033 -10000 0 -10000 0 0
mol:GM1 0 0.03 -10000 0 -0.095 47 47
mol:Choline 0.011 0.03 -10000 0 -0.22 2 2
lamellipodium assembly 0.001 0.063 -10000 0 -0.2 47 47
MAPK3 0.007 0.059 -10000 0 -0.18 47 47
ARF6/GTP/NME1/Tiam1 0.016 0.041 -10000 0 -0.12 45 45
ARF1 0.017 0.001 -10000 0 -10000 0 0
ARF6/GDP 0.002 0.062 -10000 0 -0.2 47 47
ARF1/GDP 0.01 0.058 -10000 0 -0.18 47 47
ARF6 0.011 0.027 -10000 0 -10000 0 0
RAB11A 0.017 0.001 -10000 0 -10000 0 0
TIAM1 0.015 0.008 -10000 0 -10000 0 0
fibronectin binding 0 0 -10000 0 -10000 0 0
MAPK1 0.007 0.059 -10000 0 -0.18 47 47
actin filament bundle formation -0.012 0.059 0.18 47 -10000 0 47
KALRN 0.003 0.049 -10000 0 -0.15 47 47
RAB11FIP3/RAB11A 0.025 0.001 -10000 0 -10000 0 0
RhoA/GDP 0.013 0.059 -10000 0 -0.18 47 47
NME1 -0.001 0.006 -10000 0 -10000 0 0
Rac1/GDP 0.013 0.059 -10000 0 -0.18 47 47
substrate adhesion-dependent cell spreading 0.001 0.041 -10000 0 -0.13 47 47
cortical actin cytoskeleton organization 0.001 0.063 -10000 0 -0.2 47 47
RAC1 0.017 0 -10000 0 -10000 0 0
liver development 0.001 0.041 -10000 0 -0.13 47 47
ARF6/GTP 0.001 0.041 -10000 0 -0.13 47 47
RhoA/GTP 0.014 0.033 -10000 0 -0.094 2 2
mol:GDP -0.001 0.062 -10000 0 -0.2 47 47
ARF6/GTP/RAB11FIP3/RAB11A 0.025 0.03 -10000 0 -10000 0 0
RHOA 0.017 0.001 -10000 0 -10000 0 0
PLD1 0.009 0.035 -10000 0 -0.26 2 2
RAB11FIP3 0.017 0 -10000 0 -10000 0 0
tube morphogenesis 0.001 0.063 -10000 0 -0.2 47 47
ruffle organization 0.013 0.029 -10000 0 -0.13 3 3
regulation of epithelial cell migration 0.001 0.041 -10000 0 -0.13 47 47
PLD2 0.01 0.031 -10000 0 -10000 0 0
PIP5K1A 0.013 0.029 -10000 0 -0.13 3 3
mol:Phosphatidic acid 0.011 0.03 -10000 0 -0.22 2 2
Rac1/GTP 0.001 0.063 -10000 0 -0.2 47 47
HIV-1 Nef: Negative effector of Fas and TNF-alpha

Figure S52.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S52.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
BAG4 0.017 0 -9999 0 -10000 0 0
Caspase 8 (4 units) 0.019 0.066 -9999 0 -0.26 12 12
NEF 0.004 0 -9999 0 -10000 0 0
NFKBIA 0.012 0.032 -9999 0 -0.5 1 1
BIRC3 0.002 0.11 -9999 0 -0.39 36 36
CYCS 0.013 0.054 -9999 0 -0.2 12 12
RIPK1 0.01 0.055 -9999 0 -0.41 9 9
CD247 0.019 0.026 -9999 0 -0.41 2 2
MAP2K7 0.02 0.044 -9999 0 -0.22 1 1
protein ubiquitination 0.009 0.056 -9999 0 -0.18 8 8
CRADD 0.017 0 -9999 0 -10000 0 0
DAXX 0.016 0.019 -9999 0 -0.41 1 1
FAS -0.038 0.14 -9999 0 -0.41 68 68
BID 0.01 0.056 -9999 0 -0.21 12 12
NF-kappa-B/RelA/I kappa B alpha 0.026 0.07 -9999 0 -0.23 36 36
TRADD 0.017 0 -9999 0 -10000 0 0
MAP3K5 0.017 0.001 -9999 0 -10000 0 0
CFLAR 0.013 0.042 -9999 0 -0.41 5 5
FADD 0.015 0.026 -9999 0 -0.41 2 2
NF-kappa-B/RelA/I kappa B alpha/ubiquitin 0.026 0.071 -9999 0 -0.23 36 36
MAPK8 0.023 0.042 -9999 0 -0.21 1 1
APAF1 0.017 0 -9999 0 -10000 0 0
TRAF1 0.016 0.019 -9999 0 -0.41 1 1
TRAF2 0.017 0 -9999 0 -10000 0 0
FAS/FADD/DAXX/Ask1/Caspase 8/Caspase 8/FASLG 0.011 0.054 -9999 0 -0.12 69 69
TNFR1A/Caspase 2/TNF-alpha/FADD/TRADD/RIP1/cIAP2/TRAF1/TRAF2/Ask1/RAIDD 0.004 0.064 -9999 0 -0.17 24 24
CHUK 0.009 0.058 -9999 0 -0.19 8 8
FAS/FADD/DAXX/Ask1/Caspase 8/Caspase 8 0.014 0.091 -9999 0 -0.2 75 75
TCRz/NEF 0.021 0.019 -9999 0 -0.28 2 2
TNF 0.015 0.026 -9999 0 -0.41 2 2
FASLG 0.022 0.015 -9999 0 -0.23 2 2
NFKB1 0.01 0.045 -9999 0 -0.43 4 4
TNFR1A/BAG4/TNF-alpha -0.059 0.13 -9999 0 -0.23 185 185
CASP6 0.023 0.068 -9999 0 -0.3 9 9
CASP7 0.007 0.11 -9999 0 -0.28 51 51
RELA 0.013 0.023 -9999 0 -10000 0 0
CASP2 0.016 0.019 -9999 0 -0.41 1 1
CASP3 -0.002 0.11 -9999 0 -0.28 48 48
TNFRSF1A -0.13 0.2 -9999 0 -0.41 183 183
TNFR1A/BAG4 -0.082 0.15 -9999 0 -0.28 183 183
CASP8 0.01 0.055 -9999 0 -0.41 9 9
CASP9 0.014 0.037 -9999 0 -0.41 4 4
MAP3K14 0.006 0.062 -9999 0 -0.16 26 26
APAF-1/Caspase 9 0.012 0.089 -9999 0 -0.28 37 37
BCL2 0.025 0.04 -9999 0 -0.19 1 1
Caspase cascade in apoptosis

Figure S53.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S53.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
TOP1 0.01 0.055 -10000 0 -0.21 9 9
ACTA1 0.004 0.062 0.14 20 -0.19 20 40
NUMA1 0.01 0.055 0.14 2 -0.2 10 12
SPTAN1 0.012 0.063 0.16 31 -0.19 12 43
LIMK1 0.006 0.06 0.15 15 -0.18 18 33
BIRC3 -0.01 0.1 -10000 0 -0.41 33 33
BIRC2 0.017 0 -10000 0 -10000 0 0
BAX 0.011 0.049 -10000 0 -0.41 7 7
CASP10 0.006 0.056 -10000 0 -0.25 22 22
CRMA 0 0 -10000 0 -10000 0 0
XIAP 0 0 -10000 0 -10000 0 0
PTK2 0.009 0.056 0.14 2 -0.2 12 14
DIABLO 0.017 0 -10000 0 -10000 0 0
apoptotic nuclear changes 0.014 0.065 0.16 31 -0.19 12 43
response to UV 0 0 -10000 0 -10000 0 0
CRADD 0.017 0 -10000 0 -10000 0 0
GSN 0 0.068 0.15 16 -0.19 29 45
MADD 0.017 0.001 -10000 0 -10000 0 0
TFAP2A 0.019 0.026 -10000 0 -0.28 1 1
BID 0.006 0.041 -10000 0 -0.14 35 35
MAP3K1 0.011 0.029 -10000 0 -0.15 2 2
TRADD 0.017 0 -10000 0 -10000 0 0
mol:Ca2+ 0 0 -10000 0 -10000 0 0
APAF-1/Pro-Caspase 9 0.023 0.027 -10000 0 -0.28 4 4
mol:Activated DNA 0 0 -10000 0 -10000 0 0
ARHGDIB -0.011 0.087 0.15 16 -0.22 52 68
CASP9 0.014 0.037 -10000 0 -0.41 4 4
DNA repair -0.006 0.039 0.095 22 -0.13 23 45
neuron apoptosis 0.015 0.036 -10000 0 -0.28 4 4
mol:NAD 0 0 -10000 0 -10000 0 0
DNA fragmentation during apoptosis 0.012 0.059 0.16 6 -0.22 9 15
APAF1 0.017 0 -10000 0 -10000 0 0
CASP6 0.004 0.055 -10000 0 -10000 0 0
TRAF2 0.017 0 -10000 0 -10000 0 0
ICAD/CAD 0.01 0.058 0.15 8 -0.19 12 20
CASP7 -0.008 0.07 0.19 26 -0.18 55 81
KRT18 0.001 0.049 -10000 0 -0.2 19 19
apoptosis 0.005 0.071 0.18 6 -0.21 21 27
DFFA 0.006 0.06 0.14 22 -0.18 18 40
DFFB 0.006 0.06 0.15 15 -0.18 17 32
PARP1 0.006 0.039 0.13 23 -0.095 22 45
actin filament polymerization -0.006 0.056 0.17 17 -0.14 15 32
TNF 0.015 0.026 -10000 0 -0.41 2 2
CYCS 0.011 0.029 -10000 0 -0.11 19 19
SATB1 0.024 0.059 -10000 0 -10000 0 0
SLK 0.006 0.06 0.15 15 -0.18 18 33
p15 BID/BAX 0.013 0.047 -10000 0 -0.14 41 41
CASP2 -0.005 0.058 -10000 0 -0.16 25 25
JNK cascade -0.011 0.029 0.15 2 -10000 0 2
CASP3 0.003 0.064 0.15 22 -0.19 19 41
LMNB2 0.002 0.051 -10000 0 -0.23 5 5
RIPK1 0.01 0.055 -10000 0 -0.41 9 9
CASP4 -0.07 0.17 -10000 0 -0.41 107 107
Mammalian IAPs/DIABLO 0.018 0.059 -10000 0 -0.21 33 33
negative regulation of DNA binding 0.019 0.026 -10000 0 -0.28 1 1
stress fiber formation 0.007 0.059 0.15 15 -0.18 18 33
GZMB 0.004 0.066 -10000 0 -0.31 22 22
CASP1 -0.087 0.14 -10000 0 -0.26 194 194
LMNB1 -0.014 0.059 -10000 0 -0.21 12 12
APP 0.015 0.037 -10000 0 -0.28 4 4
TNFRSF1A -0.13 0.2 -10000 0 -0.41 183 183
response to stress 0 0 -10000 0 -10000 0 0
CASP8 0.004 0.039 -10000 0 -0.29 9 9
VIM 0.002 0.072 0.17 12 -0.21 24 36
LMNA 0.005 0.048 -10000 0 -0.2 4 4
TNF-alpha/TNFR1A/TRADD/MADD/cIAP2/RIP1/TRAF2/RAIDD/PIDD -0.008 0.061 -10000 0 -0.18 24 24
LRDD 0.017 0 -10000 0 -10000 0 0
SREBF1 0.006 0.06 0.15 15 -0.18 18 33
APAF-1/Caspase 9 0.01 0.026 -10000 0 -0.17 2 2
nuclear fragmentation during apoptosis 0.01 0.054 0.14 2 -0.2 10 12
CFL2 0.006 0.057 0.14 15 -0.18 17 32
GAS2 -0.009 0.083 0.15 14 -0.2 56 70
positive regulation of apoptosis -0.003 0.054 -10000 0 -0.22 8 8
PRF1 0.007 0.064 -10000 0 -0.41 12 12
TRAIL signaling pathway

Figure S54.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S54.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
TNFSF10 -0.02 0.12 -9999 0 -0.41 46 46
positive regulation of NF-kappaB transcription factor activity -0.002 0.087 -9999 0 -0.28 46 46
MAP2K4 0.018 0.042 -9999 0 -0.18 5 5
IKBKB 0.017 0 -9999 0 -10000 0 0
TNFRSF10B 0.011 0.049 -9999 0 -0.41 7 7
TNFRSF10A 0 0 -9999 0 -10000 0 0
SMPD1 0.002 0.043 -9999 0 -0.13 52 52
IKBKG 0.017 0 -9999 0 -10000 0 0
mol:GTP 0 0 -9999 0 -10000 0 0
TNFRSF10D 0.017 0 -9999 0 -10000 0 0
TRAIL/TRAILR2 -0.006 0.094 -9999 0 -0.29 52 52
TRAIL/TRAILR3 -0.002 0.087 -9999 0 -0.28 46 46
TRAIL/TRAILR1 -0.014 0.085 -9999 0 -0.29 46 46
TRAIL/TRAILR4 -0.002 0.087 -9999 0 -0.28 46 46
TRAIL/TRAILR1/DAP3/GTP 0.001 0.067 -9999 0 -0.22 46 46
IKK complex 0.021 0.037 -9999 0 -0.15 5 5
RIPK1 0.01 0.055 -9999 0 -0.41 9 9
response to oxidative stress 0 0 -9999 0 -10000 0 0
DAP3/GTP 0.013 0 -9999 0 -10000 0 0
MAPK3 -0.009 0.085 -9999 0 -0.28 46 46
MAP3K1 0.016 0.047 -9999 0 -0.12 54 54
TRAILR4 (trimer) 0.017 0 -9999 0 -10000 0 0
TRADD 0.017 0 -9999 0 -10000 0 0
TRAILR1 (trimer) 0 0 -9999 0 -10000 0 0
TRAIL/TRAILR1/FADD/TRADD/RIP/TRAF2 0.011 0.049 -9999 0 -0.13 54 54
CFLAR 0.013 0.042 -9999 0 -0.41 5 5
MAPK1 -0.006 0.081 -9999 0 -0.28 41 41
TRAIL/TRAILR1/FADD/TRADD/RIP 0.016 0.076 -9999 0 -0.2 54 54
mol:ceramide 0.002 0.043 -9999 0 -0.13 52 52
FADD 0.015 0.026 -9999 0 -0.41 2 2
MAPK8 0.02 0.04 -9999 0 -0.18 4 4
TRAF2 0.017 0 -9999 0 -10000 0 0
TRAILR3 (trimer) 0.017 0 -9999 0 -10000 0 0
CHUK 0.016 0.019 -9999 0 -0.41 1 1
TRAIL/TRAILR1/FADD 0 0.076 -9999 0 -0.24 47 47
DAP3 0.017 0 -9999 0 -10000 0 0
CASP10 -0.006 0.063 -9999 0 -0.19 53 53
JNK cascade -0.002 0.087 -9999 0 -0.28 46 46
TRAIL (trimer) -0.02 0.12 -9999 0 -0.41 46 46
TNFRSF10C 0.017 0 -9999 0 -10000 0 0
TRAIL/TRAILR1/DAP3/GTP/FADD 0.01 0.067 -9999 0 -0.2 47 47
TRAIL/TRAILR2/FADD 0.007 0.084 -9999 0 -0.24 53 53
cell death 0.002 0.043 -9999 0 -0.13 52 52
TRAIL/TRAILR2/FADD/TRADD/RIP/TRAF2 0.014 0.053 -9999 0 -0.13 60 60
TRAILR2 (trimer) 0.011 0.049 -9999 0 -0.41 7 7
CASP8 0.01 0.035 -9999 0 -0.22 7 7
negative regulation of caspase activity 0 0 -9999 0 -10000 0 0
TRAIL/TRAILR2/FADD/TRADD/RIP 0.022 0.083 -9999 0 -0.2 60 60
RXR and RAR heterodimerization with other nuclear receptor

Figure S55.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S55.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
TGFB1 0.005 0.093 -9999 0 -0.39 28 28
VDR 0.017 0 -9999 0 -10000 0 0
FAM120B 0 0 -9999 0 -10000 0 0
RXRs/LXRs/DNA/9cRA -0.074 0.079 -9999 0 -0.26 5 5
RXRs/LXRs/DNA/Oxysterols -0.12 0.11 -9999 0 -0.18 382 382
MED1 0.017 0 -9999 0 -10000 0 0
mol:9cRA -0.021 0.016 -9999 0 -10000 0 0
RARs/THRs/DNA/Src-1 0.031 0.005 -9999 0 -10000 0 0
RXRs/NUR77 -0.008 0.044 -9999 0 -0.26 3 3
RXRs/PPAR 0.001 0.028 -9999 0 -0.16 5 5
NCOR2 0.017 0 -9999 0 -10000 0 0
VDR/VDR/Vit D3 0.013 0 -9999 0 -10000 0 0
RARs/VDR/DNA/Vit D3 0.041 0 -9999 0 -10000 0 0
RARA 0.017 0 -9999 0 -10000 0 0
NCOA1 0.017 0.003 -9999 0 -10000 0 0
VDR/VDR/DNA 0.017 0 -9999 0 -10000 0 0
RARs/RARs/DNA/9cRA 0.02 0.009 -9999 0 -10000 0 0
RARG 0.017 0 -9999 0 -10000 0 0
RPS6KB1 0.017 0.057 -9999 0 -0.22 28 28
RARs/THRs/DNA/SMRT 0.032 0 -9999 0 -10000 0 0
THRA 0.017 0 -9999 0 -10000 0 0
mol:Bile acids 0 0 -9999 0 -10000 0 0
VDR/Vit D3/DNA 0.013 0 -9999 0 -10000 0 0
RXRs/PPAR/9cRA/PGJ2/DNA -0.035 0.056 -9999 0 -0.29 3 3
NR1H4 0.017 0 -9999 0 -10000 0 0
RXRs/LXRs/DNA -0.041 0.075 -9999 0 -0.26 7 7
NR1H2 -0.006 0.017 -9999 0 -10000 0 0
NR1H3 -0.012 0.041 -9999 0 -0.42 4 4
RXRs/VDR/DNA/Vit D3 -0.008 0.041 -9999 0 -0.24 3 3
NR4A1 0.017 0 -9999 0 -10000 0 0
mol:ATRA 0 0 -9999 0 -10000 0 0
RXRs/FXR/9cRA/MED1 -0.015 0.032 -9999 0 -0.15 3 3
RXRG -0.009 0.037 -9999 0 -0.44 3 3
RXR alpha/CCPG -0.003 0.012 -9999 0 -10000 0 0
RXRA -0.006 0.017 -9999 0 -10000 0 0
RXRB -0.009 0.02 -9999 0 -10000 0 0
THRB 0.017 0 -9999 0 -10000 0 0
PPARG 0.013 0.042 -9999 0 -0.41 5 5
PPARD 0.017 0 -9999 0 -10000 0 0
TNF -0.1 0.1 -9999 0 -0.3 7 7
mol:Oxysterols -0.017 0.014 -9999 0 -10000 0 0
cholesterol transport -0.11 0.11 -9999 0 -0.18 382 382
PPARA 0.017 0 -9999 0 -10000 0 0
mol:Vit D3 0 0 -9999 0 -10000 0 0
RARB 0.017 0 -9999 0 -10000 0 0
RXRs/NUR77/BCL2 0.013 0.016 -9999 0 -0.15 3 3
SREBF1 -0.1 0.099 -9999 0 -0.28 5 5
RXRs/RXRs/DNA/9cRA -0.035 0.056 -9999 0 -0.29 3 3
ABCA1 -0.24 0.18 -9999 0 -0.35 380 380
RARs/THRs 0.051 0 -9999 0 -10000 0 0
RXRs/FXR -0.008 0.044 -9999 0 -0.26 3 3
BCL2 0.017 0 -9999 0 -10000 0 0
Canonical Wnt signaling pathway

Figure S56.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S56.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
HDAC1 -0.023 0.14 -10000 0 -0.39 66 66
AES 0.028 0.02 -10000 0 -10000 0 0
FBXW11 0.017 0 -10000 0 -10000 0 0
mol:GTP 0 0.001 -10000 0 -10000 0 0
LRP6/FZD1 0.019 0.044 -10000 0 -0.28 11 11
SMAD4 -0.086 0.18 -10000 0 -0.41 127 127
DKK2 0.009 0.058 -10000 0 -0.41 10 10
TLE1 0.028 0.02 -10000 0 -10000 0 0
MACF1 0.018 0.001 -10000 0 -10000 0 0
CTNNB1 0.065 0.034 0.22 1 -0.14 1 2
WIF1 0.002 0.006 -10000 0 -10000 0 0
beta catenin/RanBP3 0.092 0.13 0.26 187 -10000 0 187
KREMEN2 0.017 0 -10000 0 -10000 0 0
DKK1 -0.078 0.18 -10000 0 -0.41 117 117
beta catenin/beta TrCP1 0.072 0.033 0.22 1 -10000 0 1
FZD1 0.009 0.058 -10000 0 -0.41 10 10
AXIN2 -0.043 0.066 -10000 0 -0.13 169 169
AXIN1 0.018 0 -10000 0 -10000 0 0
RAN 0.017 0.002 -10000 0 -10000 0 0
Axin1/APC/GSK3/beta catenin 0.046 0.035 -10000 0 -0.31 4 4
beta catenin/TCF/CtBP/CBP/TLE1/AES/SMAD4 0.042 0.065 -10000 0 -0.2 1 1
Axin1/APC/GSK3 0.059 0.02 0.19 1 -10000 0 1
Axin1/APC/GSK3/beta catenin/Macf1 0.056 0.036 -10000 0 -10000 0 0
HNF1A 0.028 0.021 -10000 0 -10000 0 0
CTBP1 0.028 0.022 -10000 0 -10000 0 0
MYC -0.11 0.19 -10000 0 -0.43 137 137
RANBP3 0.018 0.001 -10000 0 -10000 0 0
DKK2/LRP6/Kremen 2 0.03 0.038 -10000 0 -0.23 11 11
NKD1 0 0 -10000 0 -10000 0 0
TCF4 0.028 0.022 -10000 0 -10000 0 0
TCF3 0.028 0.021 -10000 0 -10000 0 0
WNT1/LRP6/FZD1/Axin1 0.038 0.036 -10000 0 -0.21 11 11
Ran/GTP 0.014 0.002 -10000 0 -10000 0 0
CtBP/CBP/TCF/TLE1/AES 0.099 0.14 0.28 169 -10000 0 169
LEF1 0.027 0.038 -10000 0 -0.39 3 3
DVL1 0.004 0.012 -10000 0 -10000 0 0
CSNK2A1 0.017 0 -10000 0 -10000 0 0
beta catenin/TCF/CtBP/CBP/TLE1/AES 0.04 0.052 -10000 0 -0.2 1 1
DKK1/LRP6/Kremen 2 -0.025 0.11 -10000 0 -0.23 118 118
LRP6 0.016 0.019 -10000 0 -0.41 1 1
CSNK1A1 0.031 0.024 -10000 0 -10000 0 0
NLK 0.015 0.005 -10000 0 -10000 0 0
CCND1 -0.087 0.17 -10000 0 -0.44 98 98
WNT1 0.017 0.001 -10000 0 -10000 0 0
GSK3A 0.017 0.001 -10000 0 -10000 0 0
GSK3B 0.017 0.002 -10000 0 -10000 0 0
FRAT1 0.016 0.019 -10000 0 -0.41 1 1
PPP2R5D 0.007 0.016 -10000 0 -10000 0 0
APC 0.021 0.031 -10000 0 -0.19 11 11
WNT1/LRP6/FZD1 0.003 0.011 -10000 0 -0.12 2 2
CREBBP 0.028 0.021 -10000 0 -10000 0 0
IL6-mediated signaling events

Figure S57.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S57.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
BCL2L1 -0.038 0.16 -10000 0 -0.43 36 36
CRP -0.038 0.16 -10000 0 -0.43 36 36
cell cycle arrest -0.059 0.17 -10000 0 -0.44 56 56
TIMP1 -0.2 0.22 -10000 0 -0.46 145 145
IL6ST 0.016 0.008 -10000 0 -10000 0 0
Rac1/GDP 0.007 0.075 -10000 0 -0.23 16 16
AP1 -0.035 0.1 -10000 0 -0.23 67 67
GAB2 0.017 0.019 -10000 0 -0.41 1 1
TNFSF11 -0.038 0.16 -10000 0 -0.43 36 36
HSP90B1 0.014 0.055 -10000 0 -0.39 2 2
GAB1 0.014 0.037 -10000 0 -0.41 4 4
MAPK14 0.019 0.048 -10000 0 -0.18 1 1
AKT1 0.028 0.039 -10000 0 -0.2 7 7
FOXO1 0.025 0.05 -10000 0 -0.29 4 4
MAP2K6 0.012 0.056 -10000 0 -0.17 13 13
mol:GTP -0.001 0.002 -10000 0 -10000 0 0
MAP2K4 -0.001 0.096 -10000 0 -0.3 14 14
MITF 0.004 0.067 -10000 0 -0.2 28 28
positive regulation of NF-kappaB transcription factor activity 0 0 -10000 0 -10000 0 0
TYK2 0.016 0.019 -10000 0 -0.41 1 1
A2M -0.009 0.11 -10000 0 -0.44 30 30
CEBPB 0.015 0.062 -10000 0 -0.41 11 11
GRB2/SOS1/GAB family/SHP2 0.009 0.052 0.14 1 -0.28 4 5
STAT3 -0.061 0.18 -10000 0 -0.45 56 56
STAT1 0.003 0.046 -10000 0 -10000 0 0
CEBPD -0.038 0.16 -10000 0 -0.43 36 36
PIK3CA -0.002 0.091 -10000 0 -0.41 25 25
PI3K 0.011 0.065 -10000 0 -0.28 25 25
JUN 0.016 0.019 -10000 0 -0.41 1 1
PIAS3/MITF 0.011 0.068 -10000 0 -0.21 18 18
MAPK11 0.02 0.047 -10000 0 -10000 0 0
STAT3 (dimer)/FOXO1 -0.036 0.16 -10000 0 -0.46 27 27
GRB2/SOS1/GAB family 0.007 0.077 -10000 0 -0.22 21 21
IL6/IL6RA/gp130 (dimer)/JAK1/JAK1/LMO4/HCK -0.008 0.085 -10000 0 -0.19 66 66
GRB2 0.017 0.003 -10000 0 -10000 0 0
JAK2 0.017 0 -10000 0 -10000 0 0
LBP -0.026 0.15 -10000 0 -0.4 35 35
PIK3R1 0.016 0.005 -10000 0 -10000 0 0
JAK1 0.017 0.003 -10000 0 -10000 0 0
MYC -0.084 0.22 -10000 0 -0.46 95 95
FGG -0.041 0.17 -10000 0 -0.46 39 39
macrophage differentiation -0.059 0.17 -10000 0 -0.44 56 56
IL6/IL6RA/gp130 (dimer)/JAK2/JAK2/LMO4 0.025 0.078 -10000 0 -0.21 52 52
JUNB -0.04 0.16 -10000 0 -0.45 37 37
FOS -0.085 0.18 -10000 0 -0.41 125 125
IL6/IL6RA/gp130 (dimer)/JAK1/JAK1/LMO4 0.002 0.069 -10000 0 -0.2 32 32
STAT1/PIAS1 -0.004 0.086 -10000 0 -0.23 29 29
GRB2/SOS1/GAB family/SHP2/PI3K 0.024 0.033 -10000 0 -0.23 2 2
STAT3 (dimer) -0.061 0.18 -10000 0 -0.45 56 56
PRKCD -0.008 0.12 -10000 0 -0.36 15 15
IL6R 0.018 0.003 -10000 0 -10000 0 0
SOCS3 0.027 0.04 -10000 0 -10000 0 0
gp130 (dimer)/JAK1/JAK1/LMO4 0.033 0.018 -10000 0 -10000 0 0
Rac1/GTP 0.003 0.084 -10000 0 -0.26 16 16
HCK -0.053 0.16 -10000 0 -0.41 86 86
MAPKKK cascade 0.014 0.051 -10000 0 -0.35 4 4
bone resorption -0.036 0.16 -10000 0 -0.42 36 36
IRF1 -0.061 0.2 -10000 0 -0.48 72 72
mol:GDP 0.003 0.07 -10000 0 -0.2 28 28
SOS1 0.001 0.003 -10000 0 -10000 0 0
VAV1 0.003 0.07 -10000 0 -0.2 28 28
IL6/IL6RA/gp130 (dimer)/JAK1/JAK1/LMO4/SOCS3 0.025 0.047 -10000 0 -0.25 2 2
PTPN11 0.011 0.017 -10000 0 -10000 0 0
IL6/IL6RA -0.006 0.095 -10000 0 -0.29 52 52
gp130 (dimer)/TYK2/TYK2/LMO4 0.033 0.016 -10000 0 -0.23 1 1
gp130 (dimer)/JAK2/JAK2/LMO4 0.034 0.012 -10000 0 -10000 0 0
IL6 -0.026 0.13 -10000 0 -0.42 52 52
PIAS3 0.015 0.026 -10000 0 -0.41 2 2
PTPRE 0.017 0.01 -10000 0 -10000 0 0
PIAS1 0.017 0 -10000 0 -10000 0 0
RAC1 0.017 0.001 -10000 0 -10000 0 0
IL6/IL6RA/gp130 (dimer)/TYK2/TYK2/LMO4 0.004 0.055 -10000 0 -0.15 50 50
LMO4 0.016 0.008 -10000 0 -10000 0 0
STAT3 (dimer)/PIAS3 -0.044 0.17 -10000 0 -0.48 37 37
MCL1 0.03 0.049 -10000 0 -0.38 4 4
Signaling events mediated by PTP1B

Figure S58.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S58.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
PDGFRB 0.015 0.032 -10000 0 -0.41 3 3
Jak2/Leptin Receptor 0.017 0.034 -10000 0 -0.16 3 3
PTP1B/AKT1 -0.002 0.048 -10000 0 -0.2 7 7
FYN 0.015 0.026 -10000 0 -0.41 2 2
p210 bcr-abl/PTP1B -0.01 0.045 -10000 0 -0.15 11 11
EGFR -0.14 0.21 -10000 0 -0.41 194 194
EGF/EGFR -0.055 0.1 -10000 0 -0.18 196 196
CSF1 0.017 0 -10000 0 -10000 0 0
AKT1 0.014 0.037 -10000 0 -0.41 4 4
INSR 0.017 0 -10000 0 -10000 0 0
PTP1B/N-cadherin -0.004 0.049 -10000 0 -0.2 6 6
Insulin Receptor/Insulin 0.018 0.041 -10000 0 -0.21 4 4
HCK -0.053 0.16 -10000 0 -0.41 86 86
CRK 0.017 0 -10000 0 -10000 0 0
TYK2 -0.006 0.044 -10000 0 -0.2 3 3
EGF 0.013 0.027 -10000 0 -0.41 2 2
YES1 -0.048 0.15 -10000 0 -0.41 80 80
CAV1 -0.069 0.068 -10000 0 -0.17 120 120
TXN 0.015 0.002 -10000 0 -10000 0 0
PTP1B/IRS1/GRB2 0.003 0.05 -10000 0 -0.18 7 7
cell migration 0.01 0.045 0.15 11 -10000 0 11
STAT3 0.009 0.059 -10000 0 -0.41 10 10
PRLR 0.02 0 -10000 0 -10000 0 0
ITGA2B 0.016 0 -10000 0 -10000 0 0
CSF1R -0.016 0.12 -10000 0 -0.41 41 41
Prolactin Receptor/Prolactin 0.029 0.033 -10000 0 -0.28 6 6
FGR 0.003 0.076 -10000 0 -0.41 17 17
PTP1B/p130 Cas -0.01 0.042 -10000 0 -0.12 41 41
Crk/p130 Cas -0.003 0.044 -10000 0 -0.14 7 7
DOK1 0.003 0.04 -10000 0 -0.16 4 4
JAK2 0.011 0.03 -10000 0 -10000 0 0
Jak2/Leptin Receptor/Leptin 0.022 0.051 -10000 0 -0.21 8 8
PIK3R1 0.016 0.004 -10000 0 -10000 0 0
PTPN1 -0.01 0.046 -10000 0 -0.13 42 42
LYN -0.035 0.14 -10000 0 -0.41 64 64
CDH2 0.014 0.032 -10000 0 -0.41 3 3
SRC 0.014 0.019 -10000 0 -10000 0 0
ITGB3 0.016 0 -10000 0 -10000 0 0
CAT1/PTP1B -0.027 0.093 -10000 0 -0.22 76 76
CAPN1 0.016 0.001 -10000 0 -10000 0 0
CSK 0.017 0 -10000 0 -10000 0 0
PI3K 0.015 0.057 -10000 0 -0.18 28 28
mol:H2O2 -0.002 0.003 -10000 0 -10000 0 0
STAT3 (dimer) 0.023 0.048 -10000 0 -0.21 8 8
negative regulation of transcription 0.011 0.03 -10000 0 -10000 0 0
FCGR2A -0.2 0.22 -10000 0 -0.41 266 266
FER 0.015 0.002 -10000 0 -10000 0 0
alphaIIb/beta3 Integrin 0.023 0.001 -10000 0 -10000 0 0
BLK 0.017 0 -10000 0 -10000 0 0
Insulin Receptor/Insulin/Shc 0.011 0.077 -10000 0 -0.24 47 47
RHOA 0.016 0.001 -10000 0 -10000 0 0
LEPR 0.014 0.032 -10000 0 -0.41 3 3
BCAR1 0 0 -10000 0 -10000 0 0
p210 bcr-abl/Grb2 0.017 0.002 -10000 0 -10000 0 0
mol:NADPH -0.002 0.002 -10000 0 -10000 0 0
TRPV6 -0.021 0.1 -10000 0 -0.23 75 75
PRL 0.015 0.045 -10000 0 -0.41 6 6
SOCS3 0.009 0.009 -10000 0 -10000 0 0
SPRY2 0.009 0.053 -10000 0 -0.42 8 8
Insulin Receptor/Insulin/IRS1 0.033 0.026 -10000 0 -0.24 5 5
CSF1/CSF1R -0.011 0.068 -10000 0 -0.18 43 43
Ras protein signal transduction 0.013 0.031 0.29 5 -10000 0 5
IRS1 0.013 0.042 -10000 0 -0.41 5 5
INS 0.017 0 -10000 0 -10000 0 0
LEP 0.017 0 -10000 0 -10000 0 0
STAT5B 0.003 0.039 -10000 0 -0.16 2 2
STAT5A 0.003 0.039 -10000 0 -0.16 2 2
GRB2 0.017 0.002 -10000 0 -10000 0 0
PDGFB-D/PDGFRB -0.004 0.048 -10000 0 -0.18 7 7
CSN2 0.023 0.015 -10000 0 -10000 0 0
PIK3CA -0.003 0.091 -10000 0 -0.41 25 25
LAT -0.065 0.081 -10000 0 -0.2 27 27
YBX1 0.015 0.064 -10000 0 -0.4 12 12
LCK 0.014 0.037 -10000 0 -0.41 4 4
SHC1 -0.021 0.12 -10000 0 -0.41 47 47
NOX4 -0.042 0.15 -10000 0 -0.42 70 70
FoxO family signaling

Figure S59.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S59.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
G6PC 0.016 0.041 -9999 0 -0.27 1 1
PLK1 -0.078 0.15 -9999 0 -0.51 25 25
CDKN1B -0.071 0.1 -9999 0 -0.23 45 45
FOXO3 -0.083 0.14 -9999 0 -0.31 54 54
KAT2B -0.012 0.016 -9999 0 -0.041 25 25
FOXO1/SIRT1 0.014 0.045 -9999 0 -0.25 2 2
CAT -0.071 0.13 -9999 0 -0.36 26 26
CTNNB1 0.017 0 -9999 0 -10000 0 0
AKT1 -0.001 0.042 -9999 0 -0.43 4 4
FOXO1 0.011 0.046 -9999 0 -0.15 37 37
MAPK10 -0.002 0.044 -9999 0 -0.21 21 21
mol:GTP -0.001 0.003 -9999 0 -10000 0 0
FOXO4 -0.013 0.08 -9999 0 -0.24 24 24
response to oxidative stress -0.01 0.016 -9999 0 -0.038 29 29
FOXO3A/SIRT1 -0.094 0.12 -9999 0 -0.34 37 37
XPO1 0.017 0.001 -9999 0 -10000 0 0
EP300 0.018 0.001 -9999 0 -10000 0 0
BCL2L11 0.006 0.022 -9999 0 -10000 0 0
FOXO1/SKP2 0.018 0.048 -9999 0 -0.29 4 4
mol:GDP -0.01 0.016 -9999 0 -0.038 29 29
RAN 0.017 0.002 -9999 0 -10000 0 0
GADD45A -0.063 0.14 -9999 0 -0.42 47 47
YWHAQ 0.017 0 -9999 0 -10000 0 0
FOXO1/14-3-3 family 0.012 0.044 -9999 0 -0.16 5 5
MST1 -0.004 0.05 -9999 0 -0.43 6 6
CSNK1D 0.015 0.026 -9999 0 -0.41 2 2
CSNK1E 0.017 0.001 -9999 0 -10000 0 0
FOXO4/14-3-3 family -0.035 0.079 -9999 0 -0.25 28 28
YWHAB 0.017 0.001 -9999 0 -10000 0 0
MAPK8 -0.008 0.063 -9999 0 -0.21 45 45
MAPK9 -0.007 0.063 -9999 0 -0.21 45 45
YWHAG 0 0 -9999 0 -10000 0 0
YWHAE 0.017 0.001 -9999 0 -10000 0 0
YWHAZ 0.017 0.002 -9999 0 -10000 0 0
SIRT1 0.013 0.006 -9999 0 -10000 0 0
SOD2 -0.2 0.2 -9999 0 -0.36 289 289
RBL2 -0.051 0.1 -9999 0 -0.31 3 3
RAL/GDP -0.009 0.074 -9999 0 -0.25 45 45
CHUK 0 0.026 -9999 0 -0.4 1 1
Ran/GTP 0.012 0.005 -9999 0 -10000 0 0
CSNK1G2 0.017 0 -9999 0 -10000 0 0
RAL/GTP -0.008 0.069 -9999 0 -0.22 45 45
CSNK1G1 0.017 0 -9999 0 -10000 0 0
FASLG 0.006 0.022 -9999 0 -10000 0 0
SKP2 0.015 0.026 -9999 0 -0.41 2 2
USP7 0.017 0.002 -9999 0 -10000 0 0
IKBKB 0.001 0.02 -9999 0 -10000 0 0
CCNB1 -0.18 0.21 -9999 0 -0.36 296 296
FOXO1-3a-4/beta catenin -0.08 0.13 -9999 0 -0.32 17 17
proteasomal ubiquitin-dependent protein catabolic process 0.018 0.047 -9999 0 -0.29 4 4
CSNK1A1 0.017 0 -9999 0 -10000 0 0
SGK1 -0.012 0.016 -9999 0 -0.041 25 25
CSNK1G3 0.017 0 -9999 0 -10000 0 0
Ran/GTP/Exportin 1 0.022 0.007 -9999 0 -10000 0 0
ZFAND5 -0.005 0.071 -9999 0 -0.23 10 10
SFN -0.01 0.1 -9999 0 -0.41 33 33
CDK2 -0.003 0.094 -9999 0 -0.41 27 27
FOXO3A/14-3-3 -0.041 0.072 -9999 0 -0.22 36 36
CREBBP 0.019 0.002 -9999 0 -10000 0 0
FBXO32 -0.076 0.12 -9999 0 -0.32 37 37
BCL6 -0.059 0.12 -9999 0 -0.44 18 18
RALB 0.016 0.019 -9999 0 -0.41 1 1
RALA -0.019 0.12 -9999 0 -0.41 44 44
YWHAH 0.008 0.009 -9999 0 -10000 0 0
Presenilin action in Notch and Wnt signaling

Figure S60.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S60.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
Delta 1/NOTCH/NOTCH(cleaved) 0.006 0.057 -10000 0 -0.2 34 34
HDAC1 -0.03 0.14 -10000 0 -0.4 66 66
AES 0.019 0.004 -10000 0 -10000 0 0
FBXW11 0.017 0 -10000 0 -10000 0 0
DTX1 0 0 -10000 0 -10000 0 0
LRP6/FZD1 0.019 0.044 -10000 0 -0.29 11 11
TLE1 0.019 0.004 -10000 0 -10000 0 0
AP1 -0.02 0.068 -10000 0 -0.14 125 125
NCSTN -0.007 0.099 -10000 0 -0.41 30 30
ADAM10 0.003 0.078 -10000 0 -0.41 18 18
Beta Catenin/TCF1/CtBP/CBP/TLE1/AES/SMAD4 -0.016 0.08 -10000 0 -0.22 11 11
NICD/RBPSUH 0.018 0.059 -10000 0 -0.26 10 10
WIF1 0.002 0.006 -10000 0 -10000 0 0
NOTCH1 0.009 0.06 -10000 0 -0.21 34 34
PSENEN 0.017 0.001 -10000 0 -10000 0 0
KREMEN2 0.017 0 -10000 0 -10000 0 0
DKK1 -0.078 0.18 -10000 0 -0.41 117 117
beta catenin/beta TrCP1 0.023 0.03 -10000 0 -10000 0 0
APH1B 0.017 0 -10000 0 -10000 0 0
APH1A 0.008 0.061 -10000 0 -0.41 11 11
AXIN1 0.003 0.028 0.18 5 -10000 0 5
CtBP/CBP/TCF1/TLE1/AES 0.035 0.065 0.17 31 -0.13 32 63
PSEN1 0.016 0.019 -10000 0 -0.41 1 1
FOS -0.084 0.18 -10000 0 -0.41 125 125
JUN 0.016 0.019 -10000 0 -0.41 1 1
MAP3K7 0.019 0.02 -10000 0 -0.41 1 1
CTNNB1 0.016 0.028 -10000 0 -10000 0 0
MAPK3 0.017 0 -10000 0 -10000 0 0
DKK2/LRP6/Kremen 2 0.029 0.038 -10000 0 -0.24 11 11
HNF1A 0.019 0.004 -10000 0 -10000 0 0
CTBP1 0.019 0.005 -10000 0 -10000 0 0
MYC -0.092 0.18 -10000 0 -0.4 137 137
NKD1 0.001 0.002 -10000 0 -10000 0 0
FZD1 0.009 0.059 -10000 0 -0.41 10 10
NOTCH1 precursor/Deltex homolog 1 0.007 0.057 -10000 0 -0.2 34 34
apoptosis -0.02 0.068 -10000 0 -0.14 125 125
Delta 1/NOTCHprecursor 0.007 0.057 -10000 0 -0.2 34 34
DLL1 0 0 -10000 0 -10000 0 0
PPARD 0.003 0.031 -10000 0 -10000 0 0
Gamma Secretase 0.031 0.068 -10000 0 -0.2 40 40
APC -0.01 0.063 0.18 2 -0.29 21 23
DVL1 0.003 0.009 -10000 0 -10000 0 0
CSNK2A1 0.016 0.002 -10000 0 -10000 0 0
MAP3K7IP1 0.02 0.006 -10000 0 -10000 0 0
DKK1/LRP6/Kremen 2 -0.025 0.11 -10000 0 -0.23 118 118
LRP6 0.016 0.019 -10000 0 -0.41 1 1
CSNK1A1 0.016 0.002 -10000 0 -10000 0 0
NLK 0.028 0.017 -10000 0 -0.18 1 1
CCND1 -0.065 0.17 -10000 0 -0.41 98 98
WNT1 0.017 0 -10000 0 -10000 0 0
Axin1/APC/beta catenin 0.024 0.052 0.19 2 -0.2 6 8
DKK2 0.009 0.058 -10000 0 -0.41 10 10
NOTCH1 precursor/DVL1 0.01 0.051 -10000 0 -0.2 12 12
GSK3B 0.017 0.002 -10000 0 -10000 0 0
FRAT1 0.017 0.019 -10000 0 -0.4 1 1
NOTCH/Deltex homolog 1 0.006 0.057 -10000 0 -0.2 34 34
PPP2R5D 0.002 0.007 -10000 0 -10000 0 0
MAPK1 0.017 0.003 -10000 0 -10000 0 0
WNT1/LRP6/FZD1 0.003 0.023 -10000 0 -0.21 2 2
RBPJ 0.017 0 -10000 0 -10000 0 0
CREBBP 0.013 0.01 -10000 0 -10000 0 0
TCGA08_rtk_signaling

Figure S61.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S61.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
PDGFRA -0.025 0.13 -9999 0 -0.41 51 51
HRAS 0.016 0.019 -9999 0 -0.41 1 1
EGFR -0.14 0.21 -9999 0 -0.41 194 194
AKT 0.015 0.035 -9999 0 -0.27 5 5
FOXO3 0.017 0 -9999 0 -10000 0 0
AKT1 0.014 0.037 -9999 0 -0.41 4 4
FOXO1 0.008 0.061 -9999 0 -0.41 11 11
AKT3 0.016 0.019 -9999 0 -0.41 1 1
FOXO4 0.017 0 -9999 0 -10000 0 0
MET 0.009 0.058 -9999 0 -0.41 10 10
PIK3CA -0.003 0.091 -9999 0 -0.41 25 25
PIK3CB 0.017 0 -9999 0 -10000 0 0
NRAS -0.094 0.19 -9999 0 -0.41 137 137
PIK3CG 0.017 0 -9999 0 -10000 0 0
PIK3R3 0.016 0.019 -9999 0 -0.41 1 1
PIK3R2 0.017 0 -9999 0 -10000 0 0
NF1 0.017 0 -9999 0 -10000 0 0
RAS -0.047 0.063 -9999 0 -0.17 61 61
ERBB2 0.017 0 -9999 0 -10000 0 0
proliferation/survival/translation -0.041 0.026 -9999 0 -10000 0 0
PI3K -0.028 0.056 -9999 0 -0.12 71 71
PIK3R1 0.016 0.004 -9999 0 -10000 0 0
KRAS 0.017 0.002 -9999 0 -10000 0 0
FOXO 0.021 0.034 -9999 0 -0.13 11 11
AKT2 0.017 0 -9999 0 -10000 0 0
PTEN 0.015 0.026 -9999 0 -0.41 2 2
Regulation of Telomerase

Figure S62.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S62.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
Telomerase catalytic core complex -0.028 0.11 -9999 0 -0.3 23 23
RAD9A 0.016 0.019 -9999 0 -0.41 1 1
AP1 -0.049 0.13 -9999 0 -0.29 125 125
IFNAR2 0.017 0.005 -9999 0 -10000 0 0
AKT1 0.018 0.021 -9999 0 -0.2 4 4
ER alpha/Oestrogen 0.012 0.003 -9999 0 -10000 0 0
NFX1/SIN3/HDAC complex -0.006 0.061 -9999 0 -0.18 27 27
EGF 0.015 0.026 -9999 0 -0.41 2 2
SMG5 0.017 0 -9999 0 -10000 0 0
SMG6 0.017 0 -9999 0 -10000 0 0
SP3/HDAC2 -0.023 0.12 -9999 0 -0.3 78 78
TERT/c-Abl -0.024 0.1 -9999 0 -0.31 15 15
SAP18 0.017 0.001 -9999 0 -10000 0 0
MRN complex 0.035 0 -9999 0 -10000 0 0
WT1 0.013 0.042 -9999 0 -0.42 5 5
WRN 0.013 0.042 -9999 0 -0.41 5 5
SP1 0.016 0.008 -9999 0 -10000 0 0
SP3 -0.046 0.15 -9999 0 -0.41 77 77
TERF2IP 0.016 0.005 -9999 0 -10000 0 0
Telomerase/Nucleolin -0.009 0.1 -9999 0 -0.31 11 11
Mad/Max 0.025 0.006 -9999 0 -10000 0 0
TERT -0.029 0.11 -9999 0 -0.3 26 26
CCND1 -0.053 0.17 -9999 0 -0.39 98 98
MAX 0.017 0.002 -9999 0 -10000 0 0
RBBP7 0.017 0.001 -9999 0 -10000 0 0
RBBP4 -0.065 0.17 -9999 0 -0.41 101 101
TERF2 0.016 0.01 -9999 0 -10000 0 0
PTGES3 0.017 0.001 -9999 0 -10000 0 0
SIN3A 0 0.001 -9999 0 -10000 0 0
Telomerase/911 0.026 0.034 -9999 0 -0.22 5 5
CDKN1B -0.005 0.086 -9999 0 -0.22 71 71
RAD1 0.015 0.026 -9999 0 -0.41 2 2
XRCC5 0.017 0 -9999 0 -10000 0 0
XRCC6 0.017 0 -9999 0 -10000 0 0
SAP30 0.017 0.001 -9999 0 -10000 0 0
TRF2/PARP2 0.024 0.01 -9999 0 -10000 0 0
UBE3A 0.017 0.002 -9999 0 -10000 0 0
JUN 0.016 0.019 -9999 0 -0.41 1 1
E6 0 0.002 -9999 0 -10000 0 0
HPV-16 E6/E6AP 0.012 0.006 -9999 0 -10000 0 0
FOS -0.085 0.18 -9999 0 -0.41 125 125
IFN-gamma/IRF1 -0.007 0.11 -9999 0 -0.28 71 71
PARP2 0.017 0.001 -9999 0 -10000 0 0
BLM -0.083 0.18 -9999 0 -0.41 124 124
Telomerase 0.013 0.034 -9999 0 -0.17 7 7
IRF1 -0.036 0.14 -9999 0 -0.41 70 70
ESR1 0.017 0.001 -9999 0 -10000 0 0
KU/TER 0.025 0 -9999 0 -10000 0 0
ATM/TRF2 0.011 0.055 -9999 0 -0.24 25 25
ubiquitin-dependent protein catabolic process -0.003 0.064 -9999 0 -0.19 23 23
HPV-16 E6/E6AP/NFX1/SIN3/HDAC complex -0.003 0.065 -9999 0 -0.19 23 23
HDAC1 -0.037 0.14 -9999 0 -0.41 66 66
HDAC2 0.012 0.043 -9999 0 -0.42 5 5
ATM -0.007 0.056 -9999 0 -0.26 25 25
SMAD3 0.002 0.066 -9999 0 -0.28 27 27
ABL1 0.016 0.019 -9999 0 -0.41 1 1
MXD1 0.017 0.002 -9999 0 -10000 0 0
MRE11A 0.017 0 -9999 0 -10000 0 0
HUS1 0.017 0 -9999 0 -10000 0 0
RPS6KB1 0.016 0.019 -9999 0 -0.41 1 1
TERT/NF kappa B1/14-3-3 -0.003 0.1 -9999 0 -0.32 7 7
NR2F2 0.014 0.037 -9999 0 -0.41 4 4
MAPK3 0.017 0.004 -9999 0 -10000 0 0
MAPK1 0.017 0.005 -9999 0 -10000 0 0
TGFB1/TGF beta receptor Type II -0.005 0.094 -9999 0 -0.41 27 27
NFKB1 0.014 0.037 -9999 0 -0.41 4 4
HNRNPC 0.017 0 -9999 0 -10000 0 0
DNA damage response signal transduction by p53 class mediator resulting in induction of apoptosis -0.007 0.056 -9999 0 -0.26 25 25
NBN 0.017 0 -9999 0 -10000 0 0
EGFR -0.14 0.21 -9999 0 -0.41 194 194
mol:Oestrogen 0 0.001 -9999 0 -10000 0 0
EGF/EGFR -0.09 0.15 -9999 0 -0.28 196 196
MYC -0.094 0.19 -9999 0 -0.41 137 137
IL2 0.016 0.009 -9999 0 -10000 0 0
KU 0.025 0 -9999 0 -10000 0 0
RAD50 0.017 0 -9999 0 -10000 0 0
HSP90AA1 0.017 0 -9999 0 -10000 0 0
TGFB1 -0.005 0.094 -9999 0 -0.41 27 27
TRF2/BLM -0.044 0.12 -9999 0 -0.26 124 124
FRAP1 0.016 0.019 -9999 0 -0.41 1 1
KU/TERT -0.013 0.11 -9999 0 -0.31 12 12
SP1/HDAC2 0.021 0.034 -9999 0 -0.3 5 5
PINX1 0 0 -9999 0 -10000 0 0
Telomerase/EST1A -0.009 0.1 -9999 0 -0.31 11 11
Smad3/Myc -0.054 0.13 -9999 0 -0.25 153 153
911 complex 0.033 0.02 -9999 0 -0.23 3 3
IFNG 0.02 0.019 -9999 0 -0.41 1 1
Telomerase/PinX1 -0.033 0.09 -9999 0 -0.31 11 11
Telomerase/AKT1/mTOR/p70S6K 0.024 0.04 -9999 0 -0.21 3 3
SIN3B 0.017 0.001 -9999 0 -10000 0 0
YWHAE 0.017 0.001 -9999 0 -10000 0 0
Telomerase/EST1B -0.009 0.1 -9999 0 -0.31 10 10
response to DNA damage stimulus 0 0.014 -9999 0 -0.062 25 25
MRN complex/TRF2/Rap1 0.044 0.017 -9999 0 -10000 0 0
TRF2/WRN 0.021 0.03 -9999 0 -0.26 5 5
Telomerase/hnRNP C1/C2 -0.009 0.1 -9999 0 -0.31 11 11
E2F1 0.017 0.005 -9999 0 -10000 0 0
ZNFX1 0 0.001 -9999 0 -10000 0 0
PIF1 0 0 -9999 0 -10000 0 0
NCL 0.017 0 -9999 0 -10000 0 0
DKC1 0.011 0.049 -9999 0 -0.41 7 7
telomeric DNA binding 0 0 -9999 0 -10000 0 0
Ceramide signaling pathway

Figure S63.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S63.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
SPHK2 0.012 0.041 -10000 0 -0.28 10 10
MAP4K4 -0.014 0.067 -10000 0 -0.2 24 24
BAG4 0.017 0 -10000 0 -10000 0 0
PKC zeta/ceramide -0.005 0.019 0.1 10 -0.1 8 18
NFKBIA 0.016 0.019 -10000 0 -0.41 1 1
BIRC3 -0.01 0.1 -10000 0 -0.41 33 33
BAX 0.004 0.021 -10000 0 -0.15 7 7
RIPK1 0.01 0.055 -10000 0 -0.41 9 9
AKT1 0.007 0.034 -10000 0 -0.38 4 4
BAD -0.001 0.02 0.11 10 -0.1 1 11
SMPD1 -0.021 0.056 -10000 0 -0.097 185 185
RB1 -0.001 0.02 0.11 10 -10000 0 10
FADD/Caspase 8 -0.007 0.068 -10000 0 -0.18 32 32
MAP2K4 0.002 0.02 0.11 10 -0.19 1 11
NSMAF 0.015 0.026 -10000 0 -0.41 2 2
response to UV 0 0 -10000 0 -10000 0 0
RAF1 0.002 0.021 0.11 10 -0.19 1 11
EGF 0.015 0.026 -10000 0 -0.41 2 2
mol:ceramide -0.005 0.021 0.12 10 -0.11 8 18
MADD 0.017 0.001 -10000 0 -10000 0 0
response to oxidative stress 0 0 -10000 0 -10000 0 0
mol:Free Fatty acid 0.012 0.041 -10000 0 -0.28 10 10
ASAH1 0.017 0.001 -10000 0 -10000 0 0
negative regulation of cell cycle -0.001 0.02 0.11 10 -10000 0 10
cell proliferation 0.026 0.026 -10000 0 -0.16 5 5
BID -0.002 0.053 -10000 0 -0.21 4 4
MAP3K1 -0.001 0.022 0.11 10 -0.11 9 19
EIF2A 0.003 0.019 -10000 0 -10000 0 0
TRADD 0.017 0 -10000 0 -10000 0 0
CRADD 0.017 0 -10000 0 -10000 0 0
MAPK3 0.011 0.022 -10000 0 -0.18 1 1
response to heat 0 0 -10000 0 -10000 0 0
MAPK1 0.008 0.027 -10000 0 -0.18 2 2
Cathepsin D/ceramide 0.001 0.042 0.11 10 -0.19 19 29
FADD -0.015 0.068 -10000 0 -0.19 26 26
KSR1 -0.001 0.02 0.11 10 -0.1 3 13
MAPK8 0.008 0.023 0.11 10 -0.12 1 11
PRKRA -0.001 0.02 0.11 10 -0.097 8 18
PDGFA 0.009 0.058 -10000 0 -0.41 10 10
TRAF2 0.017 0 -10000 0 -10000 0 0
IGF1 0.014 0.037 -10000 0 -0.41 4 4
mol:GD3 0 0 -10000 0 -10000 0 0
ganglioside biosynthetic process -0.005 0.021 0.12 10 -0.11 8 18
CTSD 0.004 0.073 -10000 0 -0.41 16 16
regulation of nitric oxide biosynthetic process 0.023 0.027 -10000 0 -0.28 4 4
response to radiation 0 0 -10000 0 -10000 0 0
ERK1/PKC delta 0.028 0.027 -10000 0 -0.16 5 5
PRKCD 0.017 0 -10000 0 -10000 0 0
PRKCZ 0 0 -10000 0 -10000 0 0
mol:GW4869 0 0 -10000 0 -10000 0 0
mol:sphingosine 0.012 0.041 -10000 0 -0.28 10 10
RelA/NF kappa B1 0.023 0.027 -10000 0 -0.28 4 4
mol:glutathione 0 0 -10000 0 -10000 0 0
PAWR 0.017 0 -10000 0 -10000 0 0
TNF-alpha/TNFR1A/TRADD/MADD/cIAP2/RIP1/TRAF2/RAIDD -0.018 0.072 -10000 0 -0.21 24 24
TNFR1A/BAG4/TNF-alpha -0.059 0.13 -10000 0 -0.23 185 185
mol:Sphingosine-1-phosphate 0.012 0.041 -10000 0 -0.28 10 10
MAP2K1 0.005 0.02 -10000 0 -0.18 1 1
mol:C11AG 0 0 -10000 0 -10000 0 0
RELA 0.017 0 -10000 0 -10000 0 0
CYCS 0.002 0.018 -10000 0 -0.16 1 1
TNFRSF1A -0.13 0.2 -10000 0 -0.41 183 183
NFKB1 0.014 0.037 -10000 0 -0.41 4 4
TNFR1A/BAG4 -0.082 0.15 -10000 0 -0.28 183 183
EIF2AK2 0.003 0.02 0.11 12 -10000 0 12
TNF-alpha/TNFR1A/FAN -0.06 0.13 -10000 0 -0.23 187 187
response to hydrogen peroxide 0 0 -10000 0 -10000 0 0
CASP8 0.004 0.051 -10000 0 -0.14 32 32
MAP2K2 0.005 0.02 -10000 0 -0.18 1 1
SMPD3 -0.018 0.058 -10000 0 -0.096 185 185
TNF 0.015 0.026 -10000 0 -0.41 2 2
PKC zeta/PAR4 0.013 0 -10000 0 -10000 0 0
mol:PHOSPHOCHOLINE -0.013 0.022 0.093 12 -0.082 2 14
NF kappa B1/RelA/I kappa B alpha 0.039 0.023 -10000 0 -0.19 5 5
AIFM1 -0.001 0.028 -10000 0 -0.14 12 12
BCL2 0.017 0 -10000 0 -10000 0 0
E-cadherin signaling in the nascent adherens junction

Figure S64.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S64.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
CTTN 0.025 0.029 -9999 0 -0.15 8 8
KLHL20 0.004 0.065 -9999 0 -0.13 94 94
CYFIP2 0.01 0.008 -9999 0 -10000 0 0
Rac1/GDP 0.033 0.027 -9999 0 -0.14 2 2
ENAH 0.016 0.054 -9999 0 -0.18 34 34
AP1M1 0 0 -9999 0 -10000 0 0
RAP1B 0 0 -9999 0 0 4 4
RAP1A 0.017 0 -9999 0 -10000 0 0
CTNNB1 0.017 0 -9999 0 -10000 0 0
CDC42/GTP 0 0.02 -9999 0 -10000 0 0
ABI1/Sra1/Nap1 -0.015 0.032 -9999 0 -0.099 13 13
E-cadherin/beta catenin/alpha catenin/beta7/alphaE Integrin 0.039 0.037 -9999 0 -0.23 9 9
RAPGEF1 0.027 0.026 -9999 0 -0.14 4 4
CTNND1 0.009 0.058 -9999 0 -0.41 10 10
regulation of calcium-dependent cell-cell adhesion 0.024 0.03 -9999 0 -0.13 18 18
CRK 0.026 0.028 -9999 0 -0.14 8 8
E-cadherin/gamma catenin/alpha catenin 0.023 0.064 -9999 0 -0.29 19 19
alphaE/beta7 Integrin 0.024 0.019 -9999 0 -0.28 2 2
IQGAP1 -0.086 0.18 -9999 0 -0.41 127 127
NCKAP1 0.017 0 -9999 0 -10000 0 0
Rap1/GTP/I-afadin 0.022 0.001 -9999 0 -10000 0 0
DLG1 0.025 0.03 -9999 0 -0.16 9 9
ChemicalAbstracts:7440-70-2 0 0 -9999 0 -10000 0 0
mol:PI-3-4-5-P3 -0.006 0.025 -9999 0 -0.17 4 4
MLLT4 0.017 0 -9999 0 -10000 0 0
ARF6/GTP/NME1/Tiam1 0.021 0.004 -9999 0 -10000 0 0
PI3K -0.008 0.031 -9999 0 -0.21 4 4
ARF6 0.017 0 -9999 0 -10000 0 0
mol:Ca2+ 0 0 -9999 0 -0.001 92 92
E-cadherin/gamma catenin 0.012 0.073 -9999 0 -0.35 19 19
TIAM1 0.016 0.003 -9999 0 -10000 0 0
E-cadherin(dimer)/Ca2+ 0.032 0.043 -9999 0 -0.2 18 18
AKT1 0.016 0.028 -9999 0 -0.12 8 8
PIK3R1 0.016 0.004 -9999 0 -10000 0 0
CDH1 0.01 0.052 -9999 0 -0.41 8 8
RhoA/GDP 0.034 0.025 -9999 0 -0.14 2 2
actin cytoskeleton organization 0.004 0.049 -9999 0 -0.098 94 94
CDC42/GDP 0.035 0.025 -9999 0 -10000 0 0
E-cadherin/Ca2+/gamma catenin/alpha catenin/p120 catenin 0.012 0.043 -9999 0 -0.16 28 28
ITGB7 0.015 0.026 -9999 0 -0.41 2 2
RAC1 0.017 0 -9999 0 -10000 0 0
E-cadherin/beta catenin/alpha catenin/p120 catenin 0.035 0.046 -9999 0 -0.21 18 18
E-cadherin/Ca2+/beta catenin/alpha catenin 0.027 0.028 -9999 0 -0.2 8 8
mol:GDP 0.027 0.027 -9999 0 -0.16 2 2
CDC42/GTP/IQGAP1 -0.04 0.11 -9999 0 -0.24 127 127
JUP 0.004 0.073 -9999 0 -0.41 16 16
p120 catenin/RhoA/GDP 0.036 0.032 -9999 0 -0.15 5 5
RAC1/GTP/IQGAP1 -0.04 0.11 -9999 0 -0.24 127 127
PIP5K1C/AP1M1 0.012 0.002 -9999 0 -10000 0 0
RHOA 0.017 0.001 -9999 0 -10000 0 0
CDC42 0.017 0 -9999 0 -10000 0 0
CTNNA1 0.017 0 -9999 0 -10000 0 0
positive regulation of S phase of mitotic cell cycle -0.013 0.074 -9999 0 -0.17 98 98
NME1 0 0 -9999 0 -0.001 98 98
clathrin coat assembly 0 0 -9999 0 -10000 0 0
TJP1 0.025 0.029 -9999 0 -0.15 8 8
regulation of cell-cell adhesion -0.003 0.016 -9999 0 -10000 0 0
WASF2 -0.008 0.018 -9999 0 -0.055 13 13
Rap1/GTP 0.025 0.026 -9999 0 -0.14 4 4
E-cadherin/gamma catenin/alpha catenin/beta7/alphaE Integrin 0.039 0.061 -9999 0 -0.25 20 20
CCND1 -0.017 0.09 -9999 0 -0.2 98 98
VAV2 0.031 0.03 -9999 0 -10000 0 0
RAP1/GDP 0.028 0.026 -9999 0 -0.15 2 2
adherens junction assembly 0.025 0.028 -9999 0 -0.15 8 8
homophilic cell adhesion 0 0 -9999 0 -10000 0 0
ABI1 0.017 0 -9999 0 -10000 0 0
PIP5K1C 0.016 0.003 -9999 0 -10000 0 0
regulation of heterotypic cell-cell adhesion 0.037 0.058 -9999 0 -0.24 20 20
E-cadherin/beta catenin 0.019 0.032 -9999 0 -0.16 8 8
mol:GTP 0 0 -9999 0 -0.001 98 98
SRC 0.025 0.029 -9999 0 -0.14 13 13
PIK3CA -0.003 0.091 -9999 0 -0.41 25 25
Rac1/GTP -0.037 0.077 -9999 0 -0.2 94 94
E-cadherin/beta catenin/alpha catenin 0.03 0.033 -9999 0 -0.24 8 8
ITGAE 0.017 0.001 -9999 0 -10000 0 0
E-cadherin/Ca2+/beta catenin/alpha catenin/p120 catenin 0.024 0.03 -9999 0 -0.13 18 18
Coregulation of Androgen receptor activity

Figure S65.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S65.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
NRIP1 0.015 0.037 -9999 0 -0.41 4 4
SVIL 0.003 0.08 -9999 0 -0.41 19 19
ZNF318 0.014 0 -9999 0 -10000 0 0
JMJD2C 0.023 0 -9999 0 -10000 0 0
T-DHT/AR/Ubc9 0.03 0.034 -9999 0 -0.23 8 8
CARM1 0.017 0 -9999 0 -10000 0 0
PRDX1 0.017 0.001 -9999 0 -10000 0 0
PELP1 0.017 0 -9999 0 -10000 0 0
CTNNB1 0.018 0 -9999 0 -10000 0 0
AKT1 0.013 0.037 -9999 0 -0.41 4 4
PTK2B 0.018 0 -9999 0 -10000 0 0
MED1 0.016 0 -9999 0 -10000 0 0
MAK 0.008 0.052 -9999 0 -0.41 8 8
response to oxidative stress 0 0 -9999 0 -10000 0 0
HIP1 -0.026 0.13 -9999 0 -0.41 54 54
GSN 0.006 0.071 -9999 0 -0.41 15 15
NCOA2 0.017 0 -9999 0 -10000 0 0
NCOA6 0.018 0.001 -9999 0 -10000 0 0
DNA-PK 0.02 0.055 -9999 0 -0.24 23 23
NCOA4 0.017 0.001 -9999 0 -10000 0 0
PIAS3 0.016 0.026 -9999 0 -0.41 2 2
cell proliferation 0.012 0.033 -9999 0 -0.24 8 8
XRCC5 0.017 0 -9999 0 -10000 0 0
UBE3A 0.019 0 -9999 0 -10000 0 0
T-DHT/AR/SNURF 0.019 0.032 -9999 0 -0.23 8 8
FHL2 0.028 0.038 -9999 0 -0.37 4 4
RANBP9 0.018 0.001 -9999 0 -10000 0 0
JMJD1A 0.021 0.065 -9999 0 -0.4 12 12
CDK6 0.017 0 -9999 0 -10000 0 0
TGFB1I1 -0.34 0.16 -9999 0 -0.41 441 441
T-DHT/AR/CyclinD1 -0.017 0.11 -9999 0 -0.24 103 103
XRCC6 0.017 0 -9999 0 -10000 0 0
T-DHT/AR 0.047 0.04 -9999 0 -0.22 8 8
CTDSP1 0.015 0.032 -9999 0 -0.41 3 3
CTDSP2 -0.015 0.11 -9999 0 -0.41 37 37
BRCA1 0.014 0.042 -9999 0 -0.41 5 5
TCF4 0.016 0.002 -9999 0 -10000 0 0
CDKN2A -0.031 0.13 -9999 0 -0.41 58 58
SRF 0.021 0.011 -9999 0 -10000 0 0
NKX3-1 0.032 0.038 -9999 0 -0.18 12 12
KLK3 0.017 0.029 -9999 0 -10000 0 0
TMF1 0.014 0.037 -9999 0 -0.41 4 4
HNRNPA1 0.016 0 -9999 0 -10000 0 0
AOF2 0.013 0.049 -9999 0 -0.41 7 7
APPL1 0.014 0.026 -9999 0 -0.29 4 4
T-DHT/AR/Caspase 8 0.024 0.049 -9999 0 -0.24 17 17
AR 0.015 0.052 -9999 0 -0.4 8 8
UBA3 0 0 -9999 0 -10000 0 0
PATZ1 0.016 0 -9999 0 -10000 0 0
PAWR 0.017 0 -9999 0 -10000 0 0
PRKDC -0.002 0.088 -9999 0 -0.41 23 23
PA2G4 0.015 0.019 -9999 0 -0.41 1 1
UBE2I 0.017 0 -9999 0 -10000 0 0
T-DHT/AR/Cyclin D3/CDK11 p58 0.028 0.032 -9999 0 -0.2 9 9
RPS6KA3 0.018 0.019 -9999 0 -0.41 1 1
T-DHT/AR/ARA70 0.03 0.034 -9999 0 -0.23 8 8
LATS2 -0.001 0 -9999 0 -10000 0 0
T-DHT/AR/PRX1 0.027 0.031 -9999 0 -0.2 8 8
Cyclin D3/CDK11 p58 0.012 0.013 -9999 0 -0.29 1 1
VAV3 -0.011 0.11 -9999 0 -0.41 36 36
KLK2 0.033 0.017 -9999 0 -10000 0 0
CASP8 0.009 0.056 -9999 0 -0.41 9 9
T-DHT/AR/TIF2/CARM1 0.04 0.033 -9999 0 -0.2 8 8
TMPRSS2 0.031 0.047 -9999 0 -0.22 15 15
CCND1 -0.062 0.17 -9999 0 -0.41 98 98
PIAS1 0.019 0 -9999 0 -10000 0 0
mol:T-DHT 0.005 0.006 -9999 0 -0.045 7 7
CDC2L1 0 0 -9999 0 -10000 0 0
PIAS4 0.02 0 -9999 0 -10000 0 0
T-DHT/AR/CDK6 0.029 0.034 -9999 0 -0.23 8 8
CMTM2 0 0 -9999 0 -10000 0 0
SNURF 0 0 -9999 0 -10000 0 0
ZMIZ1 0.021 0.009 -9999 0 -10000 0 0
CCND3 0.016 0.019 -9999 0 -0.41 1 1
TGIF1 -0.29 0.2 -9999 0 -0.41 372 372
FKBP4 0.018 0 -9999 0 -10000 0 0
BMP receptor signaling

Figure S66.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S66.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
BMP7/BMPR2/BMPR1A-1B/FS 0.04 0.051 -9999 0 -0.19 25 25
SMAD6-7/SMURF1 0.034 0.012 -9999 0 -0.23 1 1
NOG 0 0 -9999 0 -10000 0 0
SMAD9 0.02 0.019 -9999 0 -10000 0 0
SMAD4 -0.086 0.18 -9999 0 -0.41 127 127
SMAD5 0.02 0.034 -9999 0 -0.17 8 8
BMP7/USAG1 0.02 0.04 -9999 0 -0.28 9 9
SMAD5/SKI 0.029 0.035 -9999 0 -0.19 5 5
SMAD1 -0.004 0.074 -9999 0 -0.14 114 114
BMP2 -0.027 0.13 -9999 0 -0.41 54 54
SMAD1/SMAD1/SMAD4 -0.058 0.084 -9999 0 -0.26 49 49
BMPR1A 0.012 0.045 -9999 0 -0.41 6 6
BMPR1B 0.016 0.019 -9999 0 -0.41 1 1
BMPR1A-1B/BAMBI 0.014 0.074 -9999 0 -0.25 39 39
AHSG 0.015 0.026 -9999 0 -0.41 2 2
CER1 0.017 0 -9999 0 -10000 0 0
BMP2-4/CER1 0.003 0.087 -9999 0 -0.23 62 62
BMP2-4/BMPR2/BMPR1A-1B/RGM/ENDOFIN/GADD34/PP1CA 0.016 0.046 -9999 0 -0.22 8 8
BMP2-4 (homodimer) -0.011 0.1 -9999 0 -0.28 62 62
RGMB 0 0 -9999 0 -10000 0 0
BMP6/BMPR2/BMPR1A-1B 0.04 0.033 -9999 0 -0.21 9 9
RGMA 0 0 -9999 0 -10000 0 0
SMURF1 0.017 0 -9999 0 -10000 0 0
BMP2-4/BMPR2/BMPR1A-1B/RGM/XIAP 0.007 0.039 -9999 0 -0.15 11 11
BMP2-4/USAG1 0 0.094 -9999 0 -0.24 66 66
SMAD6/SMURF1/SMAD5 0.029 0.035 -9999 0 -0.19 5 5
SOSTDC1 0.011 0.049 -9999 0 -0.41 7 7
BMP7/BMPR2/BMPR1A-1B 0.04 0.033 -9999 0 -0.21 9 9
SKI 0.017 0 -9999 0 -10000 0 0
BMP6 (homodimer) 0.015 0.026 -9999 0 -0.41 2 2
HFE2 0 0 -9999 0 -10000 0 0
ZFYVE16 0.013 0.042 -9999 0 -0.41 5 5
MAP3K7 0.016 0.019 -9999 0 -0.41 1 1
BMP2-4/CHRD 0.003 0.087 -9999 0 -0.23 62 62
SMAD5/SMAD5/SMAD4 -0.019 0.098 -9999 0 -0.18 128 128
MAPK1 0.017 0.003 -9999 0 -10000 0 0
TAK1/TAB family 0.035 0.041 -9999 0 -0.16 6 6
BMP7 (homodimer) 0.015 0.026 -9999 0 -0.41 2 2
NUP214 0.017 0 -9999 0 -10000 0 0
BMP6/FETUA 0.023 0.027 -9999 0 -0.28 4 4
SMAD1/SKI 0.003 0.075 -9999 0 -0.25 8 8
SMAD6 0.017 0 -9999 0 -10000 0 0
CTDSP2 -0.013 0.11 -9999 0 -0.41 37 37
BMP2-4/FETUA 0.002 0.089 -9999 0 -0.24 63 63
MAP3K7IP1 0.017 0 -9999 0 -10000 0 0
GREM1 -0.002 0.088 -9999 0 -0.41 23 23
BMPR2 (homodimer) 0.017 0 -9999 0 -10000 0 0
GADD34/PP1CA 0.032 0.029 -9999 0 -0.23 6 6
BMPR1A-1B (homodimer) 0.021 0.035 -9999 0 -0.28 7 7
CHRDL1 0 0 -9999 0 -10000 0 0
ENDOFIN/SMAD1 0.001 0.077 -9999 0 -0.23 13 13
SMAD6-7/SMURF1/SMAD1 0.016 0.075 -9999 0 -0.23 8 8
SMAD6/SMURF1 0.017 0 -9999 0 -10000 0 0
BAMBI -0.011 0.1 -9999 0 -0.41 34 34
SMURF2 0.015 0.026 -9999 0 -0.41 2 2
BMP2-4/CHRDL1 -0.007 0.084 -9999 0 -0.24 62 62
BMP2-4/GREM1 -0.008 0.1 -9999 0 -0.24 82 82
SMAD7 0.016 0.019 -9999 0 -0.41 1 1
SMAD8A/SMAD8A/SMAD4 -0.023 0.096 -9999 0 -0.19 127 127
SMAD1/SMAD6 0.003 0.075 -9999 0 -0.25 8 8
TAK1/SMAD6 0.025 0.013 -9999 0 -0.28 1 1
BMP7 0.015 0.026 -9999 0 -0.41 2 2
BMP6 0.015 0.026 -9999 0 -0.41 2 2
MAP3K7IP2 0.017 0 -9999 0 -10000 0 0
BMP2-4/BMPR2/BMPR1A-1B/RGM/SMAD7/SMURF1 0.013 0.038 -9999 0 -0.19 5 5
PPM1A 0.017 0 -9999 0 -10000 0 0
SMAD1/SMURF2 0.002 0.075 -9999 0 -0.23 10 10
SMAD7/SMURF1 0.025 0.013 -9999 0 -0.28 1 1
CTDSPL 0.017 0 -9999 0 -10000 0 0
PPP1CA 0.017 0 -9999 0 -10000 0 0
XIAP 0 0 -9999 0 -10000 0 0
CTDSP1 0.015 0.032 -9999 0 -0.41 3 3
PPP1R15A 0.016 0.019 -9999 0 -0.41 1 1
BMP2-4/BMPR2/BMPR1A-1B/RGM/FS 0.007 0.046 -9999 0 -0.14 26 26
CHRD 0.017 0 -9999 0 -10000 0 0
BMPR2 0.017 0 -9999 0 -10000 0 0
BMP2-4/BMPR2/BMPR1A-1B/RGM 0.006 0.045 -9999 0 -0.11 64 64
BMP4 0.011 0.052 -9999 0 -0.41 8 8
FST 0.004 0.073 -9999 0 -0.41 16 16
BMP2-4/NOG -0.007 0.084 -9999 0 -0.24 62 62
BMP7/BMPR2/BMPR1A-1B/SMAD6/SMURF1 0.047 0.031 -9999 0 -0.19 9 9
Glucocorticoid receptor regulatory network

Figure S67.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S67.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
PCK2 -0.01 0.052 0.2 5 -0.32 10 15
SMARCC2 0.016 0.019 -10000 0 -0.41 1 1
SMARCC1 0.002 0.078 -10000 0 -0.41 18 18
TBX21 0.016 0.033 0.17 1 -0.19 1 2
SUMO2 0.018 0.004 -10000 0 -10000 0 0
STAT1 (dimer) -0.012 0.11 -10000 0 -0.26 64 64
FKBP4 0.017 0 -10000 0 -10000 0 0
FKBP5 -0.004 0.093 -10000 0 -0.41 26 26
GR alpha/HSP90/FKBP51/HSP90 -0.009 0.048 0.2 1 -0.26 11 12
PRL 0.014 0.056 -10000 0 -0.42 6 6
cortisol/GR alpha (dimer)/TIF2 -0.015 0.059 0.32 6 -0.32 2 8
RELA -0.01 0.073 -10000 0 -0.2 40 40
FGG -0.021 0.061 0.35 1 -0.41 5 6
GR beta/TIF2 -0.005 0.026 0.2 1 -10000 0 1
IFNG -0.038 0.13 -10000 0 -0.32 48 48
apoptosis 0.022 0.078 0.32 25 -0.27 2 27
CREB1 0.023 0.024 -10000 0 -0.18 7 7
histone acetylation 0.013 0.025 0.15 1 -10000 0 1
BGLAP 0.017 0.034 -10000 0 -0.18 1 1
GR/PKAc 0.006 0.015 -10000 0 -10000 0 0
NF kappa B1 p50/RelA -0.014 0.14 -10000 0 -0.36 43 43
SMARCD1 0.017 0 -10000 0 -10000 0 0
MDM2 -0.009 0.029 0.16 1 -0.14 12 13
GATA3 0.026 0.042 -10000 0 -0.4 5 5
AKT1 0.01 0.041 -10000 0 -0.42 4 4
CSF2 0.004 0.04 -10000 0 -10000 0 0
GSK3B 0.018 0.004 -10000 0 -10000 0 0
NR1I3 0.075 0.1 0.36 16 -0.25 2 18
CSN2 0 0.086 0.32 28 -0.29 2 30
BRG1/BAF155/BAF170/BAF60A 0.035 0.047 -10000 0 -0.21 19 19
NFATC1 0.026 0 -10000 0 -10000 0 0
POU2F1 0.022 0.015 -10000 0 -10000 0 0
CDKN1A -0.058 0.15 -10000 0 -0.32 107 107
response to stress 0 0 -10000 0 -10000 0 0
response to UV 0.001 0.005 -10000 0 -10000 0 0
SFN -0.01 0.1 -10000 0 -0.41 33 33
GR alpha/HSP90/FKBP51/HSP90/14-3-3 -0.012 0.063 -10000 0 -0.24 27 27
prolactin receptor activity 0 0 -10000 0 -10000 0 0
EGR1 0.069 0.11 0.36 11 -0.33 6 17
JUN 0.018 0.058 -10000 0 -0.3 9 9
IL4 0.018 0.033 -10000 0 -0.18 1 1
CDK5R1 0.014 0.007 -10000 0 -10000 0 0
PRKACA 0.017 0 -10000 0 -10000 0 0
cortisol/GR alpha (monomer)/AP-1 -0.021 0.081 0.12 7 -0.25 43 50
GR alpha/HSP90/FKBP51/HSP90/PP5C 0 0.045 0.2 1 -0.24 11 12
cortisol/GR alpha (monomer) -0.022 0.07 0.35 6 -0.39 2 8
NCOA2 0.017 0 -10000 0 -10000 0 0
response to hypoxia 0 0 -10000 0 -10000 0 0
FOS -0.071 0.18 -10000 0 -0.39 130 130
AP-1/NFAT1-c-4 -0.027 0.13 -10000 0 -0.42 22 22
AFP 0.016 0.062 -10000 0 -0.51 2 2
SUV420H1 0.016 0.019 -10000 0 -0.41 1 1
IRF1 -0.043 0.11 0.22 2 -0.3 70 72
TP53 -0.046 0.17 -10000 0 -0.43 71 71
PPP5C 0.017 0 -10000 0 -10000 0 0
KRT17 -0.043 0.14 -10000 0 -0.36 51 51
KRT14 0.003 0.063 -10000 0 -0.48 8 8
TBP 0.025 0.019 -10000 0 -0.4 1 1
CREBBP 0.01 0.018 -10000 0 -10000 0 0
HDAC1 -0.042 0.14 -10000 0 -0.42 66 66
HDAC2 0.011 0.042 -10000 0 -0.41 5 5
AP-1 -0.027 0.13 -10000 0 -0.42 22 22
MAPK14 0.017 0.027 -10000 0 -0.41 2 2
MAPK10 0.01 0.01 -10000 0 -10000 0 0
MAPK11 0.018 0.004 -10000 0 -10000 0 0
KRT5 -0.043 0.14 -10000 0 -0.31 88 88
interleukin-1 receptor activity -0.002 0 -10000 0 -10000 0 0
NCOA1 0.017 0.01 -10000 0 -10000 0 0
STAT1 -0.012 0.11 -10000 0 -0.26 64 64
CGA 0.012 0.059 -10000 0 -0.38 8 8
NF kappa B1 p50/RelA/Cbp/cortisol/GR alpha (monomer)/HDAC2 -0.007 0.034 0.18 5 -0.21 3 8
MAPK3 0.018 0.005 -10000 0 -10000 0 0
MAPK1 0.018 0.005 -10000 0 -10000 0 0
ICAM1 -0.053 0.16 -10000 0 -0.35 94 94
NFKB1 -0.013 0.084 -10000 0 -0.23 43 43
MAPK8 0.019 0.048 0.19 1 -0.23 7 8
MAPK9 0.018 0.004 -10000 0 -10000 0 0
cortisol/GR alpha (dimer) 0.022 0.077 0.33 24 -0.28 2 26
BAX -0.035 0.099 -10000 0 -0.23 75 75
POMC -0.045 0.083 0.21 1 -10000 0 1
EP300 0.01 0.018 0.16 8 -10000 0 8
cortisol/GR alpha (dimer)/p53 -0.029 0.088 0.34 5 -0.33 22 27
proteasomal ubiquitin-dependent protein catabolic process -0.005 0.018 -10000 0 -0.19 1 1
SGK1 0.025 0.029 0.18 8 -10000 0 8
IL13 -0.015 0.092 -10000 0 -0.26 20 20
IL6 -0.069 0.2 -10000 0 -0.4 114 114
PRKACG 0.017 0 -10000 0 -10000 0 0
IL5 -0.004 0.087 0.24 6 -0.23 8 14
IL2 -0.037 0.13 -10000 0 -0.28 87 87
CDK5 0.017 0.005 -10000 0 -10000 0 0
PRKACB 0.016 0.005 -10000 0 -10000 0 0
HSP90AA1 0.017 0 -10000 0 -10000 0 0
IL8 -0.099 0.23 -10000 0 -0.48 128 128
CDK5R1/CDK5 0.021 0.012 -10000 0 -10000 0 0
NF kappa B1 p50/RelA/PKAc 0.021 0.1 -10000 0 -0.26 36 36
cortisol/GR alpha (dimer)/Hsp90/FKBP52/HSP90 -0.011 0.055 0.31 6 -0.29 2 8
SMARCA4 0.017 0.001 -10000 0 -10000 0 0
chromatin remodeling -0.007 0.034 0.2 4 -0.17 6 10
NF kappa B1 p50/RelA/Cbp 0.004 0.11 -10000 0 -0.28 41 41
JUN (dimer) 0.018 0.058 -10000 0 -0.3 9 9
YWHAH 0.008 0.009 -10000 0 -10000 0 0
VIPR1 0.016 0.033 -10000 0 -0.19 1 1
NR3C1 -0.013 0.039 0.23 2 -0.21 2 4
NR4A1 0.023 0.001 -10000 0 -10000 0 0
TIF2/SUV420H1 0.025 0.014 -10000 0 -0.28 1 1
MAPKKK cascade 0.022 0.078 0.32 25 -0.27 2 27
cortisol/GR alpha (dimer)/Src-1 -0.014 0.054 0.36 3 -0.28 2 5
PBX1 0.022 0.015 -10000 0 -10000 0 0
POU1F1 0.022 0.015 -10000 0 -10000 0 0
SELE -0.045 0.14 -10000 0 -0.31 97 97
cortisol/GR alpha/BRG1/BAF155/BAF170/BAF60A -0.007 0.034 0.2 4 -0.17 6 10
cortisol/GR alpha (monomer)/Hsp90/FKBP52/HSP90 -0.011 0.055 0.31 6 -0.29 2 8
mol:cortisol -0.017 0.041 0.19 4 -0.2 3 7
MMP1 -0.025 0.13 -10000 0 -0.44 43 43
ceramide signaling pathway

Figure S68.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S68.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
MAP4K4 -0.013 0.074 -10000 0 -0.21 24 24
BAG4 0.017 0 -10000 0 -10000 0 0
BAD 0.003 0.027 -10000 0 -10000 0 0
NFKBIA 0.016 0.019 -10000 0 -0.41 1 1
BIRC3 -0.009 0.1 -10000 0 -0.41 33 33
BAX 0.001 0.036 -10000 0 -0.21 7 7
EnzymeConsortium:3.1.4.12 -0.002 0.021 -10000 0 -0.055 24 24
IKBKB -0.009 0.071 -10000 0 -0.2 24 24
MAP2K2 0.01 0.026 -10000 0 -0.15 1 1
MAP2K1 0.009 0.025 -10000 0 -0.15 1 1
SMPD1 0.002 0.021 -10000 0 -10000 0 0
GO:0005551 0 0 -10000 0 -10000 0 0
FADD/Caspase 8 -0.008 0.073 -10000 0 -0.19 30 30
MAP2K4 0.006 0.026 -10000 0 -0.16 1 1
protein ubiquitination -0.009 0.071 0.15 1 -0.2 24 25
EnzymeConsortium:2.7.1.37 0.015 0.03 -10000 0 -0.15 1 1
response to UV 0 0 0.001 5 -0.001 1 6
RAF1 0.008 0.027 -10000 0 -0.16 1 1
CRADD 0.017 0 -10000 0 -10000 0 0
mol:ceramide 0 0.028 -10000 0 -0.073 24 24
I-kappa-B-alpha/RELA/p50/ubiquitin 0.023 0.011 -10000 0 -0.24 1 1
MADD 0.017 0.002 -10000 0 -10000 0 0
MAP3K1 0.003 0.028 -10000 0 -0.17 1 1
TRADD 0.017 0 -10000 0 -10000 0 0
RELA/p50 0.017 0 -10000 0 -10000 0 0
MAPK3 0.014 0.028 -10000 0 -0.14 1 1
MAPK1 0.012 0.028 -10000 0 -0.14 1 1
p50/RELA/I-kappa-B-alpha 0.025 0.013 -10000 0 -0.28 1 1
FADD -0.014 0.074 -10000 0 -0.21 26 26
KSR1 0.004 0.027 -10000 0 -10000 0 0
MAPK8 0.013 0.032 0.13 15 -0.14 1 16
TRAF2 0.017 0.001 -10000 0 -10000 0 0
response to radiation 0 0 -10000 0 -10000 0 0
CHUK -0.01 0.071 -10000 0 -0.2 25 25
TNF R/SODD -0.082 0.15 -10000 0 -0.28 183 183
TNF 0.016 0.026 -10000 0 -0.41 2 2
CYCS 0.002 0.03 -10000 0 -0.14 5 5
IKBKG -0.009 0.071 -10000 0 -0.2 24 24
TNF/TNF R/TRADD/MADD/cIAP/RIP/TRAF2/RAIDD -0.017 0.077 -10000 0 -0.22 24 24
RELA 0.017 0 -10000 0 -10000 0 0
RIPK1 0.01 0.055 -10000 0 -0.41 9 9
AIFM1 0 0.033 -10000 0 -0.14 9 9
TNF/TNF R/SODD -0.059 0.13 -10000 0 -0.23 185 185
TNFRSF1A -0.13 0.2 -10000 0 -0.41 183 183
response to heat 0 0 -10000 0 -10000 0 0
CASP8 0.013 0.032 -10000 0 -0.18 5 5
NSMAF -0.013 0.073 -10000 0 -0.2 26 26
response to hydrogen peroxide 0 0 0.001 5 -0.001 1 6
BCL2 0.017 0 -10000 0 -10000 0 0
Calcineurin-regulated NFAT-dependent transcription in lymphocytes

Figure S69.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S69.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
FOXP3 0.022 0.005 -10000 0 -10000 0 0
NFATC2 0.041 0.11 -10000 0 -0.29 14 14
NFATC3 0.03 0.086 0.2 2 -0.22 1 3
CD40LG -0.038 0.18 -10000 0 -0.45 36 36
ITCH 0.026 0.037 -10000 0 -0.25 1 1
CBLB 0.026 0.034 -10000 0 -10000 0 0
CD4-positive CD25-positive alpha-beta regulatory T cell lineage commitment 0.004 0.12 -10000 0 -0.35 15 15
JUNB 0.011 0.052 -10000 0 -0.41 8 8
CaM/Ca2+/Calcineurin A alpha-beta B1 0.03 0.043 -10000 0 -0.21 16 16
T cell anergy 0.012 0.053 -10000 0 -0.22 18 18
TLE4 0.031 0.072 -10000 0 -0.22 5 5
Jun/NFAT1-c-4/p21SNFT 0.028 0.16 -10000 0 -0.34 16 16
AP-1/NFAT1-c-4 -0.022 0.22 -10000 0 -0.49 36 36
IKZF1 0.031 0.072 -10000 0 -0.22 5 5
T-helper 2 cell differentiation 0.019 0.092 -10000 0 -0.32 1 1
AP-1/NFAT1 -0.029 0.14 -10000 0 -0.25 103 103
CALM1 0.022 0.026 -10000 0 -10000 0 0
EGR2 0.075 0.14 -10000 0 -0.39 12 12
EGR3 0.083 0.12 -10000 0 -0.67 1 1
NFAT1/FOXP3 0.042 0.082 -10000 0 -0.22 5 5
EGR1 0.006 0.071 -10000 0 -0.41 15 15
JUN 0.013 0.028 -10000 0 -0.4 1 1
EGR4 0.018 0.003 -10000 0 -10000 0 0
mol:Ca2+ 0.005 0.029 -10000 0 -0.14 20 20
GBP3 0.024 0.069 -10000 0 -0.19 14 14
FOSL1 0.007 0.066 -10000 0 -0.41 13 13
NFAT1-c-4/MAF/IRF4 0.033 0.15 -10000 0 -0.35 6 6
DGKA 0.031 0.072 -10000 0 -0.24 3 3
CREM 0.016 0 -10000 0 -10000 0 0
NFAT1-c-4/PPARG 0.022 0.16 -10000 0 -0.34 15 15
CTLA4 0.037 0.055 -10000 0 -0.19 3 3
NFAT1-c-4 (dimer)/EGR1 0.022 0.16 -10000 0 -0.38 10 10
NFAT1-c-4 (dimer)/EGR4 0.028 0.16 -10000 0 -0.32 14 14
FOS -0.087 0.18 -10000 0 -0.42 125 125
IFNG 0.019 0.08 -10000 0 -0.45 1 1
T cell activation -0.003 0.11 -10000 0 -0.38 2 2
MAF 0.017 0.019 -10000 0 -0.41 1 1
T-helper 2 cell lineage commitment 0 0 -10000 0 -10000 0 0
activation-induced cell death of T cells -0.083 0.13 0.32 6 -0.3 74 80
TNF 0.016 0.14 -10000 0 -0.34 8 8
FASLG -0.013 0.21 -10000 0 -0.46 21 21
TBX21 0.022 0.004 -10000 0 -10000 0 0
BATF3 0 0 -10000 0 -10000 0 0
PRKCQ 0.02 0.001 -10000 0 -10000 0 0
PTPN1 0.031 0.072 -10000 0 -0.22 5 5
NFAT1-c-4/ICER1 0.022 0.16 -10000 0 -0.32 15 15
GATA3 0.016 0.042 -10000 0 -0.41 5 5
T-helper 1 cell differentiation 0.019 0.08 -10000 0 -0.44 1 1
IL2RA 0.003 0.13 -10000 0 -0.37 15 15
T-helper 1 cell lineage commitment 0 0 -10000 0 -10000 0 0
CASP3 -0.024 0.16 -10000 0 -0.34 97 97
E2F1 -0.059 0.062 -10000 0 -0.13 27 27
PPARG 0.013 0.041 -10000 0 -0.41 5 5
SLC3A2 0.025 0.093 -10000 0 -0.39 12 12
IRF4 0.017 0.019 -10000 0 -0.41 1 1
PTGS2 -0.049 0.2 -10000 0 -0.53 43 43
CSF2 -0.038 0.18 -10000 0 -0.45 36 36
JunB/Fra1/NFAT1-c-4 0.023 0.16 -10000 0 -0.37 9 9
IL4 0.019 0.093 -10000 0 -0.33 1 1
IL5 -0.038 0.18 -10000 0 -0.45 36 36
IL2 -0.003 0.11 -10000 0 -0.38 2 2
IL3 -0.001 0.03 -10000 0 -10000 0 0
RNF128 0.016 0.076 -10000 0 -0.37 19 19
NFATC1 0.083 0.13 0.3 74 -0.32 6 80
CDK4 -0.19 0.18 0.29 4 -0.44 154 158
PTPRK 0.031 0.072 -10000 0 -0.22 5 5
IL8 -0.08 0.23 -10000 0 -0.5 90 90
POU2F1 0.023 0 -10000 0 -10000 0 0
IL23-mediated signaling events

Figure S70.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S70.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
CCL2 -0.025 0.29 -9999 0 -0.68 42 42
IL23A 0.027 0.23 -9999 0 -0.71 18 18
NF kappa B1 p50/RelA/I kappa B alpha 0.034 0.23 -9999 0 -0.58 33 33
positive regulation of T cell mediated cytotoxicity 0.028 0.24 -9999 0 -0.6 40 40
ITGA3 0.025 0.24 -9999 0 -0.67 23 23
IL17F 0.025 0.18 -9999 0 -0.48 21 21
IL12B 0.025 0.029 -9999 0 -10000 0 0
STAT1 (dimer) 0.017 0.23 -9999 0 -0.58 40 40
CD4 0.026 0.24 -9999 0 -0.61 35 35
IL23 0.026 0.22 -9999 0 -0.7 18 18
IL23R 0.018 0.064 -9999 0 -0.13 16 16
IL1B 0.027 0.24 -9999 0 -0.6 39 39
T-helper cell lineage commitment 0 0 -9999 0 -10000 0 0
IL24 0.032 0.22 -9999 0 -0.66 19 19
TYK2 0.02 0.027 -9999 0 -0.39 1 1
STAT4 0.01 0.008 -9999 0 -10000 0 0
STAT3 0.009 0.058 -9999 0 -0.41 10 10
IL18RAP 0.018 0.002 -9999 0 -10000 0 0
IL12RB1 0.021 0.021 -9999 0 -10000 0 0
PIK3CA -0.003 0.091 -9999 0 -0.41 25 25
IL12Rbeta1/TYK2 0.028 0.029 -9999 0 -0.26 1 1
IL23R/JAK2 0.034 0.085 -9999 0 -0.18 5 5
positive regulation of chronic inflammatory response 0.028 0.24 -9999 0 -0.6 40 40
natural killer cell activation -0.001 0.006 -9999 0 -10000 0 0
JAK2 0.025 0.029 -9999 0 -10000 0 0
PIK3R1 0.016 0.004 -9999 0 -10000 0 0
NFKB1 0.015 0.038 -9999 0 -0.42 4 4
RELA 0.018 0.003 -9999 0 -10000 0 0
positive regulation of dendritic cell antigen processing and presentation 0.027 0.22 -9999 0 -0.67 18 18
ALOX12B 0.032 0.22 -9999 0 -0.65 20 20
CXCL1 0.022 0.25 -9999 0 -0.64 39 39
T cell proliferation 0.028 0.24 -9999 0 -0.6 40 40
NFKBIA 0.017 0.019 -9999 0 -0.42 1 1
IL17A 0.047 0.16 -9999 0 -0.42 15 15
PI3K 0.024 0.22 -9999 0 -0.59 27 27
IFNG 0.012 0.017 -9999 0 -0.053 4 4
STAT3 (dimer) 0.028 0.22 -9999 0 -0.64 21 21
IL18R1 0.018 0.002 -9999 0 -10000 0 0
IL23/IL23R/JAK2/TYK2/SOCS3 0.039 0.16 -9999 0 -0.42 12 12
IL18/IL18R 0.016 0.075 -9999 0 -0.23 45 45
macrophage activation 0.001 0.014 -9999 0 -0.039 12 12
TNF 0.029 0.23 -9999 0 -0.57 40 40
STAT3/STAT4 -0.017 0.2 -9999 0 -0.68 19 19
STAT4 (dimer) -0.018 0.2 -9999 0 -0.6 29 29
IL18 -0.019 0.12 -9999 0 -0.41 45 45
IL19 0.033 0.22 -9999 0 -0.65 19 19
STAT5A (dimer) 0.024 0.23 -9999 0 -0.6 32 32
STAT1 0.002 0.078 -9999 0 -0.41 18 18
SOCS3 0.017 0 -9999 0 -10000 0 0
CXCL9 0.01 0.25 -9999 0 -0.68 29 29
MPO 0.033 0.22 -9999 0 -0.55 39 39
positive regulation of humoral immune response 0.028 0.24 -9999 0 -0.6 40 40
IL23/IL23R/JAK2/TYK2 0.027 0.24 -9999 0 -0.61 40 40
IL6 0.014 0.26 -9999 0 -0.72 34 34
STAT5A 0.016 0.019 -9999 0 -0.41 1 1
IL2 0.018 0.004 -9999 0 -10000 0 0
positive regulation of tyrosine phosphorylation of STAT protein -0.001 0.006 -9999 0 -10000 0 0
CD3E 0.032 0.22 -9999 0 -0.57 32 32
keratinocyte proliferation 0.028 0.24 -9999 0 -0.6 40 40
NOS2 0.026 0.22 -9999 0 -0.55 39 39
IFN-gamma pathway

Figure S71.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S71.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
IFN-gamma/IFN-gammaR/JAK1/JAK1/JAK2/JAK2 0.028 0.046 -10000 0 -0.18 14 14
positive regulation of NF-kappaB transcription factor activity 0 0 -10000 0 -10000 0 0
CRKL 0.017 0 -10000 0 -10000 0 0
STAT1 (dimer)/Cbp/p300 0.01 0.11 -10000 0 -0.25 70 70
IFN-gammaR/JAK1/JAK1/JAK2/JAK2 0.027 0.042 -10000 0 -0.24 13 13
antigen processing and presentation of peptide antigen via MHC class I -0.051 0.077 -10000 0 -0.18 113 113
CaM/Ca2+ 0.028 0.042 -10000 0 -0.18 8 8
RAP1A 0.017 0 -10000 0 -10000 0 0
STAT1 (dimer)/SHP2 0.009 0.068 -10000 0 -0.22 32 32
AKT1 0.008 0.053 -10000 0 -0.2 10 10
MAP2K1 0.017 0.036 -10000 0 -0.19 4 4
MAP3K11 0.016 0.038 -10000 0 -0.18 10 10
IFNGR1 0.007 0.067 -10000 0 -0.41 13 13
mol:GTP 0 0 -10000 0 -10000 0 0
CaM/Ca2+/CAMKII -0.003 0.033 -10000 0 -0.19 10 10
Rap1/GTP -0.006 0.022 -10000 0 -0.17 3 3
CRKL/C3G 0.025 0 -10000 0 -10000 0 0
IFN-gamma/IFN-gammaR/JAK1/JAK1/JAK2/JAK2 /TC-PTP 0.042 0.041 -10000 0 -0.19 15 15
CEBPB 0.037 0.056 -10000 0 -0.27 4 4
STAT3 0.009 0.058 -10000 0 -0.41 10 10
IFN-gamma/IFN-gammaR/JAK1/JAK1/JAK2/JAK2/SOCS1 0.043 0.036 -10000 0 -10000 0 0
STAT1 0.003 0.066 -10000 0 -0.22 32 32
CALM1 0.016 0.004 -10000 0 -10000 0 0
IFN-gamma (dimer) 0.016 0.019 -10000 0 -0.41 1 1
PIK3CA -0.003 0.091 -10000 0 -0.41 25 25
STAT1 (dimer)/PIAS1 0.012 0.065 -10000 0 -0.21 28 28
CEBPB/PTGES2/Cbp/p300 -0.002 0.041 -10000 0 -0.23 4 4
mol:Ca2+ 0.026 0.045 -10000 0 -0.18 14 14
MAPK3 0.03 0.035 -10000 0 -10000 0 0
STAT1 (dimer) -0.064 0.11 -10000 0 -0.24 113 113
MAPK1 0.013 0.11 -10000 0 -0.58 15 15
JAK2 0.017 0.006 -10000 0 -10000 0 0
PIK3R1 0.016 0.004 -10000 0 -10000 0 0
JAK1 0.017 0.006 -10000 0 -10000 0 0
CAMK2D 0 0 -10000 0 -10000 0 0
DAPK1 0.038 0.042 -10000 0 -0.19 3 3
SMAD7 -0.001 0.06 -10000 0 -0.12 43 43
CBL/CRKL/C3G 0.031 0.039 -10000 0 -0.2 3 3
PI3K 0.016 0.059 -10000 0 -0.18 32 32
IFNG 0.016 0.019 -10000 0 -0.41 1 1
apoptosis 0.026 0.043 0.22 4 -0.21 1 5
CAMK2G 0.008 0.008 -10000 0 -10000 0 0
STAT3 (dimer) 0.009 0.058 -10000 0 -0.41 10 10
CAMK2A 0.016 0.004 -10000 0 -10000 0 0
CAMK2B 0.002 0.006 -10000 0 -10000 0 0
FRAP1 0.016 0.058 0.19 2 -0.23 6 8
PRKCD 0.015 0.059 0.2 2 -0.2 10 12
RAP1B 0 0 -10000 0 -10000 0 0
negative regulation of cell growth -0.051 0.077 -10000 0 -0.18 113 113
PTPN2 0.016 0.019 -10000 0 -0.41 1 1
EP300 0.017 0.002 -10000 0 -10000 0 0
IRF1 -0.015 0.14 -10000 0 -0.36 70 70
STAT1 (dimer)/PIASy 0.009 0.065 -10000 0 -0.23 22 22
SOCS1 0.017 0.003 -10000 0 -10000 0 0
mol:GDP 0.028 0.037 -10000 0 -0.19 3 3
CASP1 -0.044 0.12 -10000 0 -0.21 172 172
PTGES2 0.017 0 -10000 0 -10000 0 0
IRF9 0.029 0.028 -10000 0 -0.12 1 1
mol:PI-3-4-5-P3 0.008 0.054 -10000 0 -0.18 32 32
RAP1/GDP 0.02 0.031 -10000 0 -0.17 3 3
CBL 0.015 0.038 -10000 0 -0.17 14 14
MAP3K1 0.016 0.039 -10000 0 -0.17 15 15
PIAS1 0.017 0 -10000 0 -10000 0 0
PIAS4 0.017 0 -10000 0 -10000 0 0
antigen processing and presentation of peptide antigen via MHC class II -0.051 0.077 -10000 0 -0.18 113 113
PTPN11 0.011 0.039 -10000 0 -0.18 14 14
CREBBP 0.017 0.002 -10000 0 -10000 0 0
RAPGEF1 0.017 0 -10000 0 -10000 0 0
IL2 signaling events mediated by PI3K

Figure S72.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S72.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
BCL2L1 0.034 0.044 -10000 0 -0.26 5 5
UGCG 0.012 0.026 -10000 0 -0.22 1 1
AKT1/mTOR/p70S6K/Hsp90/TERT 0.017 0.092 -10000 0 -0.23 21 21
mol:GTP 0 0 -10000 0 -10000 0 0
mol:glucosylceramide 0.012 0.026 -10000 0 -0.22 1 1
mol:DAG 0.006 0.01 -10000 0 -10000 0 0
CaM/Ca2+/Calcineurin A alpha-beta B1 0.01 0.1 -10000 0 -0.28 17 17
FRAP1 0.002 0.12 -10000 0 -0.27 46 46
FOXO3 -0.003 0.12 -10000 0 -0.27 44 44
AKT1 -0.008 0.13 -10000 0 -0.28 50 50
GAB2 0.015 0.019 -10000 0 -0.41 1 1
SMPD1 0.013 0.024 -10000 0 -10000 0 0
SGMS1 0.012 0.027 -10000 0 -0.26 1 1
positive regulation of NF-kappaB transcription factor activity 0 0 -10000 0 -10000 0 0
mol:Ca2+ 0 0 -10000 0 -10000 0 0
mol:GDP -0.001 0.053 -10000 0 -0.23 25 25
CALM1 0.016 0.004 -10000 0 -10000 0 0
cell proliferation -0.001 0.077 -10000 0 -0.26 4 4
EIF3A 0.017 0 -10000 0 -10000 0 0
PI3K 0.011 0.066 -10000 0 -0.28 25 25
RPS6KB1 0.017 0.027 -10000 0 -0.34 1 1
mol:sphingomyelin 0.006 0.01 -10000 0 -10000 0 0
natural killer cell activation -0.001 0.003 -10000 0 -0.006 134 134
JAK3 0.018 0.003 -10000 0 -10000 0 0
PIK3R1 0.017 0.006 -10000 0 -10000 0 0
JAK1 0.018 0.004 -10000 0 -10000 0 0
NFKB1 0.014 0.037 -10000 0 -0.41 4 4
MYC -0.043 0.18 -10000 0 -0.35 137 137
MYB 0.023 0.05 -10000 0 -0.38 8 8
IL2/IL2R alpha/beta/gamma/JAK1/LCK/JAK3/SHC/GAB2/GRB2/SOS1/SHP2/PI3K 0.008 0.092 -10000 0 -0.23 37 37
40S S6 ribosomal protein /40s Ribosomal subunit/eIF3 0.037 0.026 -10000 0 -0.3 1 1
mol:PI-3-4-5-P3 0.008 0.09 -10000 0 -0.22 37 37
Rac1/GDP 0.01 0.049 -10000 0 -0.21 24 24
T cell proliferation 0.008 0.086 -10000 0 -0.21 38 38
SHC1 -0.022 0.12 -10000 0 -0.41 47 47
RAC1 0.017 0 -10000 0 -10000 0 0
positive regulation of cyclin-dependent protein kinase activity 0.004 0.005 -10000 0 -0.039 8 8
PRKCZ 0.007 0.088 -10000 0 -0.21 38 38
NF kappa B1 p50/RelA 0.014 0.12 -10000 0 -0.29 23 23
IL2/IL2R beta/gamma/JAK1/LCK/JAK3/PI3K 0.03 0.047 -10000 0 -0.26 6 6
HSP90AA1 0.017 0 -10000 0 -10000 0 0
RELA 0.017 0 -10000 0 -10000 0 0
IL2RA 0.011 0.046 -10000 0 -0.41 6 6
IL2RB 0.015 0.038 -10000 0 -0.42 4 4
TERT 0.017 0 -10000 0 -10000 0 0
E2F1 0.023 0.032 -10000 0 -0.23 8 8
SOS1 -0.001 0.003 -10000 0 -0.006 134 134
RPS6 0.017 0 -10000 0 -10000 0 0
mol:cAMP -0.002 0.002 0.018 8 -10000 0 8
PTPN11 0.016 0.003 -10000 0 -10000 0 0
IL2RG 0.01 0.056 -10000 0 -0.42 9 9
actin cytoskeleton organization 0.008 0.086 -10000 0 -0.21 38 38
GRB2 0.016 0.003 -10000 0 -10000 0 0
IL2 0.018 0.004 -10000 0 -10000 0 0
PIK3CA -0.003 0.091 -10000 0 -0.41 25 25
Rac1/GTP 0.019 0.051 -10000 0 -0.2 24 24
LCK 0.014 0.038 -10000 0 -0.42 4 4
BCL2 0.012 0.1 -10000 0 -0.25 23 23
Neurotrophic factor-mediated Trk receptor signaling

Figure S73.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S73.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
CRKL 0.017 0 -10000 0 -10000 0 0
RAS family/GTP/Tiam1 -0.01 0.065 -10000 0 -0.12 132 132
NT3 (dimer)/TRKC 0.025 0.004 -10000 0 -10000 0 0
NT3 (dimer)/TRKB 0.021 0.052 -10000 0 -0.23 20 20
SHC/Grb2/SOS1/GAB1/PI3K 0.004 0.057 -10000 0 -0.14 71 71
RAPGEF1 0.017 0 -10000 0 -10000 0 0
BDNF 0.005 0.008 -10000 0 -10000 0 0
PIK3CA -0.003 0.091 -10000 0 -0.41 25 25
DYNLT1 -0.044 0.15 -10000 0 -0.41 75 75
NTRK1 0.015 0.026 -10000 0 -0.41 2 2
NTRK2 0.015 0.005 -10000 0 -10000 0 0
NTRK3 0.017 0.003 -10000 0 -10000 0 0
NT-4/5 (dimer)/TRKB 0.011 0.05 -10000 0 -0.23 22 22
neuron apoptosis 0.01 0.048 0.19 17 -10000 0 17
SHC 2-3/Grb2 -0.011 0.051 -10000 0 -0.2 17 17
SHC1 -0.021 0.12 -10000 0 -0.41 47 47
SHC2 -0.012 0.05 -10000 0 -0.17 37 37
SHC3 -0.014 0.06 -10000 0 -0.19 40 40
STAT3 (dimer) -0.027 0.11 -10000 0 -0.24 104 104
NT3 (dimer)/TRKA 0.023 0.058 -10000 0 -0.24 23 23
RIN/GDP 0.014 0.029 -10000 0 -0.12 5 5
GIPC1 0.017 0 -10000 0 -10000 0 0
KRAS 0.017 0.002 -10000 0 -10000 0 0
DNAJA3 0.002 0.043 -10000 0 -0.17 23 23
RIN/GTP 0.005 0.023 -10000 0 -0.29 3 3
CCND1 -0.058 0.17 -10000 0 -0.4 104 104
MAGED1 0.017 0.001 -10000 0 -10000 0 0
PTPN11 0.017 0 -10000 0 -10000 0 0
RICS 0.012 0.008 -10000 0 -10000 0 0
NT-4/5 (dimer) 0 0 -10000 0 -10000 0 0
SHC/GRB2/SOS1 0 0.074 -10000 0 -0.24 47 47
GRB2 0.017 0.002 -10000 0 -10000 0 0
NGF (dimer)/TRKA/MATK 0.022 0.016 -10000 0 -0.24 2 2
TRKA/NEDD4-2 0.024 0.019 -10000 0 -0.28 2 2
ELMO1 0.011 0.008 -10000 0 -10000 0 0
RhoG/GTP/ELMO1/DOCK1 0.015 0.011 -10000 0 -10000 0 0
NGF 0 0 -10000 0 -10000 0 0
HRAS 0.016 0.019 -10000 0 -0.41 1 1
DOCK1 0.017 0 -10000 0 -10000 0 0
GAB2 0.016 0.019 -10000 0 -0.41 1 1
RIT2 0.007 0.033 -10000 0 -0.41 3 3
RIT1 -0.12 0.2 -10000 0 -0.41 163 163
FRS2 0.015 0.032 -10000 0 -0.41 3 3
DNM1 0.003 0.007 -10000 0 -10000 0 0
mol:GTP 0 0 -10000 0 -10000 0 0
CRK 0.017 0 -10000 0 -10000 0 0
SH2B1 (homopentamer) 0 0 -10000 0 -10000 0 0
RhoG/GTP 0.004 0.04 -10000 0 -0.17 19 19
mol:GDP 0.016 0.048 -10000 0 -0.14 11 11
NGF (dimer) 0 0 -10000 0 -10000 0 0
RhoG/GDP 0.008 0.006 -10000 0 -10000 0 0
RIT1/GDP -0.023 0.08 -10000 0 -0.14 114 114
TIAM1 0.016 0.003 -10000 0 -10000 0 0
PIK3R1 0.016 0.004 -10000 0 -10000 0 0
BDNF (dimer)/TRKB -0.001 0.044 -10000 0 -0.23 12 12
KIDINS220/CRKL/C3G 0.025 0 -10000 0 -10000 0 0
SHC/RasGAP -0.003 0.088 -10000 0 -0.28 47 47
FRS2 family/SHP2 0.033 0.02 -10000 0 -0.23 3 3
SHC/GRB2/SOS1/GAB1 0.009 0.072 -10000 0 -0.21 51 51
RIT1/GTP -0.08 0.14 -10000 0 -0.29 163 163
NT3 (dimer) 0.017 0 -10000 0 -10000 0 0
RAP1/GDP -0.005 0.021 -10000 0 -10000 0 0
KIDINS220/CRKL 0.017 0 -10000 0 -10000 0 0
BDNF (dimer) 0.005 0.008 -10000 0 -10000 0 0
ubiquitin-dependent protein catabolic process 0.022 0.016 -10000 0 -0.24 2 2
Schwann cell development -0.002 0.007 -10000 0 -10000 0 0
EHD4 -0.01 0.1 -10000 0 -0.41 34 34
FRS2 family/GRB2/SOS1 0.031 0.019 -10000 0 -0.21 3 3
FRS2 family/SHP2/CRK family/C3G/GAB2 0.033 0.011 -10000 0 -10000 0 0
RAP1B 0 0 -10000 0 -10000 0 0
RAP1A 0.017 0 -10000 0 -10000 0 0
CDC42/GTP 0.002 0.03 -10000 0 -0.16 9 9
ABL1 0.016 0.019 -10000 0 -0.41 1 1
SH2B family/GRB2/SOS1 0.013 0.001 -10000 0 -10000 0 0
Rap1/GTP 0.005 0.021 -10000 0 -10000 0 0
STAT3 -0.027 0.11 -10000 0 -0.24 104 104
axon guidance 0 0.027 -10000 0 -0.16 9 9
MAPK3 0.019 0.014 -10000 0 -0.21 2 2
MAPK1 0.018 0.014 -10000 0 -0.21 2 2
CDC42/GDP 0.02 0.037 -10000 0 -0.1 6 6
NTF3 0.017 0 -10000 0 -10000 0 0
NTF4 0 0 -10000 0 -10000 0 0
NGF (dimer)/TRKA/FAIM 0.013 0.05 -10000 0 -0.24 20 20
PI3K 0.009 0.065 -10000 0 -0.28 25 25
FRS3 0.017 0 -10000 0 -10000 0 0
FAIM 0.002 0.078 -10000 0 -0.41 18 18
GAB1 0.014 0.037 -10000 0 -0.41 4 4
RASGRF1 0.001 0.045 -10000 0 -0.17 25 25
SOS1 0 0 -10000 0 -10000 0 0
MCF2L 0.018 0.008 -10000 0 -10000 0 0
RGS19 0.017 0 -10000 0 -10000 0 0
CDC42 0.017 0 -10000 0 -10000 0 0
RAS family/GTP 0.001 0.061 -10000 0 -0.18 29 29
Rac1/GDP 0.02 0.037 -10000 0 -0.1 5 5
NGF (dimer)/TRKA/GRIT 0.016 0.019 -10000 0 -0.24 2 2
neuron projection morphogenesis 0 0.064 -10000 0 -0.3 6 6
NGF (dimer)/TRKA/NEDD4-2 0.022 0.016 -10000 0 -0.24 2 2
MAP2K1 0.001 0.064 -10000 0 -0.19 51 51
NGFR -0.001 0.086 -10000 0 -0.41 22 22
NGF (dimer)/TRKA/GIPC/GAIP -0.015 0.052 -10000 0 -0.14 76 76
RAS family/GTP/PI3K -0.023 0.076 -10000 0 -0.14 157 157
FRS2 family/SHP2/GRB2/SOS1 0.039 0.018 -10000 0 -0.19 3 3
NRAS -0.094 0.19 -10000 0 -0.41 137 137
GRB2/SOS1 0.013 0.001 -10000 0 -10000 0 0
PRKCI 0.016 0.019 -10000 0 -0.41 1 1
ChemicalAbstracts:146-91-8 0 0 -10000 0 -10000 0 0
RAC1 0.017 0 -10000 0 -10000 0 0
PRKCZ 0 0 -10000 0 -10000 0 0
MAPKKK cascade 0.003 0.031 -10000 0 -10000 0 0
RASA1 0.017 0.002 -10000 0 -10000 0 0
TRKA/c-Abl 0.024 0.023 -10000 0 -0.28 3 3
SQSTM1 0.016 0.019 -10000 0 -0.41 1 1
BDNF (dimer)/TRKB/GIPC -0.005 0.049 -10000 0 -0.21 15 15
NGF (dimer)/TRKA/p62/Atypical PKCs 0.029 0.02 -10000 0 -0.2 4 4
MATK 0.017 0 -10000 0 -10000 0 0
NEDD4L 0.017 0 -10000 0 -10000 0 0
RAS family/GDP -0.025 0.041 -10000 0 -0.15 25 25
NGF (dimer)/TRKA -0.001 0.046 -10000 0 -0.14 44 44
Rac1/GTP -0.015 0.033 -10000 0 -0.14 15 15
FRS2 family/SHP2/CRK family 0.05 0.018 -10000 0 -0.19 3 3
EPO signaling pathway

Figure S74.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S74.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
BCL2L1 0.033 0.072 -10000 0 -0.24 18 18
CRKL 0.027 0.04 -10000 0 -0.17 19 19
mol:DAG 0.017 0.076 -10000 0 -0.29 13 13
HRAS 0.015 0.068 -10000 0 -0.3 8 8
MAPK8 -0.001 0.079 -10000 0 -0.22 64 64
RAP1A 0.027 0.04 -10000 0 -0.17 19 19
GAB1 0.026 0.043 -10000 0 -0.17 23 23
MAPK14 -0.002 0.08 -10000 0 -0.22 66 66
EPO 0.019 0.007 -10000 0 -10000 0 0
PLCG1 0.017 0.077 -10000 0 -0.3 13 13
EPOR/TRPC2/IP3 Receptors 0.019 0.007 -10000 0 -10000 0 0
RAPGEF1 0.017 0 -10000 0 -10000 0 0
EPO/EPOR (dimer)/SOCS3 0.038 0.006 -10000 0 -10000 0 0
GAB1/SHC/GRB2/SOS1 0.017 0.073 -10000 0 -0.33 8 8
EPO/EPOR (dimer) 0.028 0.011 -10000 0 -10000 0 0
IRS2 0.027 0.039 -10000 0 -0.17 18 18
STAT1 0.019 0.088 -10000 0 -0.31 18 18
STAT5B 0.021 0.077 -10000 0 -0.29 13 13
cell proliferation -0.001 0.074 -10000 0 -0.2 66 66
GAB1/SHIP/PIK3R1/SHP2/SHC 0.012 0.065 -10000 0 -0.3 8 8
TEC 0.027 0.04 -10000 0 -0.17 19 19
SOCS3 0.017 0 -10000 0 -10000 0 0
STAT1 (dimer) 0.019 0.087 -10000 0 -0.3 18 18
JAK2 0.018 0.007 -10000 0 -10000 0 0
PIK3R1 0.016 0.004 -10000 0 -10000 0 0
EPO/EPOR (dimer)/JAK2 0.053 0.047 -10000 0 -0.18 19 19
EPO/EPOR 0.028 0.011 -10000 0 -10000 0 0
LYN -0.033 0.14 -10000 0 -0.41 64 64
TEC/VAV2 0.038 0.04 -10000 0 -0.32 2 2
elevation of cytosolic calcium ion concentration 0.018 0.007 -10000 0 -10000 0 0
SHC1 -0.021 0.12 -10000 0 -0.41 47 47
EPO/EPOR (dimer)/LYN 0.009 0.096 -10000 0 -0.25 64 64
mol:IP3 0.017 0.076 -10000 0 -0.29 13 13
PI3K regualtory subunit polypeptide 1/IRS2/SHIP 0.032 0.036 -10000 0 -0.3 2 2
SH2B3 0.01 0.059 -10000 0 -0.41 10 10
NFKB1 -0.003 0.084 -10000 0 -0.22 66 66
EPO/EPOR (dimer)/JAK2/SOCS3 0.017 0.02 0.16 10 -10000 0 10
PTPN6 0.024 0.041 -10000 0 -0.18 19 19
TEC/VAV2/GRB2 0.045 0.04 -10000 0 -0.3 2 2
EPOR 0.019 0.007 -10000 0 -10000 0 0
INPP5D 0 0 -10000 0 -10000 0 0
mol:GDP 0.017 0.073 -10000 0 -0.33 8 8
SOS1 0 0 -10000 0 -10000 0 0
PLCG2 0.009 0.058 -10000 0 -0.41 10 10
CRKL/CBL/C3G 0.046 0.04 -10000 0 -0.3 2 2
VAV2 0.027 0.04 -10000 0 -0.17 19 19
CBL 0.027 0.04 -10000 0 -0.17 19 19
SHC/Grb2/SOS1 0.008 0.071 -10000 0 -0.19 48 48
STAT5A 0.021 0.078 -10000 0 -0.29 13 13
GRB2 0.017 0.002 -10000 0 -10000 0 0
STAT5 (dimer) 0.038 0.083 -10000 0 -0.3 13 13
LYN/PLCgamma2 -0.016 0.12 -10000 0 -0.32 65 65
PTPN11 0.017 0 -10000 0 -10000 0 0
BTK 0.027 0.042 -10000 0 -0.18 19 19
BCL2 0.033 0.072 -10000 0 -0.24 18 18
Retinoic acid receptors-mediated signaling

Figure S75.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S75.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
HDAC1 -0.036 0.14 -10000 0 -0.41 66 66
HDAC3 0.017 0 -10000 0 -10000 0 0
VDR 0.017 0 -10000 0 -10000 0 0
Cbp/p300/PCAF 0.023 0 -10000 0 -10000 0 0
EP300 0.017 0 -10000 0 -10000 0 0
RARs/AIB1/Cbp/p300/PCAF/9cRA 0.034 0.011 -10000 0 -10000 0 0
KAT2B 0 0 -10000 0 -10000 0 0
MAPK14 0.015 0.026 -10000 0 -0.41 2 2
AKT1 0.068 0.053 0.12 233 -0.12 3 236
RAR alpha/9cRA/Cyclin H 0.012 0.053 -10000 0 -0.2 7 7
mol:9cRA 0 0 -10000 0 -10000 0 0
RARs/Src-1/Cbp/p300/PCAF/9cRA 0.031 0.006 -10000 0 -10000 0 0
CDC2 -0.14 0.21 -10000 0 -0.41 194 194
response to UV 0.001 0.001 -10000 0 -10000 0 0
RAR alpha/Jnk1 0.025 0.005 -10000 0 -10000 0 0
NCOR2 0.017 0 -10000 0 -10000 0 0
VDR/VDR/Vit D3 0.013 0 -10000 0 -10000 0 0
RXRs/RARs/NRIP1/9cRA 0.043 0.036 -10000 0 -0.23 4 4
NCOA2 0.017 0 -10000 0 -10000 0 0
NCOA3 0.015 0.032 -10000 0 -0.41 3 3
NCOA1 0.017 0.003 -10000 0 -10000 0 0
VDR/VDR/DNA 0.017 0 -10000 0 -10000 0 0
RARG 0.018 0.001 -10000 0 -10000 0 0
RAR gamma1/9cRA 0.024 0.001 -10000 0 -10000 0 0
MAPK3 0.018 0.001 -10000 0 -10000 0 0
MAPK1 0.017 0.003 -10000 0 -10000 0 0
MAPK8 0.018 0.002 -10000 0 -10000 0 0
mol:Vit D3 0 0 -10000 0 -10000 0 0
RXRs/VDR/DNA/Vit D3 0.011 0.052 -10000 0 -0.23 4 4
RARA 0.025 0.005 -10000 0 -10000 0 0
negative regulation of phosphoinositide 3-kinase cascade 0 0 -10000 0 -10000 0 0
RARs/TIF2/Cbp/p300/PCAF/9cRA 0.032 0.004 -10000 0 -10000 0 0
PRKCA 0.019 0.004 -10000 0 -10000 0 0
RXRs/RARs/NRIP1/9cRA/HDAC1 0.022 0.045 -10000 0 -0.32 4 4
RXRG 0.025 0.016 -10000 0 -0.17 3 3
RXRA -0.014 0.061 -10000 0 -0.2 4 4
RXRB 0.026 0.005 -10000 0 -10000 0 0
VDR/Vit D3/DNA 0.013 0 -10000 0 -10000 0 0
RBP1 -0.18 0.21 -10000 0 -0.41 237 237
CRBP1/9-cic-RA -0.12 0.15 -10000 0 -0.29 237 237
RARB 0.019 0.002 -10000 0 -10000 0 0
PRKCG 0.019 0.004 -10000 0 -10000 0 0
MNAT1 0.016 0.019 -10000 0 -0.41 1 1
RAR alpha/RXRs 0.056 0.059 -10000 0 -0.23 1 1
RXRs/RARs/SMRT(N-CoR2)/9cRA 0.049 0.028 -10000 0 -0.14 1 1
proteasomal ubiquitin-dependent protein catabolic process 0.036 0.01 -10000 0 -10000 0 0
RXRs/RARs/NRIP1/9cRA/HDAC3 0.028 0.038 -10000 0 -0.3 4 4
positive regulation of DNA binding 0.007 0.048 -10000 0 -0.19 7 7
NRIP1 0.032 0.043 -10000 0 -0.4 4 4
RXRs/RARs 0.028 0.032 -10000 0 -0.23 4 4
RXRs/RXRs/DNA/9cRA 0.004 0.051 -10000 0 -0.24 4 4
PRKACA 0.017 0 -10000 0 -10000 0 0
CDK7 0.015 0.026 -10000 0 -0.41 2 2
TFIIH 0.033 0.02 -10000 0 -0.23 3 3
RAR alpha/9cRA 0.045 0.016 -10000 0 -0.16 3 3
CCNH 0.017 0.001 -10000 0 -10000 0 0
CREBBP 0.017 0 -10000 0 -10000 0 0
RAR gamma2/9cRA 0.032 0.02 -10000 0 -0.17 5 5
TCR signaling in naïve CD8+ T cells

Figure S76.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S76.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
GRB2/SOS1/SHC 0.016 0.071 -9999 0 -0.2 34 34
FYN 0.011 0.079 -9999 0 -0.25 26 26
LAT/GRAP2/SLP76 0.026 0.074 -9999 0 -0.22 35 35
IKBKB 0.017 0 -9999 0 -10000 0 0
AKT1 0.029 0.054 -9999 0 -0.2 15 15
B2M 0.018 0.004 -9999 0 -10000 0 0
IKBKG 0.016 0.026 -9999 0 -0.086 12 12
MAP3K8 -0.017 0.12 -9999 0 -0.41 42 42
mol:Ca2+ -0.001 0.006 -9999 0 -10000 0 0
integrin-mediated signaling pathway 0.011 0 -9999 0 -10000 0 0
LAT/GRAP2/SLP76/VAV1/PI3K Class IA 0.029 0.068 -9999 0 -0.26 16 16
TRPV6 0.002 0.003 -9999 0 -10000 0 0
CD28 0.017 0.001 -9999 0 -10000 0 0
SHC1 0.011 0.081 -9999 0 -0.23 34 34
receptor internalization 0.029 0.046 -9999 0 -0.24 8 8
PRF1 0.027 0.073 -9999 0 -0.41 13 13
KRAS 0.017 0.002 -9999 0 -10000 0 0
GRB2 0.017 0.002 -9999 0 -10000 0 0
COT/AKT1 0.022 0.076 -9999 0 -0.2 47 47
LAT 0.027 0.055 -9999 0 -0.24 11 11
EntrezGene:6955 0.001 0.002 -9999 0 -10000 0 0
CD3D 0.002 0.083 -9999 0 -0.42 20 20
CD3E 0.017 0.019 -9999 0 -0.42 1 1
CD3G 0.017 0.019 -9999 0 -0.42 1 1
RASGRP2 0.01 0.008 -9999 0 -10000 0 0
RASGRP1 -0.006 0.076 -9999 0 -0.23 30 30
HLA-A 0.017 0.019 -9999 0 -0.41 1 1
RASSF5 0 0 -9999 0 -10000 0 0
RAP1A/GTP/RAPL 0.012 0 -9999 0 -10000 0 0
mol:GTP 0 0 -9999 0 -10000 0 0
mol:GDP 0.004 0.032 -9999 0 -0.079 29 29
PDK1/CARD11/BCL10/MALT1/TRAF6 -0.01 0.03 -9999 0 -0.12 21 21
PRKCA 0.021 0.042 -9999 0 -0.14 24 24
GRAP2 0.017 0 -9999 0 -10000 0 0
mol:IP3 -0.014 0.047 -9999 0 -0.2 24 24
EntrezGene:6957 0.001 0.003 -9999 0 -10000 0 0
TCR/CD3/MHC I/CD8 0.025 0.039 -9999 0 -0.26 6 6
ORAI1 0 0 -9999 0 -10000 0 0
CSK 0.026 0.055 -9999 0 -0.22 14 14
B7 family/CD28 0.033 0.082 -9999 0 -0.23 37 37
CHUK 0.016 0.019 -9999 0 -0.41 1 1
TCR/CD3/MHC I/CD8/LCK/ZAP-70 0.025 0.059 -9999 0 -0.24 14 14
PTPN6 0.02 0.07 -9999 0 -0.3 17 17
VAV1 0.027 0.056 -9999 0 -0.22 15 15
Monovalent TCR/CD3 0.017 0.041 -9999 0 -0.17 20 20
CBL 0.017 0 -9999 0 -10000 0 0
LCK 0.01 0.079 -9999 0 -0.25 26 26
PAG1 0.024 0.055 -9999 0 -0.23 14 14
RAP1A 0.017 0 -9999 0 -10000 0 0
TCR/CD3/MHC I/CD8/LCK 0.023 0.062 -9999 0 -0.23 19 19
CD80 0.017 0.019 -9999 0 -0.41 1 1
CD86 -0.003 0.091 -9999 0 -0.41 25 25
PDK1/CARD11/BCL10/MALT1 -0.011 0.036 -9999 0 -0.14 23 23
HRAS 0.016 0.019 -9999 0 -0.41 1 1
GO:0035030 0.019 0.07 -9999 0 -0.2 37 37
CD8A 0.001 0.003 -9999 0 -10000 0 0
CD8B 0.016 0.027 -9999 0 -0.42 2 2
PTPRC -0.086 0.18 -9999 0 -0.41 127 127
PDK1/PKC theta 0.033 0.063 -9999 0 -0.24 15 15
CSK/PAG1 0.026 0.053 -9999 0 -0.22 14 14
SOS1 0 0 -9999 0 -10000 0 0
peptide-MHC class I 0.026 0.015 -9999 0 -0.28 1 1
GRAP2/SLP76 0.027 0.08 -9999 0 -0.24 35 35
STIM1 0.002 0.003 -9999 0 -10000 0 0
RAS family/GTP -0.006 0.053 -9999 0 -0.11 48 48
TCR/CD3/MHC I/CD8/LCK/ZAP-70/CBL/ubiquitin 0.029 0.047 -9999 0 -0.25 8 8
mol:DAG -0.013 0.044 -9999 0 -0.16 35 35
RAP1A/GDP 0.004 0.015 -9999 0 -0.043 9 9
PLCG1 0.017 0 -9999 0 -10000 0 0
CD247 0.016 0.027 -9999 0 -0.42 2 2
cytotoxic T cell degranulation 0.027 0.071 -9999 0 -0.4 13 13
RAP1A/GTP 0 0.002 -9999 0 -10000 0 0
mol:PI-3-4-5-P3 0.029 0.061 -9999 0 -0.23 16 16
LAT/GRAP2/SLP76/VAV1/PLCgamma1 -0.015 0.058 -9999 0 -0.24 24 24
NRAS -0.094 0.19 -9999 0 -0.41 137 137
ZAP70 0.017 0 -9999 0 -10000 0 0
GRB2/SOS1 0.013 0.001 -9999 0 -10000 0 0
LAT/GRAP2/SLP76/VAV1 0.023 0.071 -9999 0 -0.21 35 35
MALT1 -0.003 0.091 -9999 0 -0.41 25 25
TRAF6 0.017 0 -9999 0 -10000 0 0
CD8 heterodimer 0.013 0.019 -9999 0 -0.29 2 2
CARD11 0 0 -9999 0 -10000 0 0
PRKCB -0.01 0.032 -9999 0 -0.12 35 35
PRKCE 0.021 0.042 -9999 0 -0.14 24 24
PRKCQ 0.031 0.067 -9999 0 -0.26 15 15
LCP2 -0.007 0.099 -9999 0 -0.41 30 30
BCL10 0.015 0.032 -9999 0 -0.41 3 3
regulation of survival gene product expression 0.028 0.049 -9999 0 -0.18 15 15
IKK complex 0.025 0.022 -9999 0 -0.066 8 8
RAS family/GDP -0.013 0.02 -9999 0 -0.046 136 136
MAP3K14 0.021 0.061 -9999 0 -0.16 44 44
PDPK1 0.03 0.053 -9999 0 -0.19 15 15
TCR/CD3/MHC I/CD8/Fyn 0.028 0.051 -9999 0 -0.26 9 9
Lissencephaly gene (LIS1) in neuronal migration and development

Figure S77.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S77.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
DYNC1H1 0.017 0.002 -9999 0 -10000 0 0
VLDLR 0.015 0.032 -9999 0 -0.41 3 3
LRPAP1 0.017 0 -9999 0 -10000 0 0
NUDC 0.017 0 -9999 0 -10000 0 0
RELN/LRP8 0.015 0.026 -9999 0 -0.23 3 3
CaM/Ca2+ 0.012 0.003 -9999 0 -10000 0 0
KATNA1 0.012 0.045 -9999 0 -0.41 6 6
GO:0030286 0 0 -9999 0 -10000 0 0
ABL1 0.01 0.019 -9999 0 -0.21 2 2
IQGAP1/CaM -0.047 0.13 -9999 0 -0.28 118 118
DAB1 0.017 0 -9999 0 -10000 0 0
IQGAP1 -0.086 0.18 -9999 0 -0.41 127 127
PLA2G7 0.011 0.052 -9999 0 -0.41 8 8
CALM1 0.016 0.004 -9999 0 -10000 0 0
DYNLT1 -0.044 0.15 -9999 0 -0.41 75 75
mol:Ca2+ 0 0 -9999 0 -10000 0 0
LRPAP1/LRP8 0.025 0 -9999 0 -10000 0 0
UniProt:Q4QZ09 0 0 -9999 0 -10000 0 0
CLIP1 0.017 0 -9999 0 -10000 0 0
CDK5R1 0.014 0.007 -9999 0 -10000 0 0
LIS1/Poliovirus Protein 3A 0.013 0.001 -9999 0 -10000 0 0
CDK5R2 0.007 0.008 -9999 0 -10000 0 0
mol:PP1 0 0 -9999 0 -10000 0 0
RELN/VLDLR/DAB1 0.014 0.029 -9999 0 -0.23 4 4
YWHAE 0.017 0.001 -9999 0 -10000 0 0
NDEL1/14-3-3 E 0.025 0.045 -9999 0 -10000 0 0
MAP1B 0.006 0.002 -9999 0 -10000 0 0
RAC1 -0.01 0.048 -9999 0 -0.096 127 127
p35/CDK5 0.013 0.019 -9999 0 -0.18 1 1
RELN 0.006 0.033 -9999 0 -0.41 3 3
PAFAH/LIS1 0.022 0.032 -9999 0 -0.23 8 8
LIS1/CLIP170 0.026 0.003 -9999 0 -10000 0 0
LIS1/NDEL1/Katanin 60/Dynein Light chain/Dynein heavy chain -0.004 0.039 -9999 0 -0.27 1 1
RELN/VLDLR/DAB1/LIS1/PAFAH1B2/PAFAH1B3 0.015 0.02 -9999 0 -0.11 3 3
GO:0005869 0 0 -9999 0 -10000 0 0
NDEL1 0.023 0.043 -9999 0 -0.16 1 1
LIS1/IQGAP1 -0.037 0.11 -9999 0 -0.23 127 127
RHOA -0.01 0.048 -9999 0 -0.096 127 127
PAFAH1B1 0.017 0.002 -9999 0 -10000 0 0
PAFAH1B3 0.016 0.019 -9999 0 -0.41 1 1
PAFAH1B2 0.017 0 -9999 0 -10000 0 0
MAP1B/LIS1/Dynein heavy chain 0.023 0.008 -9999 0 -10000 0 0
NDEL1/Katanin 60/Dynein heavy chain 0.025 0.047 -9999 0 -10000 0 0
LRP8 0.017 0 -9999 0 -10000 0 0
NDEL1/Katanin 60 0.024 0.047 -9999 0 -10000 0 0
P39/CDK5 0.006 0.016 -9999 0 -0.18 1 1
LIS1/NudC/Dynein intermediate chain/microtubule organizing center 0.026 0.003 -9999 0 -10000 0 0
CDK5 0.009 0.017 -9999 0 -0.19 2 2
PPP2R5D 0.017 0 -9999 0 -10000 0 0
LIS1/CLIP170/Dynein Complex/Dynactin Complex 0.022 0.002 -9999 0 -10000 0 0
CSNK2A1 0.017 0 -9999 0 -10000 0 0
RELN/VLDLR/DAB1/LIS1 0.019 0.029 -9999 0 -0.19 4 4
RELN/VLDLR 0.019 0.03 -9999 0 -0.21 4 4
CDC42 -0.01 0.048 -9999 0 -0.096 127 127
Regulation of p38-alpha and p38-beta

Figure S78.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S78.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
RIP1/MEKK3 0.019 0.034 -9999 0 -0.24 9 9
response to insulin stimulus 0 0 -9999 0 -10000 0 0
RIPK1 0.01 0.055 -9999 0 -0.41 9 9
response to stress 0 0 -9999 0 -10000 0 0
MAP2K6 0.017 0 -9999 0 -10000 0 0
mol:GTP 0 0 -9999 0 -10000 0 0
MAP2K4 0.016 0.003 -9999 0 -10000 0 0
RAC1-CDC42/GTP/PAK family -0.002 0.027 -9999 0 -0.12 23 23
response to UV 0 0 -9999 0 -10000 0 0
YES1 -0.048 0.15 -9999 0 -0.41 80 80
interleukin-1 receptor activity 0 0 -9999 0 -10000 0 0
tumor necrosis factor receptor activity 0 0 -9999 0 -10000 0 0
MAP3K3 0.017 0 -9999 0 -10000 0 0
FYN 0.015 0.026 -9999 0 -0.41 2 2
MAP3K12 0.017 0 -9999 0 -10000 0 0
FGR 0.003 0.076 -9999 0 -0.41 17 17
p38 alpha/TAB1 -0.003 0.067 -9999 0 -0.16 44 44
PRKG1 0.017 0 -9999 0 -10000 0 0
DUSP8 0.013 0.007 -9999 0 -10000 0 0
PGK/cGMP/p38 alpha -0.005 0.064 -9999 0 -0.16 45 45
apoptosis -0.003 0.065 -9999 0 -0.16 44 44
RAL/GTP 0.001 0.073 -9999 0 -0.24 45 45
LYN -0.035 0.14 -9999 0 -0.41 64 64
DUSP1 0.002 0.078 -9999 0 -0.41 18 18
PAK1 0.017 0 -9999 0 -10000 0 0
SRC 0.017 0 -9999 0 -10000 0 0
RAC1/OSM/MEKK3/MKK3 0.033 0 -9999 0 -10000 0 0
TRAF6 0.017 0 -9999 0 -10000 0 0
RAC1 0.017 0 -9999 0 -10000 0 0
epidermal growth factor receptor activity 0 0 -9999 0 -10000 0 0
mol:LPS 0 0 -9999 0 -10000 0 0
mol:cGMP 0 0 -9999 0 -10000 0 0
CCM2 0 0 -9999 0 -10000 0 0
RAC1-CDC42/GTP 0.023 0 -9999 0 -10000 0 0
MAPK11 -0.014 0.076 -9999 0 -0.18 52 52
BLK 0.017 0 -9999 0 -10000 0 0
HCK -0.053 0.16 -9999 0 -0.41 86 86
MAP2K3 0.017 0 -9999 0 -10000 0 0
DUSP16 0 0 -9999 0 -10000 0 0
DUSP10 0.011 0.049 -9999 0 -0.41 7 7
TRAF6/MEKK3 0.022 0 -9999 0 -10000 0 0
MAP3K7IP1 0.017 0 -9999 0 -10000 0 0
MAPK14 -0.01 0.07 -9999 0 -0.15 72 72
positive regulation of innate immune response -0.015 0.086 -9999 0 -0.2 57 57
LCK 0.014 0.037 -9999 0 -0.41 4 4
p38alpha-beta/MKP7 -0.016 0.083 -9999 0 -0.2 57 57
p38alpha-beta/MKP5 -0.01 0.09 -9999 0 -0.21 52 52
PGK/cGMP 0.013 0 -9999 0 -10000 0 0
PAK2 -0.002 0.088 -9999 0 -0.41 23 23
p38alpha-beta/MKP1 -0.013 0.096 -9999 0 -0.23 54 54
CDC42 0.017 0 -9999 0 -10000 0 0
RALB 0.016 0.019 -9999 0 -0.41 1 1
RALA -0.019 0.12 -9999 0 -0.41 44 44
PAK3 0.003 0.006 -9999 0 -10000 0 0
IL2 signaling events mediated by STAT5

Figure S79.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S79.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
GAB2 0.017 0.019 -9999 0 -0.41 1 1
ELF1 0.018 0.055 -9999 0 -0.32 13 13
CCNA2 -0.096 0.19 -9999 0 -0.41 139 139
PIK3CA -0.003 0.091 -9999 0 -0.41 25 25
JAK3 0.018 0 -9999 0 -10000 0 0
PIK3R1 0.016 0.004 -9999 0 -10000 0 0
JAK1 0.018 0.002 -9999 0 -10000 0 0
IL2/IL2R alpha/beta/gamma/JAK1/LCK/JAK3/SHC/GAB2/GRB2/SOS1/SHP2/PI3K 0.039 0.054 -9999 0 -0.2 11 11
SHC1 -0.02 0.12 -9999 0 -0.41 47 47
SP1 0.019 0.039 -9999 0 -0.22 14 14
IL2RA 0.018 0.056 -9999 0 -0.33 13 13
IL2RB 0.014 0.037 -9999 0 -0.41 4 4
SOS1 0.001 0 -9999 0 -10000 0 0
IL2RG 0.01 0.056 -9999 0 -0.41 9 9
G1/S transition of mitotic cell cycle -0.027 0.1 -9999 0 -0.24 55 55
PTPN11 0.018 0 -9999 0 -10000 0 0
CCND2 0.014 0.068 -9999 0 -0.4 14 14
LCK 0.014 0.037 -9999 0 -0.41 4 4
GRB2 0.017 0.002 -9999 0 -10000 0 0
IL2 0.018 0 -9999 0 -10000 0 0
CDK6 0.017 0 -9999 0 -10000 0 0
CCND3 0.042 0.052 -9999 0 -0.26 5 5
p75(NTR)-mediated signaling

Figure S80.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S80.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
Sortilin/TRAF6 0.025 0 -9999 0 -10000 0 0
Necdin/E2F1 0.016 0.012 -9999 0 -10000 0 0
proNGF (dimer)/p75(NTR)/Sortilin/NADE/14-3-3 E 0.03 0.047 -9999 0 -0.19 22 22
NGF (dimer)/p75(NTR)/BEX1 0.007 0.048 -9999 0 -0.21 22 22
NT-4/5 (dimer)/p75(NTR) 0 0.06 -9999 0 -0.29 22 22
IKBKB 0.017 0 -9999 0 -10000 0 0
AKT1 0.001 0.066 -9999 0 -0.2 47 47
IKBKG 0.017 0 -9999 0 -10000 0 0
BDNF 0.005 0.008 -9999 0 -10000 0 0
MGDIs/NGR/p75(NTR)/LINGO1 0.001 0.051 -9999 0 -0.24 22 22
FURIN 0.017 0 -9999 0 -10000 0 0
proBDNF (dimer)/p75(NTR)/Sortilin 0.002 0.04 -9999 0 -0.23 10 10
LINGO1 0 0 -9999 0 -10000 0 0
Sortilin/TRAF6/NRIF -0.014 0.048 -9999 0 -0.34 2 2
proBDNF (dimer) 0.005 0.008 -9999 0 -10000 0 0
NTRK1 0.015 0.026 -9999 0 -0.41 2 2
RTN4R 0 0 -9999 0 -10000 0 0
neuron apoptosis 0.052 0.071 -9999 0 -0.21 12 12
IRAK1 0.017 0.001 -9999 0 -10000 0 0
SHC1 -0.017 0.088 -9999 0 -0.24 67 67
ARHGDIA 0.017 0 -9999 0 -10000 0 0
RhoA/GTP 0.013 0.001 -9999 0 -10000 0 0
Gamma Secretase 0.032 0.068 -9999 0 -0.2 40 40
proNGF (dimer)/p75(NTR)/Sortilin/MAGE-H1 0.021 0.047 -9999 0 -0.21 20 20
MAGEH1 0.016 0.005 -9999 0 -10000 0 0
proNGF (dimer)/p75(NTR)/Sortilin/Necdin 0.012 0.043 -9999 0 -0.21 15 15
Mammalian IAPs/DIABLO 0.018 0.059 -9999 0 -0.21 33 33
proNGF (dimer) 0 0 -9999 0 -10000 0 0
MAGED1 0.017 0.001 -9999 0 -10000 0 0
APP 0.017 0.001 -9999 0 -10000 0 0
NT-4/5 (dimer) 0 0 -9999 0 -10000 0 0
ZNF274 0.013 0.042 -9999 0 -0.41 5 5
RhoA/GDP/RHOGDI 0.018 0.045 -9999 0 -0.2 22 22
NGF 0 0 -9999 0 -10000 0 0
cell cycle arrest 0 0.042 -9999 0 -0.2 22 22
NGF (dimer)/p75(NTR)/TRAF6/RIP2/IRAK 0 0.059 -9999 0 -0.13 93 93
NT-4/5 (dimer)/p75(NTR)/TRAF6 0.012 0.052 -9999 0 -0.24 22 22
NCSTN -0.007 0.099 -9999 0 -0.41 30 30
mol:GTP 0.01 0.051 -9999 0 -0.23 22 22
PSENEN 0.017 0.001 -9999 0 -10000 0 0
mol:ceramide 0.01 0.046 -9999 0 -0.21 22 22
NGF (dimer)/p75(NTR)/TRAF6/RIP2/IRAK/p62/Atypical PKCs 0.021 0.026 -9999 0 -0.098 25 25
p75(NTR)/beta APP 0.012 0.062 -9999 0 -0.28 22 22
BEX1 0.012 0.008 -9999 0 -10000 0 0
mol:GDP -0.004 0.049 -9999 0 -0.24 22 22
NGF (dimer) -0.003 0.087 -9999 0 -0.21 78 78
MGDIs/NGR/p75(NTR)/LINGO1/RHOGDI 0.012 0.047 -9999 0 -0.22 22 22
PIK3R1 0.016 0.004 -9999 0 -10000 0 0
RAC1/GTP 0.011 0.044 -9999 0 -0.2 22 22
MYD88 -0.041 0.15 -9999 0 -0.41 72 72
CHUK 0.016 0.019 -9999 0 -0.41 1 1
NGF (dimer)/p75(NTR)/PKA 0.011 0.051 -9999 0 -0.23 22 22
RHOB 0.013 0.037 -9999 0 -0.41 4 4
RHOA 0.017 0.001 -9999 0 -10000 0 0
MAGE-G1/E2F1 0.013 0 -9999 0 -10000 0 0
NT3 (dimer) 0.017 0 -9999 0 -10000 0 0
TP53 -0.015 0.061 -9999 0 -0.21 38 38
PRDM4 0.01 0.046 -9999 0 -0.21 22 22
BDNF (dimer) -0.012 0.068 -9999 0 -0.23 32 32
PIK3CA -0.003 0.091 -9999 0 -0.41 25 25
SORT1 0.017 0 -9999 0 -10000 0 0
activation of caspase activity 0.027 0.046 -9999 0 -0.19 22 22
proNGF (dimer)/p75(NTR)/Sortilin/TRAF6 0.023 0.049 -9999 0 -0.21 22 22
RHOC -0.12 0.2 -9999 0 -0.41 164 164
XIAP 0 0 -9999 0 -10000 0 0
MAPK10 0.044 0.06 -9999 0 -10000 0 0
DIABLO 0.017 0 -9999 0 -10000 0 0
SMPD2 0.01 0.046 -9999 0 -0.21 22 22
APH1B 0.017 0 -9999 0 -10000 0 0
APH1A 0.008 0.061 -9999 0 -0.41 11 11
proNGF (dimer)/p75(NTR)/Sortilin 0.012 0.052 -9999 0 -0.24 22 22
PSEN1 0.016 0.019 -9999 0 -0.41 1 1
APAF-1/Pro-Caspase 9 0.023 0.027 -9999 0 -0.28 4 4
NT3 (dimer)/p75(NTR) 0.013 0.062 -9999 0 -0.28 22 22
MAPK8 0.081 0.053 -9999 0 -10000 0 0
MAPK9 0.08 0.053 -9999 0 -10000 0 0
APAF1 0.017 0 -9999 0 -10000 0 0
NTF3 0.017 0 -9999 0 -10000 0 0
NTF4 0 0 -9999 0 -10000 0 0
NDN 0.011 0.008 -9999 0 -10000 0 0
RAC1/GDP 0.013 0 -9999 0 -10000 0 0
RhoA-B-C/GDP -0.04 0.11 -9999 0 -0.19 171 171
p75 CTF/Sortilin/TRAF6/NRIF 0.039 0.034 -9999 0 -0.21 10 10
RhoA-B-C/GTP 0.01 0.051 -9999 0 -0.23 22 22
proBDNF (dimer)/p75(NTR)/Sortilin/TRAF6/NRIF 0.007 0.041 -9999 0 -0.19 12 12
proBDNF (dimer)/p75(NTR)/Sortilin/TRAF6 0.006 0.039 -9999 0 -0.21 10 10
PRKACB 0.016 0.005 -9999 0 -10000 0 0
proBDNF (dimer)/p75 ECD 0.005 0.026 -9999 0 -0.23 5 5
ChemicalAbstracts:86-01-1 0 0 -9999 0 -10000 0 0
BIRC3 -0.01 0.1 -9999 0 -0.41 33 33
BIRC2 0.017 0 -9999 0 -10000 0 0
neuron projection morphogenesis -0.007 0.035 -9999 0 -0.18 20 20
BAD 0.082 0.052 -9999 0 -10000 0 0
RIPK2 0.016 0.019 -9999 0 -0.41 1 1
NGFR -0.001 0.086 -9999 0 -0.41 22 22
CYCS 0.014 0.043 -9999 0 -0.19 22 22
ADAM17 0.013 0.042 -9999 0 -0.41 5 5
NGF (dimer)/p75(NTR)/TRAF6/RIP2 0.022 0.05 -9999 0 -0.21 23 23
BCL2L11 0.082 0.052 -9999 0 -10000 0 0
BDNF (dimer)/p75(NTR) -0.002 0.046 -9999 0 -0.2 22 22
PI3K 0.01 0.072 -9999 0 -0.22 43 43
proNGF (dimer)/p75(NTR)/Sortilin/MAGE-G1 0.012 0.047 -9999 0 -0.22 22 22
NDNL2 0 0 -9999 0 -10000 0 0
YWHAE 0.017 0.001 -9999 0 -10000 0 0
PRKCI 0.016 0.019 -9999 0 -0.41 1 1
NGF (dimer)/p75(NTR) 0 0.06 -9999 0 -0.29 22 22
ChemicalAbstracts:146-91-8 0 0 -9999 0 -10000 0 0
proNGF (dimer)/p75(NTR)/Sortilin/NRAGE 0.023 0.049 -9999 0 -0.21 22 22
TRAF6 0.017 0 -9999 0 -10000 0 0
RAC1 0.017 0 -9999 0 -10000 0 0
PRKCZ 0 0 -9999 0 -10000 0 0
PLG 0.017 0 -9999 0 -10000 0 0
oligodendrocyte cell fate commitment 0 0 -9999 0 -10000 0 0
CASP6 -0.007 0.049 -9999 0 -0.2 19 19
SQSTM1 0.016 0.019 -9999 0 -0.41 1 1
NGFRAP1 0.017 0.002 -9999 0 -10000 0 0
CASP3 0.078 0.051 -9999 0 -10000 0 0
E2F1 0.017 0 -9999 0 -10000 0 0
CASP9 0.014 0.037 -9999 0 -0.41 4 4
IKK complex 0.037 0.029 -9999 0 -0.19 3 3
NGF (dimer)/TRKA 0.012 0.019 -9999 0 -0.29 2 2
MMP7 -0.046 0.15 -9999 0 -0.41 78 78
proNGF (dimer)/p75(NTR)/Sortilin/TRAF6/NRIF 0.029 0.052 -9999 0 -0.19 27 27
MMP3 0.011 0.049 -9999 0 -0.41 7 7
APAF-1/Caspase 9 -0.016 0.046 -9999 0 -0.31 1 1
Canonical NF-kappaB pathway

Figure S81.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S81.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
FBXW11 0.019 0.004 -9999 0 -10000 0 0
mol:GTP 0 0 -9999 0 -10000 0 0
NF kappa B1 p50/RelA/I kappa B alpha 0.06 0.024 -9999 0 -0.16 2 2
ERC1 0.016 0.019 -9999 0 -0.41 1 1
RIP2/NOD2 0.02 0.04 -9999 0 -0.28 9 9
NFKBIA 0.025 0.027 -9999 0 -0.24 5 5
BIRC2 0.017 0 -9999 0 -10000 0 0
IKBKB 0.017 0 -9999 0 -10000 0 0
RIPK2 0.016 0.019 -9999 0 -0.41 1 1
IKBKG 0.031 0.024 -9999 0 -0.17 1 1
IKK complex/A20 -0.017 0.1 -9999 0 -0.23 25 25
NEMO/A20/RIP2 0.016 0.019 -9999 0 -0.41 1 1
XPO1 0.017 0 -9999 0 -10000 0 0
NEMO/ATM 0.03 0.051 -9999 0 -0.17 26 26
tumor necrosis factor receptor activity 0 0 -9999 0 -10000 0 0
RAN 0.017 0.001 -9999 0 -10000 0 0
Exportin 1/RanGTP 0.023 0.002 -9999 0 -10000 0 0
IKK complex/ELKS 0.043 0.028 -9999 0 -0.32 1 1
BCL10/MALT1/TRAF6 0.021 0.06 -9999 0 -0.23 28 28
NOD2 0.011 0.052 -9999 0 -0.41 8 8
NFKB1 0.016 0.037 -9999 0 -0.41 4 4
RELA 0.019 0.004 -9999 0 -10000 0 0
MALT1 -0.003 0.091 -9999 0 -0.41 25 25
cIAP1/UbcH5C 0.025 0.001 -9999 0 -10000 0 0
ATM -0.003 0.091 -9999 0 -0.41 25 25
TNF/TNFR1A -0.083 0.15 -9999 0 -0.28 185 185
TRAF6 0.017 0 -9999 0 -10000 0 0
PRKCA 0.017 0 -9999 0 -10000 0 0
CHUK 0.016 0.019 -9999 0 -0.41 1 1
UBE2D3 0.017 0.001 -9999 0 -10000 0 0
TNF 0.015 0.026 -9999 0 -0.41 2 2
NF kappa B1 p50/RelA 0.042 0.026 -9999 0 -0.22 5 5
BCL10 0.015 0.032 -9999 0 -0.41 3 3
proteasomal ubiquitin-dependent protein catabolic process 0.025 0.027 -9999 0 -0.24 5 5
beta TrCP1/SCF ubiquitin ligase complex 0.019 0.004 -9999 0 -10000 0 0
TNFRSF1A -0.13 0.2 -9999 0 -0.41 183 183
IKK complex 0.048 0.027 -9999 0 -0.15 2 2
CYLD 0.017 0 -9999 0 -10000 0 0
IKK complex/PKC alpha 0.053 0.028 -9999 0 -10000 0 0
ErbB4 signaling events

Figure S82.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S82.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
ErbB4/ErbB4/HBEGF/HBEGF 0.029 0.028 -10000 0 -0.22 3 3
epithelial cell differentiation 0.032 0.031 -10000 0 -0.21 1 1
ITCH 0.018 0.02 -10000 0 -0.41 1 1
WWP1 0.025 0.025 -10000 0 -0.26 2 2
FYN 0.015 0.026 -10000 0 -0.41 2 2
EGFR -0.14 0.21 -10000 0 -0.41 194 194
PRL 0.012 0.045 -10000 0 -0.41 6 6
neuron projection morphogenesis 0.021 0.059 -10000 0 -0.2 6 6
PTPRZ1 -0.003 0.087 -10000 0 -0.41 23 23
ErbB4/ErbB4/neuregulin 1 beta/neuregulin 1 beta/GRB2/SHC 0.032 0.068 -10000 0 -0.21 8 8
ErbB4 CYT2/ErbB4 CYT2/neuregulin 1 beta/neuregulin 1 beta 0.026 0.028 -10000 0 -0.21 6 6
ADAM17 0.014 0.041 -10000 0 -0.4 5 5
ErbB4/ErbB4 0.026 0.025 -10000 0 -0.24 2 2
ErbB4/ErbB4/neuregulin 3/neuregulin 3 0.017 0.023 -10000 0 -0.26 1 1
NCOR1 0.017 0 -10000 0 -10000 0 0
ErbB4/ErbB4/neuregulin 1 beta/neuregulin 1 beta/Fyn 0.034 0.026 -10000 0 -0.2 4 4
GRIN2B 0.033 0.024 -10000 0 -0.21 2 2
ErbB4/ErbB2/betacellulin 0.035 0.027 -10000 0 -0.2 4 4
STAT1 0.002 0.078 -10000 0 -0.41 18 18
HBEGF 0.015 0.026 -10000 0 -0.41 2 2
PRLR 0.017 0 -10000 0 -10000 0 0
E4ICDs/ETO2 0.029 0.025 -10000 0 -0.26 1 1
axon guidance 0.023 0.031 -10000 0 -0.27 1 1
NEDD4 0.007 0.069 -10000 0 -0.41 14 14
Prolactin receptor/Prolactin receptor/Prolactin 0.022 0.033 -10000 0 -0.28 6 6
CBFA2T3 0.017 0 -10000 0 -10000 0 0
ErbB4/ErbB2/HBEGF 0.034 0.03 -10000 0 -0.22 2 2
MAPK3 0.022 0.061 -10000 0 -0.2 8 8
STAT1 (dimer) 0.021 0.051 -10000 0 -0.22 19 19
MAPK1 0.021 0.061 -10000 0 -0.2 7 7
JAK2 0.017 0 -10000 0 -10000 0 0
ErbB4/ErbB2/neuregulin 1 beta 0.03 0.026 -10000 0 -0.2 4 4
NRG1 0.016 0.028 -10000 0 -0.27 5 5
NRG3 0 0 -10000 0 -10000 0 0
NRG2 0.017 0 -10000 0 -10000 0 0
NRG4 0 0 -10000 0 -10000 0 0
heart development 0.023 0.031 -10000 0 -0.27 1 1
neural crest cell migration 0.029 0.026 -10000 0 -0.2 4 4
ERBB2 0.016 0.028 -10000 0 -0.27 5 5
WWOX/E4ICDs 0.029 0.025 -10000 0 -0.26 1 1
SHC1 -0.021 0.12 -10000 0 -0.41 47 47
ErbB4/EGFR/neuregulin 4 -0.054 0.11 -10000 0 -0.19 194 194
apoptosis -0.022 0.026 0.2 2 -10000 0 2
ErbB4/ErbB4/neuregulin 2 beta/neuregulin 2 beta 0.029 0.025 -10000 0 -0.26 1 1
ErbB4/ErbB2/epiregulin 0.031 0.043 -10000 0 -0.21 14 14
ErbB4/ErbB4/betacellulin/betacellulin 0.029 0.025 -10000 0 -0.26 1 1
ErbB4/ErbB4/HBEGF/HBEGF/Prolactin receptor/Prolactin receptor/Prolactin/JAK2 0.05 0.035 -10000 0 -0.21 1 1
MDM2 0.018 0.047 -10000 0 -0.21 20 20
ErbB4 JM-B/ErbB4 JM-B/neuregulin 1 beta/neuregulin 1 beta 0.03 0.027 -10000 0 -0.19 7 7
STAT5A 0.027 0.031 -10000 0 -0.25 1 1
ErbB4/EGFR/neuregulin 1 beta -0.046 0.11 -10000 0 -0.19 195 195
DLG4 0.017 0 -10000 0 -10000 0 0
GRB2/SHC -0.002 0.088 -10000 0 -0.28 47 47
E4ICDs/TAB2/NCoR1 0.038 0.023 -10000 0 -0.24 1 1
STAT5A (dimer) 0.047 0.036 -10000 0 -0.22 1 1
MAP3K7IP2 0.017 0 -10000 0 -10000 0 0
STAT5B (dimer) 0.034 0.031 -10000 0 -0.25 1 1
LRIG1 -0.002 0.087 -10000 0 -0.41 23 23
EREG 0.009 0.058 -10000 0 -0.41 10 10
BTC 0.017 0 -10000 0 -10000 0 0
ErbB4/ErbB4/neuregulin 1 beta/neuregulin 1 beta 0.023 0.031 -10000 0 -0.27 1 1
ERBB4 0.026 0.025 -10000 0 -0.24 2 2
STAT5B 0.017 0 -10000 0 -10000 0 0
YAP1 -0.001 0.061 -10000 0 -0.2 46 46
GRB2 0.017 0.002 -10000 0 -10000 0 0
ErbB4/ErbB2/neuregulin 4 0.023 0.026 -10000 0 -0.2 6 6
glial cell differentiation -0.038 0.023 0.24 1 -10000 0 1
WWOX 0.017 0 -10000 0 -10000 0 0
cell proliferation 0.033 0.025 -10000 0 -0.2 1 1
IL4-mediated signaling events

Figure S83.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S83.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
BCL2L1 -0.053 0.22 -10000 0 -0.71 11 11
STAT6 (cleaved dimer) -0.11 0.16 -10000 0 -0.69 13 13
IGHG1 -0.015 0.12 -10000 0 -0.39 13 13
IGHG3 -0.058 0.21 -10000 0 -0.69 11 11
AKT1 -0.004 0.15 -10000 0 -0.5 8 8
IL4/IL4R/JAK1/IL2R gamma/JAK3/SHP1 0.015 0.11 -10000 0 -0.37 13 13
IL4/IL4R/JAK1/IL2R gamma/JAK3/IRS1 -0.008 0.14 -10000 0 -0.46 8 8
THY1 -0.076 0.28 -10000 0 -0.7 46 46
MYB 0.011 0.052 -10000 0 -0.41 8 8
HMGA1 0.016 0.019 -10000 0 -0.41 1 1
IL4/IL4R/JAK1/IL2R gamma/JAK3 -0.013 0.16 -10000 0 -0.46 14 14
IL4/IL4R/JAK1/IL2R gamma/JAK3/SHIP -0.011 0.14 -10000 0 -0.46 8 8
SP1 -0.021 0.045 -10000 0 -10000 0 0
INPP5D 0 0 -10000 0 -10000 0 0
SOCS5 0.015 0.013 -10000 0 -10000 0 0
STAT6 (dimer)/ETS1 -0.041 0.21 -10000 0 -0.71 11 11
SOCS1 -0.012 0.18 -10000 0 -0.54 9 9
SOCS3 -0.006 0.14 -10000 0 -0.5 6 6
FCER2 -0.034 0.19 -10000 0 -0.69 6 6
PARP14 0.001 0.001 -10000 0 -10000 0 0
CCL17 -0.053 0.22 -10000 0 -0.71 11 11
GRB2 0.017 0.002 -10000 0 -10000 0 0
IL4/IL4R/JAK1/IL2R gamma/JAK3/SHC/SHIP -0.015 0.14 -10000 0 -0.38 22 22
T cell proliferation -0.042 0.22 -10000 0 -0.78 9 9
IL4R/JAK1 -0.056 0.22 -10000 0 -0.72 12 12
EGR2 -0.057 0.24 -10000 0 -0.71 17 17
JAK2 0.012 0.03 -10000 0 -10000 0 0
JAK3 0.021 0.003 -10000 0 -10000 0 0
PIK3R1 0.016 0.004 -10000 0 -10000 0 0
JAK1 0.017 0.013 -10000 0 -10000 0 0
COL1A2 -0.15 0.23 -10000 0 -0.46 118 118
CCL26 -0.059 0.22 -10000 0 -0.7 12 12
IL4R -0.06 0.24 -10000 0 -0.73 14 14
PTPN6 0.01 0.06 -10000 0 -0.4 11 11
IL13RA2 -0.13 0.28 -10000 0 -0.67 42 42
IL13RA1 -0.054 0.16 -10000 0 -0.43 80 80
IRF4 0.017 0.075 -10000 0 -0.62 1 1
ARG1 0.002 0.11 -10000 0 -0.38 13 13
CBL -0.016 0.15 -10000 0 -0.48 10 10
GTF3A 0.014 0.027 -10000 0 -10000 0 0
PIK3CA -0.003 0.091 -10000 0 -0.41 25 25
IL13RA1/JAK2 -0.029 0.12 -10000 0 -0.3 80 80
IRF4/BCL6 0.013 0.078 -10000 0 -0.35 4 4
CD40LG 0.024 0.003 -10000 0 -10000 0 0
MAPK14 -0.012 0.15 -10000 0 -0.48 10 10
mitosis -0.002 0.15 -10000 0 -0.48 8 8
STAT6 -0.052 0.24 -10000 0 -0.57 39 39
SPI1 0.016 0.053 -10000 0 -0.41 8 8
RPS6KB1 0 0.14 -10000 0 -0.46 9 9
STAT6 (dimer) -0.038 0.24 -10000 0 -0.57 40 40
STAT6 (dimer)/PARP14 -0.067 0.22 -10000 0 -0.74 11 11
mast cell activation 0 0.01 -10000 0 -10000 0 0
IL4/IL4R/JAK1/IL2R gamma/JAK3/DOK2 -0.001 0.13 -10000 0 -0.42 11 11